Other receivables (Note 1)

23,909

36,229

44,795

65,247

Other current assets (Notes 1 & 9)

30,815

26,264

1,843,805

1,461,605

Goodwill (Notes 1, 6 & 7)

1,374,112

1,391,932

2,173,889

^[1]

2,173,914

Long-term investments (Notes 1 & 3)

860,336

1,400,563

63,765

35,494

Other non-current assets (Notes 9 & 12)

65,612

58,815

6,381,519

6,522,323

Current liabilities:

Accrued liabilities (Notes 1, 9, 10, & 11)

213,193

216,246

167,182

170,584

Other current liabilities (Note 12)

60,904

31,998

441,279

418,828

Deferred tax liabilities (Note 12)

983,290

989,154

63,084

131,511

Other long-term liabilities (Notes 9, 10, 11 & 12)

118,302

86,108

Commitments and contingent liabilities (Note 10)

1,605,955

1,625,601

Stockholders’ equity:

Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding

Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 126,322 and 126,464 shares issued and outstanding at March 31, 2018 and April 1, 2017, respectively

5,237,085

5,357,394

Accumulated other comprehensive loss, net of tax

(2,752)

(4,306)

Accumulated deficit

(458,769)

(456,366)

4,775,564

4,896,722

$ 6,381,519

$ 6,522,323

[1]	The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 134	$ 58
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	405,000,000	405,000,000
Common stock, shares issued	126,322,000	126,464,000
Common stock, shares outstanding	126,322,000	126,464,000

Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 30, 2017

Sep. 30, 2017

Jul. 01, 2017

Apr. 01, 2017

Dec. 31, 2016

Oct. 01, 2016

Jul. 02, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Income Statement [Abstract]

$ 665,383

$ 845,739

$ 821,583

$ 640,831

$ 642,992

$ 826,347

$ 864,698

$ 698,537

$ 2,973,536

$ 3,032,574

$ 2,610,726

Cost of goods sold

1,826,570

1,897,062

1,561,173

Gross profit

252,640

336,927

321,022

236,377

231,596

310,642

316,799

276,475

1,146,966

1,135,512

1,049,553

Operating expenses:

445,103

470,836

448,763

Other operating expense (Notes 6 & 11)

527,751

545,588

534,099

103,830

31,029

54,723

1,076,684

1,047,453

1,037,585

Interest expense (Note 8)

70,282

88,059

11,968

(59,548)

(58,879)

(23,316)

7,017

1,212

2,068

(606)

(3,087)

6,418

Income tax expense (Note 12)

17,145

27,305

(2,862)

31,200

(98,500)

93,200

(123,200)

(57,433)

(43,863)

(25,983)

Weighted average shares of common stock outstanding (Note 13):

$ (12,501)

^{[1],[2],[3],[4]}

$ (33,082)

^{[2],[3],[4],[5]}

$ 35,919

^[2],[3],[4]

$ (30,624)

^[2],[3],[4]

$ 55,908

^{[2],[3],[4],[6]}

$ (78,638)

^{[2],[3],[4],[7]}

$ 11,847

^[2],[3],[4]

$ (5,675)

^[2],[3],[4]

$ (40,288)

$ (16,558)

$ (28,845)

Net loss per share (Note 13):

Basic

$ (0.10)

$ (0.26)

$ 0.28

$ (0.24)

$ 0.44

$ (0.62)

$ 0.09

$ (0.04)

$ (0.32)

$ (0.13)

$ (0.20)

Diluted

$ (0.10)

$ (0.26)

$ 0.27

$ (0.24)

$ 0.43

$ (0.62)

$ 0.09

$ (0.04)

$ (0.32)

$ (0.13)

$ (0.20)

Basic

126,946

127,121

141,937

Diluted

126,946

127,121

141,937

[1]	Income tax benefit of $31.2 million for the fourth quarter of fiscal 2018 relates primarily to a discrete provisional benefit for adjustments to a third quarter fiscal 2018 provisional estimate of the impact of the Tax Act (Note 12).
[2]	The Company recorded integration related expenses of $1.5 million, $1.8 million, $1.7 million and $1.2 million in the first, second, third and fourth quarters of fiscal 2018, respectively, associated with the Business Combination. The Company recorded integration related expenses of $5.3 million, $5.0 million, $3.9 million and $2.7 million in the first, second, third and fourth quarters of fiscal 2017, respectively, associated with the Business Combination (Note 6).
[3]	The Company recorded restructuring expenses of $0.5 million, $10.5 million, $15.2 million and $41.5 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded restructuring expenses of $0.8 million, $0.5 million, $0.4 million and $0.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively (Note 11).
[4]	The Company recorded start-up expenses of $6.6 million, $7.2 million, $5.4 million and $5.1 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded start-up expenses of $2.1 million, $2.0 million, $2.2 million and $3.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively.
[5]	Income tax expense of $98.5 million for the third quarter of fiscal 2018 relates primarily to a discrete provisional tax expense related to the enactment of the Tax Act (Note 12).
[6]	Income tax benefit of $93.2 million for the fourth quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).
[7]	Income tax expense of $123.2 million for the third quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Statement of Comprehensive Income [Abstract]
Net loss	$ (40,288)	$ (16,558)	$ (28,845)
Total comprehensive loss:
Unrealized gain on marketable securities, net of tax	204	53	742
Change in pension liability, net of tax	476	(339)	1,153
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term-investment nature	1,276	(1,014)	(89)
Reclassification adjustments, net of tax:
Recognized gain on marketable securities	0	0	(4,994)
Foreign currency gain recognized and included in net loss	(581)	0	0
Amortization of pension actuarial loss	179	127	179
Other comprehensive income (loss)	1,554	(1,173)	(3,009)
Total comprehensive loss	$ (38,734)	$ (17,731)	$ (31,854)

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning Balance at Mar. 28, 2015	$ 6,173,160	$ 6,584,247	$ (124)	$ (410,963)
Beginning Balance, Shares at Mar. 28, 2015	149,059
Net loss	$ (28,845)	0	0	(28,845)
Other comprehensive income (loss)	(3,009)	0	(3,009)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ 4,406	4,406	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	2,156
Issuance of common stock in connection with employee stock purchase plan	$ 17,967	17,967	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	429
Tax benefit from exercised stock options	$ 636	636	0	0
Repurchase of common stock, including transaction costs	$ (1,300,009)	(1,300,009)	0	0
Repurchase of common stock, including transaction costs, Shares	(24,258)
Stock-based compensation expense	$ 135,366	135,366	0	0
Ending Balance at Apr. 02, 2016	$ 4,999,672	5,442,613	(3,133)	(439,808)
Ending Balance, Shares at Apr. 02, 2016	127,386
Net loss	$ (16,558)	0	0	(16,558)
Other comprehensive income (loss)	(1,173)	0	(1,173)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ 16,832	16,832	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	2,484
Issuance of common stock in connection with employee stock purchase plan	$ 25,640	25,640	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	678
Tax deficiency from exercised stock options	$ 56	56	0	0
Repurchase of common stock, including transaction costs	$ (209,357)	(209,357)	0	0
Repurchase of common stock, including transaction costs, Shares	(4,084)
Stock-based compensation expense	$ 81,722	81,722	0	0
Ending Balance at Apr. 01, 2017	$ 4,896,722	5,357,394	(4,306)	(456,366)
Ending Balance, Shares at Apr. 01, 2017	126,464
Net loss	$ (40,288)	0	0	(40,288)
Other comprehensive income (loss)	1,554	0	1,554	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ 4,735	4,735	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	2,246
Issuance of common stock in connection with employee stock purchase plan	$ 28,064	28,064	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	541
Tax deficiency from exercised stock options		0	0
Cumulative-effect adoption of ASU 2016-09	$ 36,684			36,684
Cumulative-effect adoption of ASU 2016-16	1,201			1,201
Repurchase of common stock, including transaction costs	$ (219,907)	(219,907)	0	0
Repurchase of common stock, including transaction costs, Shares	(2,929)
Stock-based compensation expense	$ 66,799	66,799	0	0
Ending Balance at Mar. 31, 2018	$ 4,775,564	$ 5,237,085	$ (2,752)	$ (458,769)
Ending Balance, Shares at Mar. 31, 2018	126,322

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Cash flows from operating activities:
Net loss	$ (40,288)	$ (16,558)	$ (28,845)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	174,425	209,825	180,362
Intangible assets amortization (Note 7)	539,790	494,752	494,589
Amortization of debt issuance cost and other non-cash items	1,858	1,709	112
Excess tax benefit from exercises of stock options	0	(65)	(935)
Deferred income taxes	(32,248)	(28,027)	(12,189)
Foreign currency adjustments	953	(36)	1,705
Loss (income) on investments and other assets, net (Note 11)	49,177	5,478	(4,705)
Stock-based compensation expense	68,158	88,845	139,516
Changes in operating assets and liabilities:
Accounts receivable, net	12,906	(36,873)	36,682
Inventories	(41,887)	(6,442)	(84,116)
Prepaid expenses and other current and non-current assets	28,310	20,285	(28,871)
Accounts payable	38,952	(1,035)	(461)
Accrued liabilities	(2,623)	26,866	3,862
Income tax payable/(recoverable)	50,801	13,414	4,300
Other assets and liabilities	4,236	4,682	(13,079)
Net cash provided by operating activities	852,520	776,820	687,927
Investing activities:
Purchase of property and equipment	(269,835)	(552,702)	(315,624)
Purchase of available-for-sale securities	0	(469)	(340,527)
Proceeds from maturities of available-for-sale securities	0	186,793	390,009
Purchase of business, net of cash acquired (Note 6)	0	(117,994)	0
Other investing	(7,574)	(5,976)	(12,572)
Net cash used in investing activities	(277,409)	(490,348)	(278,714)
Financing activities:
Repurchase of common stock, including transaction costs	(219,907)	(209,357)	(1,300,009)
Proceeds from debt issuances	100,000	0	1,175,000
Payment of debt	(107,729)	0	(175,000)
Debt issuance costs	(1,916)	0	(13,588)
Proceeds from the issuance of common stock	57,412	59,148	51,875
Tax withholding paid on behalf of employees for restricted stock units	(24,708)	(15,516)	(22,168)
Excess tax benefit from exercises of stock options	0	65	935
Other financing	0	10	(29)
Net cash used in financing activities	(196,848)	(165,650)	(282,984)
Effect of exchange rate changes on cash	2,360	(1,105)	(294)
Net increase in cash, cash equivalents and restricted cash	380,623	119,717	125,935
Cash, cash equivalents and restricted cash at the beginning of the period	545,779	426,062	300,127
Cash, cash equivalents and restricted cash at the end of the period	926,402	545,779	426,062
Supplemental disclosure of cash flow information:
Cash paid during the year for interest	70,208	71,171	2,164
Cash paid during the year for income taxes	41,478	52,656	34,942
Non-cash investing and financing information:
Capital expenditure adjustments included in liabilities	$ 31,769	$ 75,340	$ 33,548

The Company and Its Significant Accounting Policies	12 Months Ended
The Company and Its Significant Accounting Policies	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES	THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES On February 22, 2014, RF Micro Devices, Inc. ("RFMD") and TriQuint Semiconductor, Inc. ("TriQuint") entered into an Agreement and Plan of Merger and Reorganization (as subsequently amended on July 15, 2014, the "Merger Agreement") providing for the business combination of RFMD and TriQuint (the "Business Combination") under a new holding company named Qorvo, Inc. The stockholders of both RFMD and TriQuint approved the Merger Agreement at each company's special meeting of stockholders on September 5, 2014. During the third quarter of fiscal 2015, all necessary regulatory approvals were received to complete the Business Combination. The Business Combination closed on January 1, 2015 (fourth quarter of fiscal 2015). For financial reporting and accounting purposes, RFMD was the acquirer of TriQuint. The Company is a product and technology leader at the forefront of the growing global demand for always-on broadband connectivity. The Company combines a broad portfolio of radio frequency (“RF”) solutions, highly differentiated semiconductor technologies, deep systems-level expertise and scale manufacturing to supply a diverse group of customers in expanding markets, including smartphones and other mobile devices, defense and aerospace, Wi-Fi customer premises equipment, cellular base stations, optical networks, automotive connectivity, and smart home applications. Within these markets, the Company's products enable a broad range of leading-edge applications - from very-high-power wired and wireless infrastructure solutions to ultra-low-power smart home solutions. The Company's products and technologies help transform how people around the world access their data, transact commerce, and interact with their communities. The Company’s design and manufacturing expertise covers many semiconductor process technologies, which it sources both internally and through external suppliers. The Company’s primary wafer fabrication facilities are located in Florida, North Carolina, Oregon and Texas and its primary assembly and test facilities are located in China, Costa Rica, Germany and Texas. The Company operates design, sales and manufacturing facilities throughout Asia, Europe and North America. Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain items in the fiscal years 2017 and 2016 financial statements have been reclassified to conform to the fiscal 2018 presentation, such as restricted cash in accordance with Accounting Standards Update ("ASU") 2016-18. Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on March 31, 2018, April 1, 2017, and April 2, 2016. Fiscal years 2018 and 2017 were 52-week years, and fiscal year 2016 was a 53-week year. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The actual results that the Company experiences may differ materially from its estimates. The Company makes estimates for the returns reserve, rebates, allowance for doubtful accounts, inventory valuation including reserves, warranty reserves, income tax valuation, current and deferred income taxes, uncertain tax positions, non-marketable equity investments, other-than-temporary impairments of investments, goodwill, long-lived assets and other financial statement amounts on a regular basis and makes adjustments based on historical experiences and expected future conditions. Accounting estimates require difficult and subjective judgments and actual results may differ from the Company’s estimates. During the first quarter of fiscal 2018, the Company changed its accounting estimate for the expected useful lives of certain machinery and equipment. The Company evaluated its asset base and reassessed the estimated useful lives of certain machinery and equipment in connection with its implementation of several capital projects, including the migration of certain surface acoustic wave ("SAW") processes from 4-inch to 6-inch toolsets and certain bulk acoustic wave ("BAW") processes from 6-inch to 8-inch toolsets. Based on its ability to re-use equipment across generations of process technologies and historical usage trends, the Company determined that the expected useful lives for certain machinery and equipment should be increased by up to three years to reflect more closely the estimated economic lives of those assets. This change in estimate was applied prospectively effective for the first quarter of fiscal 2018 and resulted in a decrease in depreciation expense of $59.7 million for fiscal 2018. This decrease in depreciation expense for fiscal 2018 resulted in the following: (1) an increase in income from operations of $47.4 million; (2) an increase in net income of $44.1 million; (3) an improvement in earnings per share of $0.34; and (4) a reduction in inventory of $12.3 million. Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly-liquid investments with original maturities of three months or less when purchased. Investments Investments available-for-sale at March 31, 2018 and April 1, 2017 consisted of auction rate securities ("ARS"). Available-for-sale investments with an original maturity date greater than approximately three months and less than one year are classified as current investments. Available-for-sale investments with an original maturity date exceeding one year are classified as long-term. Available-for-sale securities are carried at fair value with the unrealized gains and losses, net of tax, reported in “Other comprehensive income (loss).” The cost of securities sold is based on the specific identification method and any realized gain or loss is included in “Other (expense) income.” The cost of available-for-sale securities is adjusted for premiums and discounts, with the amortization or accretion of such amounts included as a portion of interest. The Company assesses individual investments for impairment quarterly. Investments are impaired when the fair value is less than the amortized cost. If an investment is impaired, the Company evaluates whether the impairment is other-than-temporary. A debt investment impairment is considered other-than-temporary if (i) the Company intends to sell the security, (ii) it is more likely than not that the Company will be required to sell the security before recovery of the entire amortized cost basis, or (iii) the Company does not expect to recover the entire amortized cost basis of the security (a credit loss). Other-than-temporary declines in the Company's debt securities are recognized as a loss in the statement of operations if due to credit loss; all other losses on debt securities are recorded in “Other comprehensive income (loss).” The previous amortized cost basis less the other-than-temporary impairment becomes the new cost basis and is not adjusted for subsequent recoveries in fair value. Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against sales forecasts on a product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of forecasted sales and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve. Abnormal production levels are charged to the income statement in the period incurred rather than as a portion of inventory cost. Product Warranty The Company generally sells products with a limited warranty on product quality. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified issues based on historical activity. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing and the short time typically between product shipment and the detection and correction of product failures and the historical rate of losses, the accrual and related expense for estimated incurred but unidentified issues was not significant during the periods presented. Other Receivables The Company records miscellaneous non-product receivables that are collectible within 12 months in “Other receivables,” such as value-added tax receivables ($38.1 million as of March 31, 2018 and $55.4 million as of April 1, 2017, which are reported on a net basis), precious metal reclaims submitted for payment and other miscellaneous items. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one year to thirty-nine years. The Company capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company’s assets acquired under capital leases and leasehold improvements are amortized over the lesser of the asset life or lease term (which is reasonably assured) and included in depreciation. The Company records capital-related government grants earned as a reduction to property and equipment and depreciates such grants over the estimated useful lives of the associated assets. The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held for use by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as “held for sale” are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Goodwill and Intangible Assets Goodwill is recorded when the purchase price paid for a business exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Intangibles are recorded when such assets are acquired by purchase or license. The value of the Company's intangibles, including goodwill, could be impacted by future adverse changes such as: (i) any future declines in the Company's operating results; (ii) a decline in the value of technology company stocks, including the value of the Company's common stock; (iii) a prolonged or more significant slowdown in the worldwide economy or the semiconductor industry; or (iv) failure to meet the performance projections included in the Company's forecasts of future operating results. The Company accounts for goodwill and indefinite-lived intangible assets in accordance with the Financial Accounting Standards Board ("FASB") guidance, which requires annual testing for impairment or whenever events or circumstances make it more likely than not that an impairment may have occurred. The Company performs its annual impairment tests on the first day of the fourth quarter in each fiscal year. Indefinite-lived intangible assets consist of in-process research and development ("IPRD"). The Company has the option to perform a qualitative assessment (commonly referred to as "step zero") to determine whether further quantitative analysis for impairment of goodwill or indefinite-lived intangible assets is necessary. In performing step zero for its impairment test, the Company is required to make assumptions and judgments, including the evaluation of macroeconomic conditions as related to the Company's business, industry and market trends, and the overall future financial performance of the Company's reporting units and future opportunities in the markets in which they operate. The Company also considers recent fair value calculations of its indefinite-lived intangible assets and reporting units as well as cost factors such as changes in raw materials, labor or other costs. If the step zero analysis indicates that it is more likely than not that the fair value of a reporting unit or indefinite-lived asset is less than its respective carrying value including goodwill, then the Company would perform an additional quantitative analysis. For goodwill, this involves a two-step process. The first step compares the fair value of the reporting unit, including its goodwill, to its carrying value. If the carrying value of the reporting unit exceeds its fair value, then the second step of the process is performed to determine the amount of impairment. The second step compares the implied fair value of the reporting unit's goodwill to the carrying value of the goodwill. An impairment charge is recognized for the amount the carrying value of the reporting unit's goodwill exceeds its implied fair value. For indefinite-lived intangible assets, the quantitative analysis compares the carrying value of the asset to its fair value and an impairment charge is recognized for the amount its carrying value exceeds its fair value. Determining the fair value of reporting units, indefinite-lived intangible assets and implied fair value of a reporting unit's goodwill is reliant upon estimated future revenues, profitability and cash flows and consideration of market factors. Assumptions, judgments and estimates are complex, subjective and can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in the Company's business strategy or its internal forecasts. Although the Company believes the assumptions, judgments and estimates it has made have been reasonable and appropriate, different assumptions, judgments and estimates could materially affect its results of operations. Goodwill Goodwill is allocated to the Company's reporting units based on the expected benefit from the synergies of the business combinations generating the underlying goodwill. As of March 31, 2018, the Company's goodwill balance of $2,173.9 million is allocated between its Mobile Products ("MP") and Infrastructure and Defense Products ("IDP") reporting units. In fiscal years 2018 and 2017, the Company completed qualitative assessments of the fair value of its reporting units and concluded that goodwill was not impaired. For fiscal 2016, although there were no indicators of impairment, the Company opted to bypass the qualitative assessment and proceeded to perform fair value assessments of its reporting units (the first step of the quantitative impairment analysis) as the fair value of the reporting units had changed (due to the Business Combination) since the last time the Company performed a quantitative analysis. The quantitative assessments performed reaffirmed that there were no indicators of impairment for fiscal 2016. In performing these quantitative assessments, consistent with its historical approach, the Company used both the income and market approaches to estimate the fair value of its reporting units. The income approach involves discounting future estimated cash flows. The sum of the reporting unit cash flow projections was compared to the Company's market capitalization in a discounted cash flow framework to calculate an overall implied internal rate of return (or discount rate) for the Company. The Company's market capitalization was adjusted to a control basis assuming a reasonable control premium, which resulted in an implied discount rate. This implied discount rate serves as a baseline for estimating the specific discount rate for each reporting unit. The discount rate used is the value-weighted average of the Company's estimated cost of equity and debt (“cost of capital”) derived using both known and estimated customary market metrics. The Company's weighted average cost of capital is adjusted for each reporting unit to reflect a risk factor, if necessary, for each reporting unit. The Company performs sensitivity tests with respect to growth rates and discount rates used in the income approach. The Company believes the income approach is appropriate because it provides a fair value estimate based upon the respective reporting unit’s expected long-term operations and cash flow performance. The Company considered historical rates and current market conditions when determining the discount and growth rates used in its analysis. For fiscal 2016, the material assumptions used for the income approach were eight years of projected net cash flows and a long-term growth rate of 3% for both the MP and IDP reporting units. A discount rate of 15% and 16% was used for the MP and IDP reporting units, respectively. In applying the market approach, valuation multiples are derived from historical and projected operating data of selected guideline companies, which are evaluated and adjusted, if necessary, based on the strengths and weaknesses of the reporting unit relative to the selected guideline companies. The valuation multiples are then applied to the appropriate historical and/or projected operating data of the reporting unit to arrive at an indication of fair value. The Company believes the market approach is appropriate because it provides a fair value using multiples from companies with operations and economic characteristics similar to its reporting units. The Company weighted the results of the income approach and the results of the market approach at 50% each and for the MP and IDP reporting units, concluded that the fair value of the reporting units was determined to be substantially in excess of the carrying value, and as such, no further analysis was warranted. Under the income approach described above, the following indicates the sensitivity of key assumptions utilized in the assessment. A one percentage point decrease in the discount rate would have increased the fair value of the MP and IDP reporting units by approximately $660.0 million and $140.0 million, respectively, while a one percentage point increase in the discount rate would have decreased the fair value of the MP and IDP reporting units by approximately $560.0 million and $110.0 million, respectively. A one percentage point decrease in the long-term growth rate would have decreased the fair value of the MP and IDP reporting units by approximately $290.0 million and $50.0 million, respectively, while a one percentage point increase in the long-term growth rate would have increased the fair value of the MP and IDP reporting units by approximately $340.0 million and $70.0 million, respectively. Intangible Assets with Indefinite Lives In fiscal 2015, as a result of the Business Combination, the Company recorded IPRD of $470.0 million. IPRD was recorded at fair value as of the date of acquisition as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development ("R&D") efforts or impairment. The fair value of the acquired IPRD was determined based on an income approach using the "excess earnings method," which estimated the value of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. Upon completion of development, acquired IPRD assets are transferred to finite-lived intangible assets and amortized over their useful lives. During fiscal years 2018, 2017 and 2016, the Company completed and transferred into developed technology approximately $37.0 million, $220.0 million and $203.0 million, respectively, of IPRD. The Company performed a qualitative assessment of the remaining IPRD of $10.0 million during fiscal 2018 and concluded that IPRD was not impaired. Intangible Assets with Definite Lives Intangible assets are recorded when such assets are acquired by purchase or license. Finite-lived intangible assets consist primarily of technology licenses, customer relationships, developed technology and trade names resulting from business combinations and are subject to amortization. Technology licenses are recorded at cost and are amortized on a straight-line basis over the lesser of the estimated useful life of the technology or the term of the license agreement, ranging from approximately five to eight years. The fair value of customer relationships acquired during fiscal years 2013, 2015 and 2017 was determined based on an income approach using the “with and without method," in which the value of the asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. Customer relationships are amortized on a straight-line basis over the estimated useful life, ranging from three to ten years. The fair value of developed technology acquired during fiscal years 2013, 2015 and 2017 was determined based on an income approach using the "excess earnings method," which estimated the value of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. Developed technology is amortized on a straight-line basis over the estimated useful life, ranging from three to six years. The fair value of trade names acquired in fiscal years 2015 and 2017 was determined based on an income approach using the "relief from royalty method," in which the value of the asset is determined by discounting the future projected cash flows generated from the trade name's estimated royalties. Trade names are amortized on a straight-line basis over the estimated useful life of two to three years. The Company regularly reviews identified intangible assets to determine if facts and circumstances indicate that the useful lives have changed from the original estimate or that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination was made. Accrued Liabilities The "Accrued liabilities" balance as of March 31, 2018 and April 1, 2017 includes accrued compensation and benefits of $96.7 million and $98.7 million, respectively, and interest payable of $23.1 million and $23.2 million, respectively. Revenue Recognition The Company's net revenue is generated principally from sales of semiconductor products. The Company recognizes revenue from product sales when the fundamental criteria are met, such as the time at which the title and risk and rewards of product ownership are transferred to the customer, price and terms are fixed or determinable, no significant vendor obligation exists and collection of the resulting receivable is reasonably assured. Sales of products are generally made through either the Company's sales force, manufacturers' representatives or through a distribution network. Revenue from the majority of the Company's products is recognized upon shipment of the product to the customer from a Company-owned or third-party location. Some revenue is recognized upon receipt of the shipment by the customer. The Company has limited rebate programs offering price protection to certain distributors. These rebates represent less than 5% of net revenue and can be reasonably estimated based on specific criteria included in the rebate agreements and other known factors at the time. The Company reduces revenue and records reserves for product returns and allowances for price protection, stock rotation, and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company also recognizes a portion of its net revenue through other agreements such as non-recurring engineering fees, contracts for R&D work, royalty income, intellectual property ("IP") revenue, and service revenue. These agreements are collectively less than 1% of consolidated annual revenue. Revenue from these agreements is recognized when the service is completed or upon certain milestones, as provided for in the agreements. Revenue from certain contracts is recognized on the percentage of completion method based on the costs incurred to date and the total contract amount, plus the contractual fee. If these contracts experience cost overruns, the percentage of completion method is used to determine revenue recognition. Revenue from fixed price contracts is recognized when the required deliverable is satisfied. Royalty income is recognized based on a percentage of sales of the relevant product reported by licensees during the period. The Company additionally licenses or sells its rights to use portions of its IP portfolio, which includes certain patent rights useful in the manufacture and sales of certain products. IP revenue recognition is dependent on the terms of each agreement. The Company will recognize IP revenue upon delivery of the IP if the Company has no substantive future obligation to perform under the arrangement. The Company will defer recognition of IP revenue where future performance obligations are required to earn the revenue or the revenue is not guaranteed. Revenue from services is recognized during the period that the service is performed. Accounts receivable are recorded for all revenue items listed above and do not bear interest. The Company evaluates the collectability of accounts receivable based on a combination of factors. In cases where the Company is aware of circumstances that may impair a specific customer’s ability to meet its financial obligations subsequent to the original sale, the Company will record an allowance against amounts due, and thereby reduce the receivable to the amount the Company reasonably believes will be collected. For all other customers, the Company recognizes allowances for doubtful accounts based on the length of time the receivables are past due, industry and geographic concentrations, the current business environment and the Company’s historical experience. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company will authorize sales returns under certain circumstances, which include perceived quality problems, courtesy returns and like-kind exchanges. The Company evaluates its estimate of returns by analyzing all types of returns and the timing of such returns in relation to the original sale. Reserves are adjusted to reflect changes in the estimated returns versus the original sale of product. Shipping and Handling Cost The Company recognizes amounts billed to a customer in a sale transaction related to shipping and handling as revenue. The costs incurred by the Company for shipping and handling are classified as cost of goods sold in the Consolidated Statements of Operations. Research and Development The Company charges all R&D costs to expense as incurred. Precious Metals Reclaim The Company uses historical experience to estimate the amount of reclaim on precious metals used in manufacturing at the end of each period and states the reclaim value at the lower of average cost or market. The estimated value to be received from precious metal reclaim is included in "Other current assets" and reclaims submitted for payment are included in "Other receivables" in the Consolidated Balance Sheets. Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more likely than not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. It is the Company’s current intent and policy to invest the earnings of foreign subsidiaries indefinitely outside the U.S., except for Qorvo International Pte. Ltd. in Singapore. Accordingly, the Company does not record a deferred tax liability for U.S. income taxes on unremitted foreign earnings of other foreign subsidiaries. Stock-Based Compensation Under FASB Accounting Standards Codification ("ASC") 718, “Compensation – Stock Compensation," stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of March 31, 2018, total remaining unearned compensation cost related to unvested restricted stock units and options was $72.8 million, which will be amortized over the weighted-average remaining service period of approximately 1.2 years. Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with FASB ASC 830, “Foreign Currency Matters.” The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenues and expenses are translated using the average exchange rates throughout the year. Translation adjustments are shown separately as a component of “Accumulated other comprehensive loss” within “Stockholders’ equity” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in “Other income (expense)” in the Consolidated Statements of Operations. Recent Accounting Pronouncements Accounting Pronouncements Not Yet Effective In January 2017, the FASB issued ASU 2017-04, "Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The new guidance simplifies the subsequent measurement of goodwill by eliminating the second step from the quantitative goodwill impairment test. The Company will continue to have the option to perform a qualitative assessment to determine if a quantitative goodwill impairment test is necessary. The new standard will become effective for the Company beginning in fiscal 2021 with early adoption permitted. The Company does not believe it will have a significant impact on its consolidated financial statements. In January 2017, the FASB issued ASU 2017-01, "Business Combinations (Topic 805): Clarifying the Definition of a Business." The new guidance clarifies the definition of a business and provides further guidance for evaluating whether a transaction will be accounted for as an acquisition of an asset or a business. The new standard will become effective for the Company beginning in the first quarter of fiscal 2019 with early adoption permitted. The update should be applied prospectively. The Company does not believe it will have a significant impact on its consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the FASB’s Emerging Issues Task Force)." The new guidance addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. The new standard will become effective for the Company beginning in the first quarter of fiscal 2019. The Company does not believe it will have a significant impact on its consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments." The new guidance requires entities to use a current lifetime expected credit loss methodology to measure impairments of certain financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. The new standard will become effective for the Company beginning in the first quarter of fiscal 2021 with early adoption permitted. The Company does not believe it will have a significant impact on its consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." The new guidance requires lessees to recognize a right-of-use asset and a lease liability for all leases with a term longer than 12 months, including those previously described as operating leases. Consistent with current U.S. generally accepted accounting principles ("GAAP"), the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will primarily depend on its classification as a finance or operating lease. The new guidance will become effective for the Company in the first quarter of fiscal 2020. The Company expects the valuation of the right-of-use assets and lease liabilities, for leases previously described as operating leases, to be the present value of its forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. In January 2016, the FASB issued ASU 2016-01, "Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities." The new guidance will affect the accounting for equity investments, financial liabilities measured under the fair value option and presentation and disclosure requirements for financial instruments. In addition, the FASB clarified guidance related to the assessment of valuation allowances when recognizing deferred tax assets related to unrealized losses on available-for-sale debt securities. The new standard is effective for the Company beginning in the first quarter of fiscal 2019. The Company does not believe it will have a significant impact on its consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)," with several amendments subsequently issued. The new guidance provides an updated framework for revenue recognition, resulting in a single revenue model to be applied by reporting companies under U.S. GAAP. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Additional disclosures will be required regarding the nature, amount, timing and uncertainty of cash flows. The Company will adopt the standard in the first quarter of fiscal 2019 using the modified retrospective approach, under which the cumulative effect of adoption is recognized at the date of initial application. The Company has evaluated the impact of the standard and does not anticipate that the adoption of this standard will have a material impact on its consolidated financial statements. The Company is implementing changes to its accounting policies, internal controls and disclosures to support the new standard; however, these changes are not expected to be material. Accounting Pronouncements Recently Adopted In March 2018, the FASB issued ASU 2018-05, "Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118." The amendments incorporate into the ASC the recent SEC guidance related to the income tax accounting implications of the Tax Cuts and Jobs Act (the "Tax Act"). See Note 12 for further disclosures. In May 2017, the FASB issued ASU 2017-09, "Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting." The new guidance clarifies when modification accounting in Topic 718 should be applied to changes to the terms or conditions of a share-based payment award. The Company elected to early-adopt the standard in the first quarter of fiscal 2018 with no impact on its consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force)." The new guidance requires that restricted cash and restricted cash equivalents be included in cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. The Company adopted the provisions of ASU 2016-18 in the second quarter of fiscal 2018 using the retrospective transition method. The adjustment to reclassify restricted cash for each period presented was less than $1.0 million. In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory." The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The Company elected to early-adopt the standard in the first quarter of fiscal 2018 using the modified retrospective method (which resulted in a cumulative adjustment to retained earnings of $1.2 million as of the beginning of the period of adoption). During fiscal 2018, the Company recognized a tax expense of $6.9 million related to transfers of intra-entity assets. In March 2016, the FASB issued ASU 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." The new guidance simplifies certain aspects of accounting for share-based payment transactions, including income tax consequences, forfeitures, classification of awards on the balance sheet and presentation on the statement of cash flows, and became effective for the Company in the first quarter of fiscal 2018. The Company recognized a cumulative-effect adjustment to reduce the Company's accumulated deficit by $36.7 million with a corresponding increase to deferred tax assets for the federal and state net operating losses attributable to excess tax benefits that had not been previously recognized. All excess tax benefits and deficiencies in the current and future periods will be recognized as income tax expense in the Company’s Consolidated Statement of Operations in the reporting period in which they occur. This will result in increased volatility in the Company’s effective tax rate. During fiscal 2018, the Company recognized a discrete tax benefit of $12.2 million related to the excess tax benefits from stock-based compensation. The Company also elected to prospectively adopt the provision that requires excess tax benefits to be presented within operating activities in the statement of cash flows and no prior periods have been restated as a result of the adoption. The Company has continued its existing practice of estimating expected forfeitures in determining compensation cost. In March 2016, the FASB issued ASU 2016-07, "Investments-Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting." The new guidance eliminates the requirement to retrospectively apply the equity method of accounting when an investment previously accounted for under the cost basis qualifies for the equity method of accounting. The Company adopted ASU 2016-07 in the first quarter of fiscal 2018 with no impact on its consolidated financial results. In July 2015, the FASB issued ASU 2015-11, "Inventory (Topic 330): Simplifying the Measurement of Inventory." The new guidance changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. ASU 2015-11 defines net realizable value as the estimated selling price in the ordinary course of business less reasonably predictable costs to completion, transportation, or disposal. The Company adopted ASU 2015-11 in the first quarter of fiscal 2018 with no significant impact on its consolidated financial statements.

Concentrations of Credit Risk

12 Months Ended

Mar. 31, 2018

Risks and Uncertainties [Abstract]

CONCENTRATIONS OF CREDIT RISK

The Company’s principal financial instrument subject to potential concentration of credit risk is accounts receivable, which is unsecured. The Company provides an allowance for doubtful accounts equal to estimated losses expected to be incurred in the collection of accounts receivable. The Company has adopted credit policies and standards intended to accommodate industry growth and inherent risk and it believes that credit risks are moderated by the financial stability of its major customers, conservative payment terms and the Company’s strict credit policies.

Revenue from significant customers, those representing 10% or more of revenue for the respective periods, are summarized as follows:



	Fiscal Year
	2018	2017	2016
Apple Inc. ("Apple")	36%	34%	37%
Huawei Technologies Co., Ltd.	8%	11%	12%

The Company provided its products to Apple through sales to multiple contract manufacturers.

These customers primarily purchase cellular RF and Wi-Fi solutions offered by the Company's MP segment for a variety of mobile devices, including smartphones, notebook computers, wearables, tablets and cellular-based applications for the Internet of Things ("IoT").

Accounts receivable related to these customers (which includes multiple contract manufacturers) accounted for 26%, 40%, and 40% of the Company's total net accounts receivable balance as of March 31, 2018, April 1, 2017 and April 2, 2016, respectively.

Investments and Fair Value Measurements

12 Months Ended

Mar. 31, 2018

Investments and Fair Value Measurements [Abstract]

INVESTMENTS AND FAIR VALUE MEASUREMENTS

INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Investments

The following is a summary of cash equivalents and available-for-sale securities as of March 31, 2018 and April 1, 2017 (in thousands):



	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
March 31, 2018
Auction rate securities	$	1,950	$	—	$	(107	)	$	1,843
Money market funds	9		—		—			9
	$	1,959	$	—	$	(107	)	$	1,852
April 1, 2017
Auction rate securities	$	2,150	$	—	$	(429	)	$	1,721
Money market funds	14		—		—			14
	$	2,164	$	—	$	(429	)	$	1,735

The estimated fair value of available-for-sale securities was based on the prevailing market values on March 31, 2018 and April 1, 2017. The Company determines the cost of an investment sold based on the specific identification method.

The expected maturity distribution of cash equivalents and available-for-sale debt securities is as follows (in thousands):



	March 31, 2018				April 1, 2017
	Cost		Estimated Fair Value		Cost		Estimated Fair Value
Due in less than one year	$	9	$	9	$	14	$	14
Due after ten years	1,950		1,843		2,150		1,721
Total investments in debt securities	$	1,959	$	1,852	$	2,164	$	1,735

Other Investments

As of March 31, 2018, the Company had invested $45.0 million to acquire shares of Series F Preferred Stock of Cavendish Kinetics Limited, a private limited company incorporated in England and Wales. This investment is accounted for as a cost method investment and classified in "Long-term investments" in the Consolidated Balance Sheets.

Fair Value of Financial Instruments

Marketable securities are measured at fair value and recorded in "Cash and cash equivalents" and "Long-term investments" in the Consolidated Balance Sheets, and the related unrealized gains and losses are included in "Accumulated other comprehensive loss," a component of stockholders’ equity, net of tax.

Recurring Fair Value Measurements

The fair value of the financial assets and liabilities measured at fair value on a recurring basis was determined using the following levels of inputs as of March 31, 2018 and April 1, 2017 (in thousands):



				Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
March 31, 2018
	Assets
		Money market funds		$	9	$	9	$	—
		Auction rate securities (1)		1,843		—		1,843
		Invested funds in deferred compensation plan (2)		14,284		14,284		—
			Total assets measured at fair value	$	16,136	$	14,293	$	1,843
	Liabilities
		Deferred compensation plan obligation (2)		$	14,284	$	14,284	$	—
			Total liabilities measured at fair value	$	14,284	$	14,284	$	—

April 1, 2017
	Assets
		Money market funds		$	14	$	14	$	—
		Auction rate securities (1)		1,721		—		1,721
		Invested funds in deferred compensation plan (2)		10,237		10,237		—
			Total assets measured at fair value	$	11,972	$	10,251	$	1,721
	Liabilities
		Deferred compensation plan obligation (2)		$	10,237	$	10,237	$	—
			Total liabilities measured at fair value	$	10,237	$	10,237	$	—

(1) Auction rate securities are debt instruments with interest rates that reset through periodic short-term auctions. The Company's Level 2 ARS are valued based on quoted prices for identical or similar instruments in markets that are not active.

(2) The non-qualified deferred compensation plan provides eligible employees and members of the Board of Directors with the opportunity to defer a specified percentage of their cash compensation. The Company includes the asset deferred by the participants in the “Other current assets” and “Other non-current assets” line items of its Consolidated Balance Sheets and the Company's obligation to deliver the deferred compensation in the "Other current liabilities" and “Other long-term liabilities” line items of its Consolidated Balance Sheets.

As of March 31, 2018 and April 1, 2017, the Company did not have any Level 3 assets or liabilities.

Nonrecurring Fair Value Measurements

The Company's non-financial assets, such as intangible assets and property and equipment, are measured at fair value when there is an indicator of impairment, and recorded at fair value only when an impairment charge is recognized. See Note 11 for further information on impairment of property and equipment.

Other Fair Value Disclosures

The carrying values of cash and cash equivalents, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. See Note 8 for the fair value of the Company's long-term debt.

Business Acquisitions	12 Months Ended
Business Acquisitions	Mar. 31, 2018
BUSINESS ACQUISITION DISCLOSURE [Abstract]
BUSINESS ACQUISITIONS	BUSINESS ACQUISITIONS Acquisition of GreenPeak Technologies, B.V. During fiscal 2017, the Company completed the acquisition of GreenPeak Technologies, B.V. ("GreenPeak"), a leader in ultra-low power, short RF communication technology. The acquisition expanded the Company's offerings to include integrated RF solutions and systems-on-a-chip ("SoCs") for the connected home. The Company acquired 100% of the outstanding equity securities of GreenPeak for a purchase price of $118.1 million, net of cash acquired of $0.7 million. The total purchase price was allocated to GreenPeak's assets and liabilities based upon fair values as determined by the Company and resulted in goodwill of $38.2 million. The measurement period (up to one year from the acquisition date pursuant to ASC Topic 805 "Business Combinations") related to the acquisition of GreenPeak was concluded during the first quarter of fiscal 2018. The GreenPeak acquisition resulted in an increase in intangible assets of $82.1 million. The more significant intangible assets acquired were developed technology of $74.2 million (which is being amortized over 7 years) and customer relationships of $5.6 million (which is being amortized over 3 years). Business Combination between RFMD and TriQuint Effective January 1, 2015, pursuant to the Merger Agreement, RFMD and TriQuint completed a strategic combination of their respective businesses through the “merger of equals” Business Combination. Based on an evaluation of the provisions of FASB ASC Topic 805, “Business Combinations,” RFMD was determined to be the acquirer for accounting purposes. The initial allocation to goodwill of $2,036.7 million represented the excess of the purchase price over the fair value of assets acquired and liabilities assumed, which amount was allocated to the Company's MP operating segment ($1,745.5 million) and IDP operating segment ($291.2 million). During the measurement period (which was concluded during the third quarter of fiscal 2016), adjustments of $3.8 million and $1.1 million were made to reduce goodwill and increase property and equipment and deferred taxes, respectively. Goodwill recognized from the Business Combination is not deductible for income tax purposes. The Business Combination resulted in an increase in intangible assets of $2,394.0 million. The more significant intangible assets acquired were developed technology of $610.0 million and customer relationships of $1,220.0 million (which are both being amortized over periods between 4 and 6 years) and IPRD of $470.0 million, of which $460.0 million has been completed as of March 31, 2018 and transferred to finite-lived intangible assets (which are being amortized over periods between 4 and 6 years). During fiscal years 2018, 2017 and 2016, the Company incurred integration costs of approximately $6.2 million, $16.9 million, and $26.5 million, respectively, associated with the Business Combination. During fiscal years 2018, 2017 and 2016, the Company incurred restructuring costs of approximately $2.6 million, $2.0 million, and $10.1 million, respectively, associated with the Business Combination. The acquisition, integration and restructuring costs are being expensed as incurred and are presented in the Consolidated Statements of Operations as "Other operating expense." See Note 11 for further information on the restructuring.

Goodwill and Intangible Assets

12 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for fiscal years 2017 and 2018, are as follows (in thousands):



	Mobile Products		Infrastructure and Defense Products			Total
Balance as of April 2, 2016 (1)	$	1,751,503	384,194			$	2,135,697
GreenPeak acquisition	—		38,217			38,217
Balance as of April 1, 2017 (1)	1,751,503		422,411			2,173,914
GreenPeak acquisition measurement adjustment	—		(25		)	(25		)
Balance as of March 31, 2018 (1)	$	1,751,503	$	422,386		$	2,173,889

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Goodwill is allocated to the reporting units that are expected to benefit from the synergies of the business combinations generating the underlying goodwill.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):



	March 31, 2018				April 1, 2017
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Intangible Assets:
Customer relationships	$	1,272,725	$	936,175	$	1,272,725	$	656,688
Developed technology	1,246,335		733,081		1,209,335		481,441
Trade names	29,391		29,377		29,353		21,912
Technology licenses	12,379		11,904		13,346		11,711
Non-compete agreement	1,026		983		1,026		470
IPRD	10,000		N/A		47,000		N/A
Total	$	2,571,856	$	1,711,520	$	2,572,785	$	1,172,222

During fiscal 2018, $37.0 million of IPRD assets were completed, transferred to finite-lived intangible assets, and are being amortized over their useful lives of 4 years. As of March 31, 2018, the IPRD remaining totaled approximately $10.0 million and is expected to be completed during fiscal 2019 with estimated remaining costs to complete of approximately $1.0 million to $2.0 million.

Total intangible assets amortization expense was $539.8 million, $494.8 million and $494.6 million in fiscal years 2018, 2017 and 2016, respectively.

The following table provides the Company's estimated amortization expense for intangible assets based on current amortization periods for the periods indicated (in thousands):



Fiscal Year	Estimated Amortization Expense
2019	$	455,000
2020	207,000
2021	155,000
2022	28,000
2023	12,000

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Debt

12 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

DEBT

Debt as of March 31, 2018 and April 1, 2017 is as follows (in thousands):



	March 31, 2018			April 1, 2017
6.75% Senior Notes due 2023	$	444,464		$	450,000
7.00% Senior Notes due 2025	548,500			550,000
Less unamortized issuance costs	(9,674		)	(10,846		)
Total long-term debt	$	983,290		$	989,154

Credit Agreement

On December 5, 2017 (the "Closing Date"), the Company and certain of its material domestic subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement with Bank of America, N.A., as administrative agent (in such capacity, the "Administrative Agent"), swing line lender and L/C issuer, and a syndicate of lenders (the "Credit Agreement"). The Credit Agreement includes a senior delayed draw term loan of up to $400.0 million (the "Term Loan") and a $300.0 million senior revolving line of credit (the "Revolving Facility", together with the Term Loan, the "Credit Facility"). On the Closing Date, $100.0 million of the Term Loan was funded (and was subsequently repaid in March 2018), with the remainder available, at the discretion of the Company, in up to two draws prior to June 5, 2018. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Company may request, at its option and at any time, that the Credit Facility be increased by an amount not to exceed $300.0 million, subject to securing additional funding commitments from the existing or new lenders. The Credit Facility is available to finance working capital, capital expenditures and other corporate purposes. The Company’s obligations under the Credit Agreement are jointly and severally guaranteed by the Guarantors. Upon execution of the Credit Agreement, the Company terminated its prior credit agreement, dated as of April 7, 2015, as amended, with Bank of America, N.A., thus terminating and releasing the Company’s obligations and guarantees of certain of its subsidiaries under that agreement. During fiscal 2018, there were no borrowings under the Revolving Facility. The Company had no outstanding amounts under the Credit Facility as of March 31, 2018.

At the Company’s option, loans under the Credit Agreement bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Eurodollar Rate (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate of the Administrative Agent, or (c) the Eurodollar Base Rate plus 1.0% (the “Base Rate”). All swingline loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Eurodollar Rate is the rate per annum equal to the reserve adjusted London Interbank Offered Rate (or a comparable or successor rate), for dollar deposits for interest periods of one, two, three, six or twelve months, as selected by the Company. The Applicable Rate for Eurodollar Rate loans ranges from 1.125% per annum to 1.375% per annum. The Applicable Rate for Base Rate loans ranges from 0.125% per annum to 0.375% per annum. Interest for Eurodollar Rate loans will be payable at the end of each applicable interest period or at three-month intervals, if such interest period exceeds three months. Interest for Base Rate loans will be payable quarterly in arrears. The Company will pay a letter of credit fee equal to the Applicable Rate multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee, and any customary documentary and processing charges for any letter of credit issued under the Credit Agreement. Interest paid on the Term Loan during fiscal 2018 was $0.7 million.

The Credit Agreement contains various conditions, covenants and representations with which the Company must comply in order to borrow funds and to avoid an event of default, including the following financial covenants that the Company must maintain: (i) a consolidated leverage ratio not to exceed 3.0 to 1.0 as of the end of any fiscal quarter of the Company, provided that in connection with a permitted acquisition in excess of $300.0 million, the Company's maximum consolidated leverage ratio may increase on two occasions during the term of the Credit Facility to 3.5 to 1.0 for four consecutive fiscal quarters, beginning with the fiscal quarter in which such acquisition occurs and (ii) an interest coverage ratio not to be less than 3.0 to 1.0 as of the end of any fiscal quarter of the Company. As of March 31, 2018, the Company was in compliance with these covenants.

The Credit Agreement also contains customary events of default. The occurrence of an event of default can result in the exercise of remedies including an increase in the applicable rate of interest by 2.00%, termination of undrawn commitments under the Credit Facility, declaration that all outstanding loans are due and payable and requiring cash collateral deposits in respect of outstanding letters of credit. Outstanding amounts are due in full on the maturity date of December 5, 2022 (with amounts borrowed under the swingline option due in full no later than ten business days after such loan is made), subject to scheduled amortization of the Term Loan principal as set forth in the Credit Agreement prior to the maturity date.

Senior Notes

On November 19, 2015, the Company completed an offering of $450.0 million aggregate principal amount of its 6.75% senior notes due December 1, 2023 (the “2023 Notes”) and $550.0 million aggregate principal amount of its 7.00% senior notes due December 1, 2025 (the “2025 Notes” and, together with the 2023 Notes, the “Notes”). The Notes were sold in the U.S. to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the U.S. pursuant to Regulation S under the Securities Act. The Notes were issued pursuant to an indenture dated as of November 19, 2015 (the "Indenture") containing customary events of default, including payment default, failure to provide certain notices and certain provisions related to bankruptcy events. The Indenture also contains customary negative covenants.

On September 19, 2016, the Company completed an exchange offer, in which all of the 2023 Notes and substantially all of the 2025 Notes were exchanged for new notes that have been registered under the Securities Act.

At any time prior to December 1, 2018, the Company may redeem all or part of the 2023 Notes, at a redemption price equal to their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to December 1, 2018, the Company may redeem up to 35% of the original aggregate principal amount of the 2023 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 106.75%, plus accrued and unpaid interest. Furthermore, at any time on or after December 1, 2018, the Company may redeem the 2023 Notes, in whole or in part, at once or over time, at the specified redemption prices set forth in the Indenture plus accrued and unpaid interest thereon to the redemption date (subject to the rights of holders of record on the relevant record date to receive interest due on the relevant interest payment date). In March 2018, the Company repurchased $5.5 million of the 2023 Notes at a redemption price of 107.50% plus accrued and unpaid interest.

At any time prior to December 1, 2020, the Company may redeem all or part of the 2025 Notes, at a redemption price equal to their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to December 1, 2018, the Company may redeem up to 35% of the original aggregate principal amount of the 2025 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 107.00%, plus accrued and unpaid interest. Furthermore, at any time on or after December 1, 2020, the Company may redeem the 2025 Notes, in whole or in part, at once or over time, at the specified redemption prices set forth in the Indenture plus accrued and unpaid interest thereon to the redemption date (subject to the rights of holders of record on the relevant record date to receive interest due on the relevant interest payment date). In March 2018, the Company repurchased $1.5 million of the 2025 Notes at a redemption price of 109.50% plus accrued and unpaid interest.

Interest is payable on June 1 and December 1 of each year on the 2023 Notes at a rate of 6.75% per annum and on the 2025 Notes at a rate of 7.00% per annum. Interest paid on the Notes during fiscal 2018 and fiscal 2017 was $68.9 million and $71.2 million, respectively.

The 2023 Notes and the 2025 Notes are traded over the counter, and their fair values as of March 31, 2018 of $474.5 million and $596.5 million, respectively (compared to carrying values of $444.5 million and $548.5 million, respectively) were estimated based upon the values of their last trade at the end of the period. The fair values of the 2023 Notes and the 2025 Notes were $489.4 million and $607.8 million, respectively (compared to carrying values of $450.0 million and $550.0 million, respectively), as of April 1, 2017.

Interest Expense

During fiscal 2018, the Company recognized $70.5 million of interest expense related to the Notes and the Term Loan, which was offset by $13.6 million of interest capitalized to property and equipment. During fiscal 2017 and fiscal 2016, the Company recognized $69.9 million and $25.8 million, respectively, of interest expense related to the Notes, which was partially offset by $13.6 million and $5.2 million, respectively, of interest capitalized to property and equipment.

Retirement Benefit Plans	12 Months Ended
Retirement Benefit Plans	Mar. 31, 2018
Retirement Benefits [Abstract]
RETIREMENT BENEFIT PLANS	RETIREMENT BENEFIT PLANS Defined Contribution Plans The Company offers tax-beneficial retirement contribution plans to eligible employees in the U.S. and certain other countries. Eligible employees in certain countries outside of the U.S. are eligible to participate in stakeholder or national pension plans with differing eligibility and contributory requirements based on local and national regulations. U.S. employees are eligible to participate in the Company's fully qualified 401(k) plan 30 days after their date of hire. An employee may invest pretax earnings in the 401(k) plan up to the maximum legal limits (as defined by Federal regulations). Employer contributions to the 401(k) plan are made at the discretion of the Company’s Board of Directors. Employees are immediately vested in their own contributions as well as employer matching contributions. In total, the Company contributed $14.0 million, $11.5 million and $11.7 million to its domestic and foreign defined contribution plans during fiscal years 2018, 2017 and 2016, respectively. Defined Benefit Pension Plans The Company maintains two qualified defined benefit pension plans for its subsidiaries located in Germany. One of the plans is funded through a self-paid reinsurance program with $4.0 million and $3.3 million of assets valued as of March 31, 2018 and April 1, 2017, respectively. Assets of the funded plan are included in "Other non-current assets" in the Consolidated Balance Sheets. The net periodic benefit obligations of both plans were $12.7 million and $11.4 million as of March 31, 2018 and April 1, 2017, respectively, which is included in “Accrued liabilities” and “Other long-term liabilities” in the Consolidated Balance Sheets. The assumptions used in calculating the benefit obligations for the plans are dependent on the local economic conditions and were measured as of March 31, 2018 and April 1, 2017. The net periodic benefit costs were approximately $0.7 million, $0.6 million and $0.8 million for fiscal years 2018, 2017 and 2016, respectively. Non-Qualified Deferred Compensation Plan Certain employees and members of the Board of Directors are eligible to participate in the Company's Non-Qualified Deferred Compensation Plan ("NQDC Plan"). The NQDC Plan provides eligible participants the opportunity to defer and invest a specified percentage of their cash compensation. The NQDC Plan is a non-qualified plan that is maintained in a rabbi trust. The amount of compensation to be deferred by each participant is based on their own elections and is adjusted for any investment changes that the participant directs. The deferred compensation obligation and the fair value of the investments held in the rabbi trust were $14.3 million and $10.2 million as of March 31, 2018 and April 1, 2017, respectively. The current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $1.0 million and $0.7 million as of March 31, 2018 and April 1, 2017, respectively, and are included in "Other current assets" and "Accrued liabilities" in the Consolidated Balance Sheets. The non-current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $13.3 million and $9.5 million as of March 31, 2018 and April 1, 2017, respectively, and are included in "Other non-current assets" and "Other long-term liabilities" in the Consolidated Balance Sheets.

Commitments and Contingent Liabilities

12 Months Ended

Mar. 31, 2018

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENT LIABILITIES

The Company leases certain of its corporate, wafer fabrication and other facilities from multiple third-party real estate developers. The operating leases expire at various dates through 2034, and some of these leases have renewal options, with the longest ranging up to two, ten-year periods. Several of these leases also include market rate rent escalations, rent holidays, and leasehold improvement incentives, all of which are recognized to expense on a straight-line basis. The amortization period of leasehold improvements made either at the inception of the lease or during the lease term is amortized over the lesser of the remaining life of the lease term (including renewals that are reasonably assured) or the useful life of the asset. The Company also leases various machinery and equipment and office equipment under non-cancelable operating leases. The remaining terms of these operating leases range from less than one year to approximately four years. As of March 31, 2018, the total future minimum lease payments related to facility and equipment operating leases was approximately $68.6 million.

In the fourth quarter of fiscal 2018, the Company entered into a capital lease for a facility in Beijing, China that will allow the Company to consolidate several leased facilities as well as provide additional manufacturing space. The lease term is expected to commence in fiscal 2020 and therefore is not recorded on the Consolidated Balance Sheet as of March 31, 2018. The initial term of the lease is five years. The lease includes multiple renewal options, and the maximum lease term cannot exceed 30 years.

Minimum future lease payments under non-cancelable operating and capital leases as of March 31, 2018, are as follows (in thousands):



Fiscal Year	Operating Leases		Capital Lease		Total
2019	$	12,490	$	0	$	12,490
2020	11,429		1,047		12,476
2021	10,469		1,047		11,516
2022	8,577		1,047		9,624
2023	7,163		1,047		8,210
Thereafter	18,454		48,243		66,697
Total minimum lease payments	$	68,582	$	52,431	$	121,013

Rent expense under operating leases, covering facilities and equipment, was approximately $16.3 million, $14.8 million, and $14.2 million for fiscal years 2018, 2017 and 2016, respectively.

Legal Matters

The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that it can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period in which such determination is made.

The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of its business that have not been fully adjudicated. These actions, when finally concluded and determined, will not, in the opinion of management, have a material adverse effect upon the Company’s consolidated financial position or results of operations.

Restructuring	12 Months Ended
Restructuring	Mar. 31, 2018
Restructuring and Related Activities [Abstract]
RESTRUCTURING	RESTRUCTURING During fiscal 2018, the Company recorded approximately $67.7 million of restructuring expenses in "Other operating expense" in the Consolidated Statements of Operations, related to actions initiated in fiscal 2018 to improve operating efficiencies and actions initiated in fiscal 2015 as a result of the Business Combination. During fiscal 2018, the Company initiated restructuring actions to improve operating efficiencies, and, as a result of these actions, recorded approximately $18.3 million of employee termination benefits. As a result of this restructuring plan, in the fourth quarter of fiscal 2018, the Company also adjusted the carrying value of certain of its held for sale assets located in China and the U.S. to fair market value (resulting in impairment charges totaling approximately $46.3 million, pursuant to ASC 360). The fair value of the assets is based on quotes from third parties. The Company expects to record approximately $0.9 million of additional restructuring charges in fiscal 2019 primarily associated with employee termination benefits. During fiscal years 2018, 2017 and 2016, the Company recorded restructuring expenses (including employee termination benefits, stock-based compensation and ongoing expenses related to exited leased facilities) of approximately $2.7 million, $2.1 million and $10.2 million, respectively, primarily as a result of the Business Combination. See Note 6 for further information on the Business Combination. As of March 31, 2018 and April 1, 2017, restructuring obligations relating to employee termination benefits totaled $6.1 million and $1.6 million, respectively, and are included in “Accrued liabilities” in the Consolidated Balance Sheets. As of March 31, 2018 and April 1, 2017, restructuring obligations relating to lease obligations totaled $2.6 million and $2.1 million, respectively, and are included in "Accrued liabilities" and "Other long-term liabilities" in the Consolidated Balance Sheets.

Income Taxes

12 Months Ended

Mar. 31, 2018

Income Tax Disclosure [Abstract]

INCOME TAXES

On December 22, 2017, the Tax Act was signed into law in the U.S. The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates, providing full expensing for investments in new and used qualified property made after September 27, 2017, and implementing a territorial tax system. Due to the timing of the Company's fiscal year, the lower corporate income tax rate will be phased in, resulting in a U.S. statutory federal rate of approximately 31.5% for our fiscal year ended March 31, 2018, and 21% for subsequent fiscal years. The Tax Act implements a territorial tax system that eliminates U.S. federal income taxes on dividends from 10% owned foreign subsidiaries, but limits the ability to credit certain foreign taxes that existed prior to enactment of the Tax Act. In connection with the transition to the new territorial tax system, a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries is being imposed (the “Transitional Repatriation Tax”), which is payable over eight years. In addition, the Tax Act includes two new U.S. tax base erosion provisions, the Global Intangible Low-Taxed Income ("GILTI") provisions and the Base-Erosion and Anti-Abuse Tax (“BEAT”) provisions, which become effective for the Company in fiscal 2019.

The SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the appropriate accounting treatment when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. SAB 118 allows for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. In the interim periods, provisional amounts are to be recorded where the income tax effect can be reasonably estimated. The Company’s accounting for the Tax Act is incomplete, but the Company has recorded the provisional estimates discussed below and will finalize and record any resulting adjustments within the one-year measurement period. The final transitional impacts of the Tax Act may differ from the below provisional estimates, possibly materially, due to, among other things: legislation by states with respect to the Tax Act; evolving technical interpretations of the Tax Act; legislative action to address questions that arise because of the Tax Act; clarification of the application of accounting standards for income taxes or related interpretations in response to the Tax Act; or updates or changes to provisional amounts the Company has utilized to calculate the transitional impacts, including impacts from changes to current year earnings and tax liabilities, deferred tax assets and liabilities, earnings and profits at foreign subsidiaries, tax pools at foreign subsidiaries, foreign tax credits and foreign exchange rates.

The impact of the Tax Act resulted in a provisional tax expense of $77.3 million in fiscal 2018. This was comprised of a provisional Transitional Repatriation Tax expense of $116.4 million, offset by a provisional deferred tax benefit of $39.1 million from the remeasurement of U.S. deferred tax assets and liabilities. Both the tax charge and the tax benefit represent provisional amounts and the Company’s current best estimates.

The Transitional Repatriation Tax is a one-time tax on accumulated and current earnings and profits (“E&P”) of foreign companies with U.S. owners that have not previously been subjected to tax in the U.S. A portion of the E&P is subject to a tax rate of 15.5% and the remainder to 8%. To determine the amount of the Transitional Repatriation Tax, the Company must determine for each foreign company in which it has a direct or indirect ownership interest, among other factors, the amount of post-1986 E&P of its foreign subsidiaries, as well as the amount of non-U.S. income taxes paid on such earnings. The Company was able to make a reasonable estimate of the Transitional Repatriation Tax on its wholly owned foreign subsidiaries and has recorded a provisional Transitional Repatriation Tax expense of $116.4 million as a component of its current income tax provision. No reasonable estimate has been made with respect to direct and indirect investments in other foreign companies. The Company is continuing to gather and analyze additional information and guidance to complete the accounting with respect to its calculation of E&P, non-U.S. income taxes paid, and the portion taxable at the 15.5% tax rate.

The Tax Act allows the tax liability arising from the Transitional Repatriation Tax to be paid on an installment basis over eight years, resulting in a provisional increase in the long-term tax liability account included in "Other long-term liabilities" in the Company's Consolidated Balance Sheets.

The deferred tax assets and liabilities of the Company are impacted by the Tax Act. The reduction in the U.S. federal corporate tax rate from 35% to 21% for tax years beginning after December 31, 2017, requires the Company to remeasure its deferred tax assets and liabilities. The Company has evaluated this change and recorded a decrease to net deferred tax liabilities with a corresponding increase to deferred tax benefit of $39.1 million. In addition, the full expensing of investments in qualified property after September 27, 2017, impacts the calculation of deferred tax balances. The provisional amount for full expensing requires further analysis to determine which fixed assets placed in service after September 27, 2017, meet the qualification requirements. The Company is still in the process of evaluating the state tax impact on deferred tax balances, including valuation allowances, from the full expensing provision and other provisions of the Tax Act.

GILTI creates a new requirement that certain income earned by foreign subsidiaries must be currently included in the gross income of the U.S. stockholder. Due to the complexity of the new GILTI tax rules, the Company continues to evaluate this provision of the Tax Act and the application of ASC 740, "Income Taxes." Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either: (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into the Company's measurement of its deferred taxes (the “deferred method”). The Company has not yet completed its analysis of the GILTI tax rules and is not yet able to reasonably estimate the effect of this provision or make the accounting policy election. As a result, the Company has not made any provisional adjustments related to potential GILTI tax in its financial statements and has not made a policy decision regarding whether to record deferred taxes for GILTI.

Beginning in calendar year 2018, the Tax Act provides a 100% deduction for dividends received from 10-percent owned foreign corporations by U.S. corporate stockholders, subject to a one-year holding period. Although dividend income is now exempt from U.S. federal tax in the hands of the U.S. corporate stockholders, companies must still apply the guidance of ASC 740-30-25-18 to account for the tax consequences of outside basis differences and other tax impacts of their investments in non-U.S. subsidiaries. While the Company has accrued the Transitional Repatriation Tax on the deemed repatriated earnings that were previously indefinitely reinvested, it currently intends to only repatriate amounts where no additional withholding taxes will be imposed on a distribution. The Company has determined that Singapore does not impose a withholding tax on dividends and no longer takes the position that earnings are permanently reinvested for our operating subsidiary in Singapore. With respect to its other foreign subsidiaries, the Company continues to account for them as permanently reinvested while it continues to evaluate the impacts of the Tax Act on its operations in accordance with guidance issued under SAB 118.

Income (loss) before income taxes consists of the following components (in thousands):



	Fiscal Year
	2018			2017		2016
United States	$	(151,083	)	$	2,439	$	(35,923	)
Foreign	168,228			24,866		33,061
Total	$	17,145		$	27,305	$	(2,862	)

The components of the income tax provision are as follows (in thousands):



	Fiscal Year
	2018			2017			2016
Current (expense) benefit:
Federal	$	(28,168	)	$	(23,835	)	$	(4,285	)
State	(229		)	(476		)	(541		)
Foreign	(61,284		)	(47,579		)	(33,346		)
	(89,681		)	(71,890		)	(38,172		)
Deferred benefit (expense):
Federal	$	11,817		$	2,762		$	27,794
State (1)	253			3,659			(31,229		)
Foreign	20,178			21,606			15,624
	32,248			28,027			12,189
Total	$	(57,433	)	$	(43,863	)	$	(25,983	)

(1) In fiscal 2016, the state deferred tax expense included a $31.0 million income tax expense related to an increase in the valuation allowance for the deferred tax asset related to state net operating losses and tax credits.

A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income (loss) for fiscal years 2018, 2017 and 2016 is as follows (dollars in thousands):



	Fiscal Year
	2018					2017					2016
	Amount			Percentage		Amount			Percentage		Amount			Percentage
Income tax (expense) benefit at statutory federal rate	$	(5,407	)	31.54	%	$	(9,557	)	35.00	%	$	1,002		35.00	%
(Increase) decrease resulting from:
State benefit (provision), net of federal (provision) benefit	474			(2.77	)	(662		)	2.42		(1,320		)	(46.14	)
Tax credits	38,054			(221.95	)	15,352			(56.22	)	15,459			540.21
Effect of changes in income tax rate applied to net deferred tax assets	39,168			(228.45	)	1,163			(4.26	)	(2,716		)	(94.92	)
Foreign tax rate difference	21,829			(127.32	)	(11,298		)	41.38		4,114			143.77
Foreign permanent differences	(2,598		)	15.15		(8,432		)	30.88		(1,700		)	(59.40	)
Change in valuation allowance	(1,632		)	9.52		1,363			(4.99	)	(25,120		)	(877.84	)
Stock-based compensation	9,924			(57.88	)	(3,228		)	11.82		(5,362		)	(187.37	)
Tax reserve adjustments	(29,188		)	170.24		(21,789		)	79.80		(8,699		)	(303.99	)
Deemed dividend	(5,098		)	29.73		(6,989		)	25.60		(3,984		)	(139.21	)
U.S. Tax Toll Charge	(116,419		)	679.03		—			—		—			—
Intra-entity transfer	(6,873		)	40.09		—			—		—			—
Other income tax (expense) benefit	333			(1.94	)	214			(0.79	)	2,343			81.89
	$	(57,433	)	334.99	%	$	(43,863	)	160.64	%	$	(25,983	)	(908.00	)%

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the basis used for income tax purposes. The deferred income tax assets and liabilities are measured in each taxing jurisdiction using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

Significant components of the Company’s net deferred income taxes are as follows (in thousands):



	Fiscal Year
	2018			2017
Deferred income tax assets:
Inventory reserve	$	9,894		$	15,599
Equity compensation	37,724			83,333
Net operating loss carry-forwards	50,128			40,575
Research and other credits	39,513			92,793
Employee benefits	12,842			13,247
Other deferred assets	16,620			23,355
Total deferred income tax assets	166,721			268,902
Valuation allowance	(42,787		)	(33,104		)
Total deferred income tax assets, net of valuation allowance	$	123,934		$	235,798

Deferred income tax liabilities:
Amortization and purchase accounting basis difference	$	(101,261	)	$	(258,422	)
Accumulated depreciation/basis difference	(63,363		)	(91,337		)
Total deferred income tax liabilities	(164,624		)	(349,759		)
Net deferred income tax liabilities	$	(40,690	)	$	(113,961	)

Amounts included in the Consolidated Balance Sheets:
Non-current assets	22,394			17,550
Non-current liabilities	(63,084		)	(131,511		)

Net deferred income tax liabilities	$	(40,690	)	$	(113,961	)

The Company has recorded a $42.8 million and a $33.1 million valuation allowance against the U.S. deferred tax assets and deferred tax assets at foreign subsidiaries as of March 31, 2018, and April 1, 2017, respectively. These valuation allowances were established based upon management's opinion that it is more likely than not (a likelihood of more than 50 percent) that the benefit of these deferred tax assets may not be realized. Realization is dependent upon generating future income in the taxing jurisdictions in which the operating loss carryovers, credit carryovers, depreciable tax basis and other tax deferred assets exist. Management reevaluates the ability to realize the benefit of the deferred tax assets of the Company on a quarterly basis.

The valuation allowance against deferred tax assets increased by $9.7 million in fiscal 2018. The increase was comprised of a $6.8 million increase resulting from tax rate changes, primarily the federal rate changes enacted in the Tax Act, a $1.9 million increase in the state deferred tax for net operating losses and tax credits, a $1.0 million increase for deferred tax assets for net operating losses at other foreign subsidiaries and a $0.5 million increase in the valuation allowance for state tax credits due to the adoption of ASU 2016-09. It was partially offset by a $0.5 million decrease in valuation allowance for federal deferred tax assets for foreign tax credits. At the end of fiscal 2018, a $2.0 million valuation allowance remained against deferred tax assets at other foreign subsidiaries and a $40.8 million valuation allowance remained against domestic deferred tax assets as management has determined it is more likely than not that the related deferred tax assets will not be realized.

The valuation allowance against deferred tax assets decreased by $1.6 million in fiscal 2017. The decrease was comprised of a $5.2 million decrease in the valuation allowance for foreign deferred tax assets primarily resulting from the removal of the valuation allowance at a China manufacturing subsidiary as management has determined it is more likely than not that the related deferred tax assets will be realized. The decrease was offset by a $2.8 million increase in the valuation allowance for federal deferred tax assets for foreign tax credits and state deferred tax assets for net operating losses and tax credits, as well as a $0.8 million increase for deferred tax assets for net operating losses at other foreign subsidiaries. At the end of fiscal 2017, a $0.8 million valuation allowance remained against deferred tax assets at other foreign subsidiaries and a $32.3 million valuation allowance remained against domestic deferred tax assets as management determined it was more likely than not that the related deferred tax assets would not be realized.

During fiscal 2017, the Company's China manufacturing subsidiary, which operates as a cost plus manufacturer for another Qorvo subsidiary, exited its start-up operational phase and generated sufficient income to substantially offset the losses earned in prior years. The balance of the cumulative pre-tax book loss was expected to be offset by income in the first half of fiscal 2018 as production at the assembly and test facility continued to increase as the Company reduced its dependence on outside assembly and test subcontractors. After evaluating the positive and negative evidence, management determined that it was more likely than not that the deferred tax assets of this China manufacturing subsidiary would be realized and a valuation allowance would not be provided as of the end of fiscal 2017.

The valuation allowance against deferred tax assets increased by $20.9 million in fiscal 2016. The increase was comprised of a $20.2 million increase in the valuation allowance for state deferred tax assets for net operating losses and tax credits, a $5.0 million increase in the valuation allowance for foreign net operating loss deferred tax assets, and a $4.3 million decrease in the valuation allowance related to a deferred tax asset recorded in the initial purchase price accounting for the Business Combination. The Business Combination adjustment related to a deferred tax asset which was recorded during fiscal 2015 in the initial purchase price accounting with a full valuation allowance, but which deferred tax asset was determined in fiscal 2016 to not exist as of the acquisition date. Accordingly, in fiscal 2016, that deferred tax asset was removed along with the offsetting deferred tax asset valuation allowance. At the end of fiscal 2016, a $5.2 million valuation allowance remained against foreign deferred tax assets and a $29.5 million valuation allowance remained against domestic deferred tax assets as management determined it was more likely than not that the related deferred tax assets would not be realized, effectively increasing the domestic net deferred tax liabilities.

During fiscal 2016, North Carolina enacted legislation to reduce the corporate income tax rate from 5% to 4% and phase-in over a three-year period a move to a single sales factor apportionment methodology. In addition, the Company underwent operational changes to leverage existing resources and capabilities of its Singapore subsidiary and consolidate operations and responsibilities associated with its foreign back-end manufacturing operations and foreign customers in that Singapore subsidiary. Together these changes resulted in a significant decrease in the amount of future taxable income expected to be allocated to North Carolina and other states in which the net operating loss and tax credit carryovers existed. As a result, it was no longer more likely than not that the deferred tax assets related to those state net operating loss and tax credit carryovers for which a valuation allowance was being provided will be used before they expire. The deferred tax asset for foreign net operating losses primarily related to the China subsidiary which owns the internal assembly and test facility that became operational during fiscal 2016 and had incurred losses since inception.

As of March 31, 2018, the Company had federal loss carryovers of approximately $305.0 million that expire in fiscal years 2020 to 2038 if unused and state losses of approximately $147.3 million that expire in fiscal years 2019 to 2038 if unused. Federal research credits of $54.9 million, and state credits of $58.7 million may expire in fiscal years 2019 to 2038 and 2019 to 2033, respectively. Foreign losses in the Netherlands of approximately $7.8 million expire in fiscal years 2019 to 2027. Included in the amounts above are certain net operating losses and other tax attribute assets acquired in conjunction with acquisitions in the current and prior years. The utilization of acquired domestic assets is subject to certain annual limitations as required under Section 382 of the Internal Revenue Code of 1986, as amended (the "Code") and similar state income tax provisions.

The Company has continued to expand its operations and increase its investments in numerous international jurisdictions. These activities expose the Company to taxation in multiple foreign jurisdictions. It is management's opinion that current and future undistributed foreign earnings will be permanently reinvested, except for the earnings of Qorvo International Pte. Ltd., our operating subsidiary in Singapore. No provision for U.S. federal, state income taxes and foreign local withholding taxes has been made with respect to any of the other foreign subsidiaries. It is not practical to estimate the additional tax that would be incurred, if any, if the permanently reinvested earnings were repatriated.

The Company has foreign subsidiaries with tax holiday agreements in Costa Rica and Singapore. These tax holiday agreements have varying rates and expire in March 2024 and December 2021, respectively. In February 2017, Singapore enacted legislation that will exclude from the Company's existing Development and Expansion Incentive grant the benefit of the reduced tax rate for intellectual property income earned after June 30, 2021. Incentives from these countries are subject to the Company meeting certain employment and investment requirements. Income tax expense decreased by $7.9 million (approximately $0.06 per basic and diluted share impact) in fiscal 2018 and $2.7 million (approximately $0.02 per basic and diluted share impact) in fiscal 2017 as a result of these agreements.

The Company’s gross unrecognized tax benefits totaled $122.8 million as of March 31, 2018, $90.6 million as of April 1, 2017, and $69.1 million as of April 2, 2016. Of these amounts, $118.7 million (net of federal benefit of state taxes), $84.4 million (net of federal benefit of state taxes) and $64.2 million (net of federal benefit of state taxes) as of March 31, 2018, April 1, 2017, and April 2, 2016, respectively, represent the amounts of unrecognized tax benefits that, if recognized, would impact the effective tax rate in each of the fiscal years.

A reconciliation of fiscal 2016 through fiscal 2018 beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):



	Fiscal Year
	2018			2017			2016
Beginning balance	$	90,615		$	69,052		$	59,397
Additions based on positions related to current year	26,431			20,036			9,374
Additions for tax positions in prior years	5,844			1,878			2,723
Reductions for tax positions in prior years	(67		)	(29		)	(1,973		)
Expiration of statute of limitations	—			(322		)	(469		)
Ending balance	$	122,823		$	90,615		$	69,052

It is the Company’s policy to recognize interest and penalties related to uncertain tax positions as a component of income tax expense. During fiscal years 2018, 2017 and 2016, the Company recognized $(2.5) million, $2.1 million and $1.6 million, respectively, of interest and penalties related to uncertain tax positions. Accrued interest and penalties related to unrecognized tax benefits totaled $4.6 million, $7.1 million and $5.0 million as of March 31, 2018, April 1, 2017, and April 2, 2016, respectively.

The unrecognized tax benefits of $122.8 million and accrued interest and penalties of $4.6 million at the end of fiscal 2018 are recorded on the Consolidated Balance Sheet as an $18.3 million long-term liability, with the balance reducing the carrying value of the gross deferred tax assets.

Within the next 12 months, the Company believes it is reasonably possible that only a minimal amount of gross unrecognized tax benefits will be reduced as a result of reductions for tax positions taken in prior years where the only uncertainty was related to the timing of the tax deduction.

Income taxes payable of $60.0 million and $31.7 million as of March 31, 2018, and April 1, 2017, respectively, are included in "Other current liabilities" in the Consolidated Balance Sheets. Long term income taxes payable of $24.2 million as of March 31, 2018, are included in "Other long-term liabilities" in the Consolidated Balance Sheets.

RFMD's fiscal 2015 and TriQuint's calendar 2014 federal, North Carolina, and California tax returns and subsequent tax years remain open for examination. The federal tax return for the short period ended January 1, 2015 for RFMD is currently under examination by the Internal Revenue Service, and the Singapore tax return for calendar year 2012 is currently under examination by the Singapore tax authorities. An examination by taxing authorities of the Company's China subsidiary in Beijing of its calendar year 2013 through 2015 tax returns was completed in fiscal 2018 with minimal adjustments and returns for subsequent tax years remain open for examination. An examination by the German taxing authorities of the returns for calendar years 2013 through 2015 was completed during fiscal 2017 with minimal adjustments and returns for subsequent tax years remain open for examination. Tax attributes (including net operating loss and credit carryovers) arising in earlier fiscal years remain open to adjustment.

Net Loss Per Share

12 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

NET INCOME (LOSS) PER SHARE

NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share data):



	For Fiscal Year
	2018			2017			2016
Numerator:
Numerator for basic and diluted net loss per share — net loss available to common stockholders	$	(40,288	)	$	(16,558	)	$	(28,845	)
Denominator:
Denominator for basic net loss per share — weighted average shares	126,946			127,121			141,937
Effect of dilutive securities:
Stock-based awards	—			—			—
Denominator for diluted net loss per share — adjusted weighted average shares and assumed conversions	126,946			127,121			141,937
Basic net loss per share	$	(0.32	)	$	(0.13	)	$	(0.20	)
Diluted net loss per share	$	(0.32	)	$	(0.13	)	$	(0.20	)

In the computation of diluted net loss per share for fiscal years 2018, 2017 and 2016, approximately 3.7 million shares, 4.8 million shares and 5.0 million shares, respectively, were excluded because the effect of their inclusion would have been anti-dilutive.

Stock-Based Compensation

12 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

Summary of Stock Option Plans

2003 Stock Incentive Plan - RF Micro Devices, Inc.

The 2003 Stock Incentive Plan (the "2003 Plan") was approved by the Company's stockholders on July 22, 2003, and the Company was permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units, under the 2003 Plan. No further awards can be granted under this plan.

2006 Directors’ Stock Option Plan - RF Micro Devices, Inc.

At the Company’s 2006 annual meeting of stockholders, stockholders of the Company adopted the 2006 Directors’ Stock Option Plan, which replaced the Non-Employee Directors’ Stock Option Plan and reserved an additional 0.3 million shares of common stock for issuance to non-employee directors. Under the terms of this plan, non-employee directors were entitled to receive options to acquire shares of common stock. No further awards can be granted under this plan.

1996 Stock Incentive Program - TriQuint Semiconductor, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 1996 Stock Incentive Program (the “TriQuint 1996 Stock Incentive Program”), originally adopted by TriQuint. The TriQuint 1996 Stock Incentive Program provided for the grant of incentive and non-qualified stock options to officers, outside directors and other employees of TriQuint or any parent or subsidiary. The TriQuint 1996 Stock Incentive Program was amended in 2002 to provide that options granted thereunder must have an exercise price per share no less than 100% of the fair market value of the share price on the grant date. In 2005, the TriQuint 1996 Stock Incentive Program was further amended to extend the term of the program to 2015 and permit the award of restricted stock, restricted stock units, stock appreciation rights, performance shares and performance units in addition to the grant of stock options. In addition, the amendment provided specific performance criteria that the plan administrator may use to establish performance objectives. The terms of each grant under the TriQuint 1996 Stock Incentive Program could not exceed ten years. No further awards can be granted under this program.

2008 Inducement Award Plan- TriQuint Semiconductor, Inc.

Effective upon the closing of the Business Combination, the Company assumed the sponsorship of the TriQuint, Inc. 2008 Inducement Award Plan (the “TriQuint 2008 Inducement Award Plan”), originally adopted by TriQuint. The TriQuint 2008 Inducement Award Plan provided for the grant of nonstatutory stock options, restricted stock, restricted stock units, stock appreciation rights and other stock or cash awards to employees of TriQuint or any parent or subsidiary. The options granted thereunder were required to have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the plan could not exceed ten years. No further awards can be granted under this plan.

2009 and 2012 Incentive Plans - TriQuint Semiconductor, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2009 Incentive Plan and TriQuint, Inc. 2012 Incentive Plan (the “TriQuint Incentive Plans”), originally adopted by TriQuint. The TriQuint Incentive Plans provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates. The options granted thereunder were required to have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the TriQuint Incentive Plans could not exceed ten years. No further awards can be granted under these plans.

2012 Stock Incentive Plan - Qorvo, Inc.

The Company currently grants stock options and restricted stock units to employees and directors under the 2012 Stock Incentive Plan (the "2012 Plan"), which was approved by the Company's stockholders on August 16, 2012, assumed by the Company in connection with the Business Combination and reapproved by the Company's stockholders on August 8, 2017 for purposes of Section 162(m) of the Code. Under the 2012 Plan, the Company is permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units. The maximum number of shares issuable under the 2012 Plan may not exceed the sum of (a) 4.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2012 Plan under the Company's prior plans and (ii) subject to an award granted under a prior plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason. As of March 31, 2018, 3.6 million shares were available for issuance under the 2012 Plan. The aggregate number of shares subject to performance-based restricted stock units awarded for fiscal 2018 under the 2012 Plan was 0.2 million shares.

2013 Incentive Plan - Qorvo, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2013 Incentive Plan (the “2013 Incentive Plan”), originally adopted by TriQuint, allowing Qorvo to issue awards under this plan. The 2013 Incentive Plan replaces the TriQuint 2012 Incentive Plan and provides for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates who were such prior to the Business Combination or who become employed by the Company or its affiliates after the closing of the Business Combination. Former employees, officers and directors of RFMD are not eligible for awards under the 2013 Incentive Plan. The options granted thereunder must have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the 2013 Incentive Plan may not exceed ten years. As of March 31, 2018, 2.4 million shares were available for issuance under the 2013 Incentive Plan.

2015 Inducement Stock Plan - Qorvo, Inc.

The 2015 Inducement Stock Plan (the "2015 Inducement Plan") provides for the grant of equity awards to persons as a material inducement to become employees of the Company or its affiliates. The plan provides for the grant of stock options, restricted stock units, stock appreciation rights and other stock-based awards. The maximum number of shares issuable under the 2015 Inducement Plan may not exceed the sum of (a) 0.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2015 Inducement Stock Plan under the TriQuint 2008 Inducement Award Plan and (ii) subject to an award granted under the TriQuint 2008 Inducement Award Plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason. No awards were made under the 2015 Inducement Plan in fiscal years 2018, 2017 or 2016. As of March 31, 2018, 0.3 million shares were available for issuance under the 2015 Inducement Plan.

Employee Stock Purchase Plan - Qorvo, Inc.

Effective upon closing of the Business Combination, the Company assumed the TriQuint Employee Stock Purchase Plan ("ESPP"), which is intended to qualify as an “employee stock purchase plan” under Section 423 of the Code. All regular full-time employees of the Company (including officers) and all other employees who meet the eligibility requirements of the plan may participate in the ESPP. The ESPP provides eligible employees an opportunity to acquire the Company’s common stock at 85.0% of the lower of the closing price per share of the Company’s common stock on the first or last day of each six-month purchase period. At March 31, 2018, 4.6 million shares were available for future issuance under this plan. The Company makes no cash contributions to the ESPP, but bears the expenses of its administration. The Company issued 0.5 million, 0.7 million and 0.4 million shares under the ESPP in fiscal years 2018, 2017 and 2016, respectively.

For fiscal years 2018, 2017 and 2016, the primary stock-based awards and their general terms and conditions are as follows:

Stock options are granted to employees with an exercise price equal to the market price of the Company’s stock at the date of grant, generally vest over a four-year period from the grant date, and generally expire 10 years from the grant date. Restricted stock units granted by the Company in fiscal years 2018, 2017 and 2016 are either service-based, performance and service-based, or based on total stockholder return. Service-based restricted stock units generally vest over a four-year period from the grant date. Performance and service-based restricted stock units are earned based on Company performance of stated metrics during the fiscal year and, if earned, generally vest one-half when earned and the balance over two years. Restricted stock units based on total stockholder return are earned based upon total stockholder return of the Company in comparison to the total stockholder return of a benchmark index and can be earned over one-, two- and three-year performance periods. In fiscal 2018, each non-employee director was eligible to receive an annual grant of restricted stock units.

The options and restricted stock units granted to certain officers of the Company generally will, in the event of the officer's termination other than for cause and subject to the officer executing certain agreements in favor of the Company, continue to vest pursuant to the same vesting schedule as if the officer had remained an employee of the Company and, as a result, these awards are expensed at grant date. In fiscal 2018, stock-based compensation of $20.5 million was recognized upon the grant of 0.3 million restricted share units to certain officers of the Company.

Stock-Based Compensation

Under ASC 718, stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. ASC 718 covers a wide range of stock-based compensation arrangements including stock options, restricted share plans, performance-based awards, share appreciation rights and employee stock purchase plans.

Total pre-tax stock-based compensation expense recognized in the Consolidated Statements of Operations was $68.2 million for fiscal 2018, net of expense capitalized into inventory. For fiscal years 2017 and 2016, the total pre-tax stock-based compensation expense recognized was $88.8 million and $139.5 million, respectively, net of expense capitalized into inventory.

A summary of activity of the Company’s director and employee stock option plans follows:



	Shares (in thousands)	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of April 1, 2017	4,177	$	19.72
Granted	—	—
Exercised	(1,544)	$	19.07
Canceled	(5)	$	41.86
Forfeited	(5)	$	19.99
Outstanding as of March 31, 2018	2,623	$	20.06	3.64	$	132,217
Vested and expected to vest as of March 31, 2018	2,623	$	20.06	3.64	$	132,216
Options exercisable as of March 31, 2018	2,597	$	19.79	3.64	$	131,585

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based upon the Company’s closing stock price of $70.45 as of March 29, 2018 (the last business day prior to the fiscal year end on March 31, 2018), that would have been received by the option holders had all option holders with in-the-money options exercised their options as of that date. As of March 31, 2018, total remaining unearned compensation cost related to unvested option awards was $0.3 million, which will be amortized over the weighted-average remaining service period of approximately 0.5 years.

The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model based on the assumptions noted in the following tables:



	Fiscal Year
	2018	2017	2016
Expected volatility	N/A	N/A	42.8		%
Expected dividend yield	N/A	N/A	0.0		%
Expected term (in years)	N/A	N/A	5.7
Risk-free interest rate	N/A	N/A	1.6		%
Weighted-average grant-date fair value of options granted during the period	N/A	N/A	$	32.62

The total intrinsic value of options exercised during fiscal 2018, was $87.8 million. For fiscal years 2017 and 2016, the total intrinsic value of options exercised was $81.0 million and $74.9 million, respectively.

Cash received from the exercise of stock options and from participation in the employee stock purchase plan (excluding accrued unremitted employee funds) was approximately $57.5 million for fiscal 2018 and is reflected in cash flows from financing activities in the Consolidated Statements of Cash Flows. The Company settles employee stock options with newly issued shares of the Company's common stock.

The Company used the implied volatility of market-traded options on the Company’s common stock for the expected volatility assumption input to the Black-Scholes option-pricing model, consistent with the guidance in ASC 718. The selection of implied volatility data to estimate expected volatility was based upon the availability of actively-traded options on the Company’s common stock and the Company’s assessment that implied volatility is more representative of future common stock price trends than historical volatility.

The dividend yield assumption is based on the Company’s history and expectation of future dividend payouts and may be subject to change in the future. The Company has never paid a dividend.

The expected life of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. The Company’s method of calculating the expected term of an option assumes that all outstanding options will be exercised at the midpoint of the current date and full contractual term, combined with the average life of all options that have been exercised or canceled. The Company believes that this method provides a better estimate of the future expected life based on analysis of historical exercise behavioral data.

The risk-free interest rate assumption is based upon observed interest rates appropriate for the terms of the Company’s employee stock options.

ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based upon historical pre-vesting forfeiture experience, the Company assumed an annualized forfeiture rate of 1.6% for both stock options and restricted stock units.

The following activity has occurred with respect to restricted stock unit awards:



	Shares (in thousands)	Weighted-Average Grant-Date Fair Value
Balance at April 1, 2017	2,375	$	53.00
Granted	998	68.67
Vested	(1,059)	50.30
Forfeited	(127)	57.73
Balance at March 31, 2018	2,187	$	59.46

As of March 31, 2018, total remaining unearned compensation cost related to unvested restricted stock units was $72.5 million, which will be amortized over the weighted-average remaining service period of approximately 1.2 years.

The total fair value of restricted stock units that vested during fiscal 2018 was $73.2 million, based upon the fair market value of the Company’s common stock on the vesting date. For fiscal years 2017 and 2016, the total fair value of restricted stock units that vested was $46.1 million and $60.2 million, respectively.

Stockholders' Equity

12 Months Ended

Mar. 31, 2018

Equity [Abstract]

SHAREHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Stock Repurchase

On November 5, 2015, the Company announced that its Board of Directors authorized a share repurchase program to repurchase up to $1.0 billion of the Company's outstanding common stock through November 4, 2016. On February 16, 2016, as part of the $1.0 billion share repurchase program, the Company entered into variable maturity accelerated share repurchase ("ASR") agreements (a $250.0 million collared agreement and a $250.0 million uncollared agreement) with Bank of America, N.A. For the upfront payment of $500.0 million, the Company received 3.1 million shares of its common stock under the collared agreement (representing 50% of the shares the Company would have repurchased assuming an average share price of $40.78) and 4.9 million shares of the Company's common stock under the uncollared agreement (representing 80% of the shares the Company would have repurchased assuming an average share price of $40.78). On March 10, 2016, the Company received an additional 2.0 million shares of its common stock under the collared agreement. Final settlements of the ASR agreements were completed during the first quarter of fiscal 2017 with 0.4 million shares received resulting in a total of 10.4 million shares of the Company's common stock repurchased under the ASR agreements. The shares were retired in the periods they were delivered, and the upfront payment was accounted for as a reduction to stockholders' equity in the Consolidated Balance Sheet in the period the payment was made. The Company reflected each ASR as a repurchase of common stock in the period delivered for purposes of calculating earnings per share.

On November 3, 2016, the Company announced that its Board of Directors authorized a share repurchase program to repurchase up to $500.0 million of the Company's outstanding stock. Under this program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases will depend on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice. The program included approximately $150.0 million authorized on the $1.0 billion repurchase program that expired November 4, 2016.

The Company repurchased 2.9 million shares, 4.1 million shares (inclusive of 0.4 million shares received under the ASR agreement) and 24.3 million shares (inclusive of 10.0 million shares received under the ASR agreement) of its common stock during fiscal years 2018, 2017 and 2016, respectively, at an aggregate cost of $219.9 million, $209.4 million and $1,300.0 million, respectively, in accordance with the share repurchase programs described above. As of March 31, 2018, $162.1 million remains available for future repurchases under our current share repurchase program.

Common Stock Reserved For Future Issuance

At March 31, 2018, the Company had reserved a total of approximately 15.7 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands):



Outstanding stock options under formal directors’ and employees’ stock option plans	2,623
Possible future issuance under Company stock incentive plans	6,254
Employee stock purchase plan	4,594
Restricted stock-based units granted	2,187
Total shares reserved	15,658

Operating Segment and Geographical Information

12 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

OPERATING SEGMENT AND GEOGRAPHIC INFORMATION

The Company's operating segments as of March 31, 2018 are MP and IDP based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on non-GAAP operating income (loss) and non-GAAP operating income (loss) as a percentage of revenue.

MP is a leading global supplier of cellular RF and Wi-Fi solutions for a variety of mobile devices, including smartphones, notebook computers, wearables, tablets, and cellular-based applications for the IoT. Mobile device manufacturers and mobile network operators are adopting new technologies to address the growing demand for data-intensive, increasingly cloud-based distributed applications and for mobile devices with smaller form factors, improved signal quality, less heat and longer talk and standby times. New wireless communications standards are being deployed to utilize available spectrum more efficiently. Carrier aggregation is being implemented to support wider bandwidths, increase data rates and improve network performance. These trends increase the complexity of smartphones, require more RF content and place a premium on performance, integration, systems-level expertise, and product and technology portfolio breadth, all of which are MP strengths. MP offers a comprehensive product portfolio of BAW and SAW filters, power amplifiers ("PAs"), low noise amplifiers ("LNAs"), switches, multimode multi-band PAs and transmit modules, RF power management integrated circuits, diversity receive modules, antenna switch modules, antenna tuning and control solutions, modules incorporating PAs and duplexers and modules incorporating switches, PAs and duplexers.

IDP is a leading global supplier of RF solutions with a diverse portfolio of solutions that "connect and protect," spanning communications and defense applications. These applications include high performance defense systems such as radar, electronic warfare and communication systems, Wi-Fi customer premises equipment for home and work, high speed connectivity in Long-Term Evolution and 5G base stations, cloud connectivity via data center communications and telecom transport, automotive connectivity and other IoT, including smart home solutions. IDP products include high power GaAs and GaN PAs, LNAs, switches, CMOS SoC solutions, premium BAW and SAW filter solutions and various multi-chip and hybrid assemblies.

The “All other” category includes operating expenses such as stock-based compensation, amortization of intangible assets, acquisition and integration related costs, restructuring and disposal costs, start-up costs, (loss) gain on assets and other miscellaneous corporate overhead expenses that the Company does not allocate to its reportable segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Except as discussed above regarding the “All other” category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

The following tables present details of the Company’s reportable segments and a reconciliation of the “All other” category (in thousands):



	Fiscal Year
	2018			2017			2016
Revenue:
MP	$	2,181,161		$	2,384,041		$	2,083,334
IDP	788,495			644,653			523,512
All other (1)	3,880			3,880			3,880
Total revenue	$	2,973,536		$	3,032,574		$	2,610,726
Income from operations:
MP	$	549,574		$	554,001		$	591,751
IDP	235,719			152,539			108,370
All other	(715,011		)	(618,481		)	(688,153		)
Income from operations	$	70,282		$	88,059		$	11,968
Interest expense	$	(59,548	)	$	(58,879	)	$	(23,316	)
Interest income	7,017			1,212			2,068
Other (expense) income	(606		)	(3,087		)	6,418
Income (loss) before income taxes	$	17,145		$	27,305		$	(2,862	)

(1) "All other" revenue relates to royalty income that is not allocated to MP or IDP.



	Fiscal Year
	2018			2017			2016
Reconciliation of “All other” category:
Stock-based compensation expense	$	(68,158	)	$	(88,845	)	$	(139,516	)
Amortization of intangible assets	(539,362		)	(494,387		)	(494,589		)
Acquisition and integration related costs	(10,561		)	(25,391		)	(26,503		)
Restructuring charges	(21,406		)	(1,696		)	(4,235		)
Start-up costs	(24,271		)	(9,694		)	(14,110		)
Other (including loss (gain) on assets and other miscellaneous corporate overhead)	(51,253		)	1,532			(9,200		)
Loss from operations for “All other”	$	(715,011	)	$	(618,481	)	$	(688,153	)

As a result of restructuring actions initiated in fiscal 2018, the Company adjusted the carrying value of certain of its held for sale assets located in China and the U.S., and recorded impairment charges totaling approximately $46.3 million. The fair value of the assets is based on quotes from third parties. See Note 11 for further information on the restructuring.

The consolidated financial statements include revenue to customers by geographic region that are summarized as follows (in thousands):



	Fiscal Year
	2018		2017		2016
Revenue:
United States	$	524,472	$	467,031	$	306,328
International	2,449,064		2,565,543		2,304,398



	Fiscal Year
	2018	2017	2016
Revenue:
United States	18%	15%	12%
Asia	78	81	83
Europe	3	3	4
Other	1	1	1

Sales, for geographic disclosure purposes, are based on the “sold to” address of the customer. The “sold to” address is not always an accurate representation of the location of final consumption of the Company’s components. Of the Company’s revenue for fiscal 2018, approximately 52% ($1,539.7 million) was from customers in China and 19% ($564.8 million) from customers in Taiwan. Of the Company’s revenue for fiscal years 2017 and 2016, approximately 62% ($1,866.0 million) and 61% ($1,601.0 million), respectively, was from customers in China and 13% ($398.4 million) and 14% ($365.1 million), respectively, was from customers in Taiwan.

The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands):



	March 31, 2018		April 1, 2017		April 2, 2016
Long-lived tangible assets:
United States	$	1,089,157	$	1,082,754	$	816,882
China	217,205		244,728		183,836
Other countries	67,750		64,450		46,170

Consolidating Financial Information

12 Months Ended

Mar. 31, 2018

Consolidating Financial Information [Abstract]

Consolidating Financial Information

CONDENSED CONSOLIDATING FINANCIAL INFORMATION

In accordance with the indenture governing the Notes, the Company's obligations under the Notes are fully and unconditionally guaranteed on a joint and several basis by each Guarantor, each of which is 100% owned, directly or indirectly, by Qorvo, Inc. A Guarantor can be released in certain customary circumstances.

The following presents the condensed consolidating financial information separately for:


(i)	Parent Company, the issuer of the guaranteed obligations;


(ii)	Guarantor subsidiaries, on a combined basis, as specified in the indenture;


(iii)	Non-guarantor subsidiaries, on a combined basis;


(iv)	Consolidating entries and eliminations representing adjustments to (a) eliminate intercompany transactions between or among Parent Company, the guarantor subsidiaries and the non-guarantor subsidiaries, (b) eliminate intercompany profit in inventory, (c) eliminate the investments in the Company’s subsidiaries and (d) record consolidating entries; and


(v)	The Company, on a consolidated basis.

Each entity in the condensed consolidating financial information follows the same accounting policies as described in the consolidated financial statements, except for the use by the Parent Company and guarantor subsidiaries of the equity method of accounting to reflect ownership interests in subsidiaries that are eliminated upon consolidation. The financial information may not necessarily be indicative of the financial position, results of operations, comprehensive (loss) income, and cash flows, had the Parent Company, guarantor or non-guarantor subsidiaries operated as independent entities.



	Condensed Consolidating Balance Sheet
	March 31, 2018
(in thousands)	Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations and Reclassifications			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	629,314	$	296,723	$	—		$	926,037
Accounts receivable, less allowance	—		76,863		269,094		—			345,957
Intercompany accounts and note receivable	—		272,409		53,363		(325,772		)	—
Inventories	—		154,651		339,434		(21,793		)	472,292
Prepaid expenses	—		17,530		6,379		—			23,909
Other receivables	—		5,959		38,836		—			44,795
Other current assets	—		29,627		1,188		—			30,815
Total current assets	—		1,186,353		1,005,017		(347,565		)	1,843,805
Property and equipment, net	—		1,085,255		289,146		(289		)	1,374,112
Goodwill	—		1,121,941		1,051,948		—			2,173,889
Intangible assets, net	—		395,317		465,019		—			860,336
Long-term investments	—		1,847		61,918		—			63,765
Long-term intercompany accounts and notes receivable	—		543,127		116,494		(659,621		)	—
Investment in subsidiaries	6,198,885		2,388,222		—		(8,587,107		)	—
Other non-current assets	72,122		31,011		32,516		(70,037		)	65,612
Total assets	$	6,271,007	$	6,753,073	$	3,022,058	$	(9,664,619	)	$	6,381,519
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	—	$	78,278	$	134,915	$	—		$	213,193
Intercompany accounts and notes payable	—		53,363		272,409		(325,772		)	—
Accrued liabilities	23,102		101,286		43,163		(369		)	167,182
Other current liabilities	—		3,882		57,022		—			60,904
Total current liabilities	23,102		236,809		507,509		(326,141		)	441,279
Long-term debt	983,290		—		—		—			983,290
Deferred tax liabilities	—		83,449		16,366		(36,731		)	63,084
Long-term intercompany accounts and notes payable	489,051		116,494		54,076		(659,621		)	—
Other long-term liabilities	—		62,417		55,885		—			118,302
Total liabilities	1,495,443		499,169		633,836		(1,022,493		)	1,605,955
Total stockholders’ equity	4,775,564		6,253,904		2,388,222		(8,642,126		)	4,775,564
Total liabilities and stockholders’ equity	$	6,271,007	$	6,753,073	$	3,022,058	$	(9,664,619	)	$	6,381,519



	Condensed Consolidating Balance Sheet
	April 1, 2017
(in thousands)	Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations and Reclassifications			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	226,186	$	319,277	$	—		$	545,463
Accounts receivable, less allowance	—		57,874		300,074		—			357,948
Intercompany accounts and notes receivable	—		392,075		36,603		(428,678		)	—
Inventories	—		131,225		322,559		(23,330		)	430,454
Prepaid expenses	—		29,032		7,197		—			36,229
Other receivables	—		7,239		58,008		—			65,247
Other current assets	—		25,534		730		—			26,264
Total current assets	—		869,165		1,044,448		(452,008		)	1,461,605
Property and equipment, net	—		1,078,761		314,910		(1,739		)	1,391,932
Goodwill	—		1,121,941		1,051,973		—			2,173,914
Intangible assets, net	—		599,618		800,945		—			1,400,563
Long-term investments	—		25,971		9,523		—			35,494
Long-term intercompany accounts and notes receivable	—		447,613		138,398		(586,011		)	—
Investment in subsidiaries	6,142,568		2,596,172		—		(8,738,740		)	—
Other non-current assets	84,153		33,249		24,746		(83,333		)	58,815
Total assets	$	6,226,721	$	6,772,490	$	3,384,943	$	(9,861,831	)	$	6,522,323
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	—	$	111,799	$	104,447	$	—		$	216,246
Intercompany accounts and notes payable	—		36,603		392,075		(428,678		)	—
Accrued liabilities	23,150		111,700		35,734		—			170,584
Other current liabilities	—		55		31,943		—			31,998
Total current liabilities	23,150		260,157		564,199		(428,678		)	418,828
Long-term debt	989,154		—		—		—			989,154
Deferred tax liabilities	—		171,284		43,560		(83,333		)	131,511
Long-term intercompany accounts and notes payable	317,695		138,398		129,918		(586,011		)	—
Other long-term liabilities	—		35,014		51,094		—			86,108
Total liabilities	1,329,999		604,853		788,771		(1,098,022		)	1,625,601
Total stockholders’ equity	4,896,722		6,167,637		2,596,172		(8,763,809		)	4,896,722
Total liabilities and stockholders’ equity	$	6,226,721	$	6,772,490	$	3,384,943	$	(9,861,831	)	$	6,522,323



	Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
	Fiscal Year 2018
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Revenue	$	—		$	1,137,783		$	2,689,676		$	(853,923	)	2,973,536
Cost of goods sold	—			828,496			1,723,829			(725,755		)	1,826,570
Gross profit	—			309,287			965,847			(128,168		)	1,146,966
Operating expenses:
Research and development	27,688			54,663			382,109			(19,357		)	445,103
Selling, general and administrative	39,882			248,601			349,739			(110,471		)	527,751
Other operating expense	588			89,454			13,463			325			103,830
Total operating expenses	68,158			392,718			745,311			(129,503		)	1,076,684
Income (loss) from operations	(68,158		)	(83,431		)	220,536			1,335			70,282
Interest expense	(58,133		)	(2,340		)	(1,505		)	2,430			(59,548		)
Interest income	—			2,696			6,751			(2,430		)	7,017
Other (expense) income	(929		)	973			(642		)	(8		)	(606		)
Income (loss) before income taxes	(127,220		)	(82,102		)	225,140			1,327			17,145
Income tax expense	(26		)	(15,586		)	(41,821		)	—			(57,433		)
Income in subsidiaries	86,958			183,319			—			(270,277		)	—
Net (loss) income	$	(40,288	)	$	85,631		$	183,319		$	(268,950	)	$	(40,288	)

Comprehensive (loss) income	$	(38,734	)	$	87,654		$	186,172		$	(273,826	)	$	(38,734	)



	Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
	Fiscal Year 2017
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Revenue	$	—		$	1,316,576		$	2,918,865		$	(1,202,867	)	3,032,574
Cost of goods sold	—			979,190			2,023,715			(1,105,843		)	1,897,062
Gross profit	—			337,386			895,150			(97,024		)	1,135,512
Operating expenses:
Research and development	35,379			40,918			416,869			(22,330		)	470,836
Selling, general and administrative	53,465			253,531			370,812			(132,220		)	545,588
Other operating expense	—			16,065			8,409			6,555			31,029
Total operating expenses	88,844			310,514			796,090			(147,995		)	1,047,453
Income (loss) from operations	(88,844		)	26,872			99,060			50,971			88,059
Interest expense	(57,344		)	(2,619		)	(3,129		)	4,213			(58,879		)
Interest income	—			4,457			759			(4,004		)	1,212
Other (expense) income	—			426			(1,999		)	(1,514		)	(3,087		)
Income (loss) before income taxes	(146,188		)	29,136			94,691			49,666			27,305
Income tax (expense) benefit	46,003			(63,893		)	(25,973		)	—			(43,863		)
Income in subsidiaries	83,627			68,718			—			(152,345		)	—
Net (loss) income	$	(16,558	)	$	33,961		$	68,718		$	(102,679	)	$	(16,558	)

Comprehensive (loss) income	$	(17,731	)	$	34,014		$	67,492		$	(101,506	)	$	(17,731	)



	Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
	Fiscal Year 2016
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Revenue	$	—		$	2,212,062		$	2,762,150		$	(2,363,486	)	2,610,726
Cost of goods sold	—			1,778,336			2,060,702			(2,277,865		)	1,561,173
Gross profit	—			433,726			701,448			(85,621		)	1,049,553
Operating expenses:
Research and development	67,158			106,560			304,219			(29,174		)	448,763
Selling, general and administrative	72,358			151,814			360,593			(50,666		)	534,099
Other operating expense	—			50,928			2,447			1,348			54,723
Total operating expenses	139,516			309,302			667,259			(78,492		)	1,037,585
Income (loss) from operations	(139,516		)	124,424			34,189			(7,129		)	11,968
Interest expense	(21,895		)	(2,419		)	(3,029		)	4,027			(23,316		)
Interest income	—			2,650			3,003			(3,585		)	2,068
Other income (expense)	—			5,467			(298		)	1,249			6,418
(Loss) income before income taxes	(161,411		)	130,122			33,865			(5,438		)	(2,862		)
Income tax (expense) benefit	44,014			(49,751		)	(20,246		)	—			(25,983		)
Income in subsidiaries	88,552			13,619			—			(102,171		)	—
Net (loss) income	$	(28,845	)	$	93,990		$	13,619		$	(107,609	)	$	(28,845	)

Comprehensive (loss) income	$	(31,854	)	$	89,738		$	14,862		$	(104,600	)	$	(31,854	)



	Condensed Consolidating Statement of Cash Flows
	Fiscal Year 2018
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Net cash provided by operating activities	$	196,848		$	165,883		$	489,789		$	—		$	852,520
Investing activities:
Purchase of property and equipment	—			(226,860		)	(42,975		)	—			(269,835		)
Other investing	—			22,800			(30,374		)	—			(7,574		)
Net transactions with related parties	—			439,925			(24,100		)	(415,825		)	—
Net cash (used in) provided by investing activities	—			235,865			(97,449		)	(415,825		)	(277,409		)
Financing activities:
Proceeds from debt issuances	100,000			—			—			—			100,000
Payment of debt	(107,729		)	—			—			—			(107,729		)
Debt issuance costs	(1,916		)	—			—			—			(1,916		)
Proceeds from the issuance of common stock	57,412			—			—			—			57,412
Repurchase of common stock, including transaction costs	(219,907		)	—			—			—			(219,907		)
Tax withholding paid on behalf of employees for restricted stock units	(24,708		)	—			—			—			(24,708		)
Net transactions with related parties	—			1,380			(417,205		)	415,825			—
Net cash (used in) provided by financing activities	(196,848		)	1,380			(417,205		)	415,825			(196,848		)
Effect of exchange rate changes on cash	—			—			2,360			—			2,360
Net increase (decrease) in cash, cash equivalents and restricted cash	—			403,128			(22,505		)	—			380,623
Cash, cash equivalents and restricted cash at the beginning of the period	—			226,186			319,593			—			545,779
Cash, cash equivalents and restricted cash at the end of the period	$	—		$	629,314		$	297,088		$	—		$	926,402



	Condensed Consolidating Statement of Cash Flows
	Fiscal Year 2017
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Net cash provided by operating activities	$	165,660		$	175,988		$	435,172					$	776,820
Investing activities:
Purchase of available-for-sale securities	—			(469		)	—			—			(469		)
Proceeds from maturities and sales of available-for-sale securities	—			186,793			—			—			186,793
Purchase of a business, net of cash acquired	—			—			(117,994		)	—			(117,994		)
Purchase of property and equipment	—			(424,175		)	(128,527		)	—			(552,702		)
Other investing	—			3,924			(9,900		)	—			(5,976		)
Net transactions with related parties	—			61,891			—			(61,891		)	—
Net cash used in investing activities	—			(172,036		)	(256,421		)	(61,891		)	(490,348		)
Financing activities:
Excess tax benefit from exercises of stock options	65			—			—			—			65
Proceeds from the issuance of common stock	59,148			—			—			—			59,148
Repurchase of common stock, including transaction costs	(209,357		)	—			—			—			(209,357		)
Tax withholding paid on behalf of employees for restricted stock units	(15,516		)	—			—			—			(15,516		)
Other financing	—			14			(4		)	—			10
Net transactions with related parties	—			1,587			(63,478		)	61,891			—
Net cash (used in) provided by financing activities	(165,660		)	1,601			(63,482		)	61,891			(165,650		)
Effect of exchange rate changes on cash	—			—			(1,105		)	—			(1,105		)
Net increase in cash, cash equivalents and restricted cash	—			5,553			114,164			—			119,717
Cash, cash equivalents and restricted cash at the beginning of the period	—			220,633			205,429			—			426,062
Cash, cash equivalents and restricted cash at the end of the period	$	—		$	226,186		$	319,593		$	—		$	545,779



	Condensed Consolidating Statement of Cash Flows
	Fiscal Year 2016
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations and Reclassifications		Consolidated
Net cash provided by operating activities	$	282,955		$	273,171		$	131,801		$	—	$	687,927
Investing activities:
Purchase of available-for-sale securities	—			(340,527		)				—		(340,527		)
Proceeds from maturities of available-for-sale securities	—			390,009						—		390,009
Purchase of property and equipment	—			(244,817		)	(70,807		)	—		(315,624		)
Other investing	—			(12,830		)	258			—		(12,572		)
Net cash used in investing activities	—			(208,165		)	(70,549		)	—		(278,714		)
Financing activities:
Proceeds from debt issuances	1,175,000			—			—			—		1,175,000
Payment of debt	(175,000		)				—			—		(175,000		)
Excess tax benefit from exercises of stock options	935			—			—			—		935
Debt issuance costs	(13,588		)	—			—			—		(13,588		)
Proceeds from the issuance of common stock	51,875			—			—			—		51,875
Repurchase of common stock, including transaction costs	(1,300,009		)	—			—			—		(1,300,009		)
Tax withholding paid on behalf of employees for restricted stock units	(22,168		)	—			—			—		(22,168		)
Other financing	—			57			(86		)	—		(29		)
Net transactions with related parties	—			1,192			(1,192		)	—		—
Net cash (used in) provided by financing activities	(282,955		)	1,249			(1,278		)	—		(282,984		)
Effect of exchange rate changes on cash	—			—			(294		)	—		(294		)
Net increase in cash, cash equivalents and restricted cash	—			66,255			59,680			—		125,935
Cash, cash equivalents and restricted cash at the beginning of the period	—			154,378			145,749			—		300,127
Cash, cash equivalents and restricted cash at the end of the period	$	—		$	220,633		$	205,429		$	—	$	426,062

Quarterly Financial Summary (Unaudited)

12 Months Ended

Mar. 31, 2018

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY FINANCIAL SUMMARY (UNAUDITED)

QUARTERLY FINANCIAL SUMMARY (UNAUDITED):



Fiscal 2018 Quarter
(in thousands, except
per share data)	First				Second			Third				Fourth
Revenue	$	640,831			$	821,583		$	845,739			$	665,383
Gross profit	236,377				321,022			336,927				252,640
Net (loss) income	(30,624		)	^(1),(2),(3)	35,919		^(1),(2),(3)	(33,082		)	^{(1),(2),(3),(4)}	(12,501		)	^{(1),(2),(3),(5)}
Net (loss) income per share:
Basic	$	(0.24	)		$	0.28		$	(0.26	)		$	(0.10	)
Diluted	$	(0.24	)		$	0.27		$	(0.26	)		$	(0.10	)

Fiscal 2017 Quarter
(in thousands, except
per share data)	First				Second			Third				Fourth
Revenue	$	698,537			$	864,698		$	826,347			$	642,992
Gross profit	276,475				316,799			310,642				231,596
Net (loss) income	(5,675		)	^(1),(2),(3)	11,847		^(1),(2),(3)	(78,638		)	^{(1),(2),(3),(6)}	55,908			^{(1),(2),(3),(7)}
Net (loss) income per share:
Basic	$	(0.04	)		$	0.09		$	(0.62	)		$	0.44
Diluted	$	(0.04	)		$	0.09		$	(0.62	)		$	0.43

1. The Company recorded integration related expenses of $1.5 million, $1.8 million, $1.7 million and $1.2 million in the first, second, third and fourth quarters of fiscal 2018, respectively, associated with the Business Combination. The Company recorded integration related expenses of $5.3 million, $5.0 million, $3.9 million and $2.7 million in the first, second, third and fourth quarters of fiscal 2017, respectively, associated with the Business Combination (Note 6).

2. The Company recorded restructuring expenses of $0.5 million, $10.5 million, $15.2 million and $41.5 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded restructuring expenses of $0.8 million, $0.5 million, $0.4 million and $0.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively (Note 11).

3. The Company recorded start-up expenses of $6.6 million, $7.2 million, $5.4 million and $5.1 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded start-up expenses of $2.1 million, $2.0 million, $2.2 million and $3.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively.

4. Income tax expense of $98.5 million for the third quarter of fiscal 2018 relates primarily to a discrete provisional tax expense related to the enactment of the Tax Act (Note 12).

5. Income tax benefit of $31.2 million for the fourth quarter of fiscal 2018 relates primarily to a discrete provisional benefit for adjustments to a third quarter fiscal 2018 provisional estimate of the impact of the Tax Act (Note 12).

6. Income tax expense of $123.2 million for the third quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

7. Income tax benefit of $93.2 million for the fourth quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The first fiscal quarter of each year ends on the Saturday closest to June 30, the second fiscal quarter of each year ends on the Saturday closest to September 30 and the third fiscal quarter of each year ends on the Saturday closest to December 31. Each quarter of fiscal 2018 and fiscal 2017 contained a comparable number of weeks (13 weeks).

The Company and Its Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain items in the fiscal years 2017 and 2016 financial statements have been reclassified to conform to the fiscal 2018 presentation, such as restricted cash in accordance with Accounting Standards Update ("ASU") 2016-18.
Accounting Periods	Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on March 31, 2018, April 1, 2017, and April 2, 2016. Fiscal years 2018 and 2017 were 52-week years, and fiscal year 2016 was a 53-week year.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The actual results that the Company experiences may differ materially from its estimates. The Company makes estimates for the returns reserve, rebates, allowance for doubtful accounts, inventory valuation including reserves, warranty reserves, income tax valuation, current and deferred income taxes, uncertain tax positions, non-marketable equity investments, other-than-temporary impairments of investments, goodwill, long-lived assets and other financial statement amounts on a regular basis and makes adjustments based on historical experiences and expected future conditions. Accounting estimates require difficult and subjective judgments and actual results may differ from the Company’s estimates. During the first quarter of fiscal 2018, the Company changed its accounting estimate for the expected useful lives of certain machinery and equipment. The Company evaluated its asset base and reassessed the estimated useful lives of certain machinery and equipment in connection with its implementation of several capital projects, including the migration of certain surface acoustic wave ("SAW") processes from 4-inch to 6-inch toolsets and certain bulk acoustic wave ("BAW") processes from 6-inch to 8-inch toolsets. Based on its ability to re-use equipment across generations of process technologies and historical usage trends, the Company determined that the expected useful lives for certain machinery and equipment should be increased by up to three years to reflect more closely the estimated economic lives of those assets. This change in estimate was applied prospectively effective for the first quarter of fiscal 2018 and resulted in a decrease in depreciation expense of $59.7 million for fiscal 2018. This decrease in depreciation expense for fiscal 2018 resulted in the following: (1) an increase in income from operations of $47.4 million; (2) an increase in net income of $44.1 million; (3) an improvement in earnings per share of $0.34; and (4) a reduction in inventory of $12.3 million.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly-liquid investments with original maturities of three months or less when purchased.
Investments	Investments Investments available-for-sale at March 31, 2018 and April 1, 2017 consisted of auction rate securities ("ARS"). Available-for-sale investments with an original maturity date greater than approximately three months and less than one year are classified as current investments. Available-for-sale investments with an original maturity date exceeding one year are classified as long-term. Available-for-sale securities are carried at fair value with the unrealized gains and losses, net of tax, reported in “Other comprehensive income (loss).” The cost of securities sold is based on the specific identification method and any realized gain or loss is included in “Other (expense) income.” The cost of available-for-sale securities is adjusted for premiums and discounts, with the amortization or accretion of such amounts included as a portion of interest. The Company assesses individual investments for impairment quarterly. Investments are impaired when the fair value is less than the amortized cost. If an investment is impaired, the Company evaluates whether the impairment is other-than-temporary. A debt investment impairment is considered other-than-temporary if (i) the Company intends to sell the security, (ii) it is more likely than not that the Company will be required to sell the security before recovery of the entire amortized cost basis, or (iii) the Company does not expect to recover the entire amortized cost basis of the security (a credit loss). Other-than-temporary declines in the Company's debt securities are recognized as a loss in the statement of operations if due to credit loss; all other losses on debt securities are recorded in “Other comprehensive income (loss).” The previous amortized cost basis less the other-than-temporary impairment becomes the new cost basis and is not adjusted for subsequent recoveries in fair value.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against sales forecasts on a product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of forecasted sales and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve. Abnormal production levels are charged to the income statement in the period incurred rather than as a portion of inventory cost.
Product Warranty	Product Warranty The Company generally sells products with a limited warranty on product quality. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified issues based on historical activity. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing and the short time typically between product shipment and the detection and correction of product failures and the historical rate of losses, the accrual and related expense for estimated incurred but unidentified issues was not significant during the periods presented.
Other Receivables	Other Receivables The Company records miscellaneous non-product receivables that are collectible within 12 months in “Other receivables,” such as value-added tax receivables ($38.1 million as of March 31, 2018 and $55.4 million as of April 1, 2017, which are reported on a net basis), precious metal reclaims submitted for payment and other miscellaneous items.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one year to thirty-nine years. The Company capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company’s assets acquired under capital leases and leasehold improvements are amortized over the lesser of the asset life or lease term (which is reasonably assured) and included in depreciation. The Company records capital-related government grants earned as a reduction to property and equipment and depreciates such grants over the estimated useful lives of the associated assets. The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held for use by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as “held for sale” are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is recorded when the purchase price paid for a business exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Intangibles are recorded when such assets are acquired by purchase or license. The value of the Company's intangibles, including goodwill, could be impacted by future adverse changes such as: (i) any future declines in the Company's operating results; (ii) a decline in the value of technology company stocks, including the value of the Company's common stock; (iii) a prolonged or more significant slowdown in the worldwide economy or the semiconductor industry; or (iv) failure to meet the performance projections included in the Company's forecasts of future operating results. The Company accounts for goodwill and indefinite-lived intangible assets in accordance with the Financial Accounting Standards Board ("FASB") guidance, which requires annual testing for impairment or whenever events or circumstances make it more likely than not that an impairment may have occurred. The Company performs its annual impairment tests on the first day of the fourth quarter in each fiscal year. Indefinite-lived intangible assets consist of in-process research and development ("IPRD"). The Company has the option to perform a qualitative assessment (commonly referred to as "step zero") to determine whether further quantitative analysis for impairment of goodwill or indefinite-lived intangible assets is necessary. In performing step zero for its impairment test, the Company is required to make assumptions and judgments, including the evaluation of macroeconomic conditions as related to the Company's business, industry and market trends, and the overall future financial performance of the Company's reporting units and future opportunities in the markets in which they operate. The Company also considers recent fair value calculations of its indefinite-lived intangible assets and reporting units as well as cost factors such as changes in raw materials, labor or other costs. If the step zero analysis indicates that it is more likely than not that the fair value of a reporting unit or indefinite-lived asset is less than its respective carrying value including goodwill, then the Company would perform an additional quantitative analysis. For goodwill, this involves a two-step process. The first step compares the fair value of the reporting unit, including its goodwill, to its carrying value. If the carrying value of the reporting unit exceeds its fair value, then the second step of the process is performed to determine the amount of impairment. The second step compares the implied fair value of the reporting unit's goodwill to the carrying value of the goodwill. An impairment charge is recognized for the amount the carrying value of the reporting unit's goodwill exceeds its implied fair value. For indefinite-lived intangible assets, the quantitative analysis compares the carrying value of the asset to its fair value and an impairment charge is recognized for the amount its carrying value exceeds its fair value. Determining the fair value of reporting units, indefinite-lived intangible assets and implied fair value of a reporting unit's goodwill is reliant upon estimated future revenues, profitability and cash flows and consideration of market factors. Assumptions, judgments and estimates are complex, subjective and can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in the Company's business strategy or its internal forecasts. Although the Company believes the assumptions, judgments and estimates it has made have been reasonable and appropriate, different assumptions, judgments and estimates could materially affect its results of operations. Goodwill Goodwill is allocated to the Company's reporting units based on the expected benefit from the synergies of the business combinations generating the underlying goodwill. As of March 31, 2018, the Company's goodwill balance of $2,173.9 million is allocated between its Mobile Products ("MP") and Infrastructure and Defense Products ("IDP") reporting units. In fiscal years 2018 and 2017, the Company completed qualitative assessments of the fair value of its reporting units and concluded that goodwill was not impaired. For fiscal 2016, although there were no indicators of impairment, the Company opted to bypass the qualitative assessment and proceeded to perform fair value assessments of its reporting units (the first step of the quantitative impairment analysis) as the fair value of the reporting units had changed (due to the Business Combination) since the last time the Company performed a quantitative analysis. The quantitative assessments performed reaffirmed that there were no indicators of impairment for fiscal 2016. In performing these quantitative assessments, consistent with its historical approach, the Company used both the income and market approaches to estimate the fair value of its reporting units. The income approach involves discounting future estimated cash flows. The sum of the reporting unit cash flow projections was compared to the Company's market capitalization in a discounted cash flow framework to calculate an overall implied internal rate of return (or discount rate) for the Company. The Company's market capitalization was adjusted to a control basis assuming a reasonable control premium, which resulted in an implied discount rate. This implied discount rate serves as a baseline for estimating the specific discount rate for each reporting unit. The discount rate used is the value-weighted average of the Company's estimated cost of equity and debt (“cost of capital”) derived using both known and estimated customary market metrics. The Company's weighted average cost of capital is adjusted for each reporting unit to reflect a risk factor, if necessary, for each reporting unit. The Company performs sensitivity tests with respect to growth rates and discount rates used in the income approach. The Company believes the income approach is appropriate because it provides a fair value estimate based upon the respective reporting unit’s expected long-term operations and cash flow performance. The Company considered historical rates and current market conditions when determining the discount and growth rates used in its analysis. For fiscal 2016, the material assumptions used for the income approach were eight years of projected net cash flows and a long-term growth rate of 3% for both the MP and IDP reporting units. A discount rate of 15% and 16% was used for the MP and IDP reporting units, respectively. In applying the market approach, valuation multiples are derived from historical and projected operating data of selected guideline companies, which are evaluated and adjusted, if necessary, based on the strengths and weaknesses of the reporting unit relative to the selected guideline companies. The valuation multiples are then applied to the appropriate historical and/or projected operating data of the reporting unit to arrive at an indication of fair value. The Company believes the market approach is appropriate because it provides a fair value using multiples from companies with operations and economic characteristics similar to its reporting units. The Company weighted the results of the income approach and the results of the market approach at 50% each and for the MP and IDP reporting units, concluded that the fair value of the reporting units was determined to be substantially in excess of the carrying value, and as such, no further analysis was warranted. Under the income approach described above, the following indicates the sensitivity of key assumptions utilized in the assessment. A one percentage point decrease in the discount rate would have increased the fair value of the MP and IDP reporting units by approximately $660.0 million and $140.0 million, respectively, while a one percentage point increase in the discount rate would have decreased the fair value of the MP and IDP reporting units by approximately $560.0 million and $110.0 million, respectively. A one percentage point decrease in the long-term growth rate would have decreased the fair value of the MP and IDP reporting units by approximately $290.0 million and $50.0 million, respectively, while a one percentage point increase in the long-term growth rate would have increased the fair value of the MP and IDP reporting units by approximately $340.0 million and $70.0 million, respectively. Intangible Assets with Indefinite Lives In fiscal 2015, as a result of the Business Combination, the Company recorded IPRD of $470.0 million. IPRD was recorded at fair value as of the date of acquisition as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development ("R&D") efforts or impairment. The fair value of the acquired IPRD was determined based on an income approach using the "excess earnings method," which estimated the value of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. Upon completion of development, acquired IPRD assets are transferred to finite-lived intangible assets and amortized over their useful lives. During fiscal years 2018, 2017 and 2016, the Company completed and transferred into developed technology approximately $37.0 million, $220.0 million and $203.0 million, respectively, of IPRD. The Company performed a qualitative assessment of the remaining IPRD of $10.0 million during fiscal 2018 and concluded that IPRD was not impaired. Intangible Assets with Definite Lives Intangible assets are recorded when such assets are acquired by purchase or license. Finite-lived intangible assets consist primarily of technology licenses, customer relationships, developed technology and trade names resulting from business combinations and are subject to amortization. Technology licenses are recorded at cost and are amortized on a straight-line basis over the lesser of the estimated useful life of the technology or the term of the license agreement, ranging from approximately five to eight years. The fair value of customer relationships acquired during fiscal years 2013, 2015 and 2017 was determined based on an income approach using the “with and without method," in which the value of the asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. Customer relationships are amortized on a straight-line basis over the estimated useful life, ranging from three to ten years. The fair value of developed technology acquired during fiscal years 2013, 2015 and 2017 was determined based on an income approach using the "excess earnings method," which estimated the value of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. Developed technology is amortized on a straight-line basis over the estimated useful life, ranging from three to six years. The fair value of trade names acquired in fiscal years 2015 and 2017 was determined based on an income approach using the "relief from royalty method," in which the value of the asset is determined by discounting the future projected cash flows generated from the trade name's estimated royalties. Trade names are amortized on a straight-line basis over the estimated useful life of two to three years. The Company regularly reviews identified intangible assets to determine if facts and circumstances indicate that the useful lives have changed from the original estimate or that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets and occur in the period in which the impairment determination was made.
Accrued Liabilities	Accrued Liabilities The "Accrued liabilities" balance as of March 31, 2018 and April 1, 2017 includes accrued compensation and benefits of $96.7 million and $98.7 million, respectively, and interest payable of $23.1 million and $23.2 million, respectively.
Revenue Recognition	Revenue Recognition The Company's net revenue is generated principally from sales of semiconductor products. The Company recognizes revenue from product sales when the fundamental criteria are met, such as the time at which the title and risk and rewards of product ownership are transferred to the customer, price and terms are fixed or determinable, no significant vendor obligation exists and collection of the resulting receivable is reasonably assured. Sales of products are generally made through either the Company's sales force, manufacturers' representatives or through a distribution network. Revenue from the majority of the Company's products is recognized upon shipment of the product to the customer from a Company-owned or third-party location. Some revenue is recognized upon receipt of the shipment by the customer. The Company has limited rebate programs offering price protection to certain distributors. These rebates represent less than 5% of net revenue and can be reasonably estimated based on specific criteria included in the rebate agreements and other known factors at the time. The Company reduces revenue and records reserves for product returns and allowances for price protection, stock rotation, and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company also recognizes a portion of its net revenue through other agreements such as non-recurring engineering fees, contracts for R&D work, royalty income, intellectual property ("IP") revenue, and service revenue. These agreements are collectively less than 1% of consolidated annual revenue. Revenue from these agreements is recognized when the service is completed or upon certain milestones, as provided for in the agreements. Revenue from certain contracts is recognized on the percentage of completion method based on the costs incurred to date and the total contract amount, plus the contractual fee. If these contracts experience cost overruns, the percentage of completion method is used to determine revenue recognition. Revenue from fixed price contracts is recognized when the required deliverable is satisfied. Royalty income is recognized based on a percentage of sales of the relevant product reported by licensees during the period. The Company additionally licenses or sells its rights to use portions of its IP portfolio, which includes certain patent rights useful in the manufacture and sales of certain products. IP revenue recognition is dependent on the terms of each agreement. The Company will recognize IP revenue upon delivery of the IP if the Company has no substantive future obligation to perform under the arrangement. The Company will defer recognition of IP revenue where future performance obligations are required to earn the revenue or the revenue is not guaranteed. Revenue from services is recognized during the period that the service is performed. Accounts receivable are recorded for all revenue items listed above and do not bear interest. The Company evaluates the collectability of accounts receivable based on a combination of factors. In cases where the Company is aware of circumstances that may impair a specific customer’s ability to meet its financial obligations subsequent to the original sale, the Company will record an allowance against amounts due, and thereby reduce the receivable to the amount the Company reasonably believes will be collected. For all other customers, the Company recognizes allowances for doubtful accounts based on the length of time the receivables are past due, industry and geographic concentrations, the current business environment and the Company’s historical experience. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company will authorize sales returns under certain circumstances, which include perceived quality problems, courtesy returns and like-kind exchanges. The Company evaluates its estimate of returns by analyzing all types of returns and the timing of such returns in relation to the original sale. Reserves are adjusted to reflect changes in the estimated returns versus the original sale of product.
Shipping and Handling Cost	Shipping and Handling Cost The Company recognizes amounts billed to a customer in a sale transaction related to shipping and handling as revenue. The costs incurred by the Company for shipping and handling are classified as cost of goods sold in the Consolidated Statements of Operations.
Research and Development	Research and Development The Company charges all R&D costs to expense as incurred.
Precious Metals Reclaim	Precious Metals Reclaim The Company uses historical experience to estimate the amount of reclaim on precious metals used in manufacturing at the end of each period and states the reclaim value at the lower of average cost or market. The estimated value to be received from precious metal reclaim is included in "Other current assets" and reclaims submitted for payment are included in "Other receivables" in the Consolidated Balance Sheets.
Income Taxes	Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more likely than not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. It is the Company’s current intent and policy to invest the earnings of foreign subsidiaries indefinitely outside the U.S., except for Qorvo International Pte. Ltd. in Singapore. Accordingly, the Company does not record a deferred tax liability for U.S. income taxes on unremitted foreign earnings of other foreign subsidiaries.
Stock-Based Compensation	Stock-Based Compensation Under FASB Accounting Standards Codification ("ASC") 718, “Compensation – Stock Compensation," stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of March 31, 2018, total remaining unearned compensation cost related to unvested restricted stock units and options was $72.8 million, which will be amortized over the weighted-average remaining service period of approximately 1.2 years.
Foreign Currency Translation	Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with FASB ASC 830, “Foreign Currency Matters.” The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenues and expenses are translated using the average exchange rates throughout the year. Translation adjustments are shown separately as a component of “Accumulated other comprehensive loss” within “Stockholders’ equity” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in “Other income (expense)” in the Consolidated Statements of Operations.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Pronouncements Not Yet Effective In January 2017, the FASB issued ASU 2017-04, "Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The new guidance simplifies the subsequent measurement of goodwill by eliminating the second step from the quantitative goodwill impairment test. The Company will continue to have the option to perform a qualitative assessment to determine if a quantitative goodwill impairment test is necessary. The new standard will become effective for the Company beginning in fiscal 2021 with early adoption permitted. The Company does not believe it will have a significant impact on its consolidated financial statements. In January 2017, the FASB issued ASU 2017-01, "Business Combinations (Topic 805): Clarifying the Definition of a Business." The new guidance clarifies the definition of a business and provides further guidance for evaluating whether a transaction will be accounted for as an acquisition of an asset or a business. The new standard will become effective for the Company beginning in the first quarter of fiscal 2019 with early adoption permitted. The update should be applied prospectively. The Company does not believe it will have a significant impact on its consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the FASB’s Emerging Issues Task Force)." The new guidance addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. The new standard will become effective for the Company beginning in the first quarter of fiscal 2019. The Company does not believe it will have a significant impact on its consolidated financial statements. In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments." The new guidance requires entities to use a current lifetime expected credit loss methodology to measure impairments of certain financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. The new standard will become effective for the Company beginning in the first quarter of fiscal 2021 with early adoption permitted. The Company does not believe it will have a significant impact on its consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." The new guidance requires lessees to recognize a right-of-use asset and a lease liability for all leases with a term longer than 12 months, including those previously described as operating leases. Consistent with current U.S. generally accepted accounting principles ("GAAP"), the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will primarily depend on its classification as a finance or operating lease. The new guidance will become effective for the Company in the first quarter of fiscal 2020. The Company expects the valuation of the right-of-use assets and lease liabilities, for leases previously described as operating leases, to be the present value of its forecasted future lease commitments. The Company is continuing to assess the overall impacts of the new standard, including the discount rate to be applied in these valuations. In January 2016, the FASB issued ASU 2016-01, "Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities." The new guidance will affect the accounting for equity investments, financial liabilities measured under the fair value option and presentation and disclosure requirements for financial instruments. In addition, the FASB clarified guidance related to the assessment of valuation allowances when recognizing deferred tax assets related to unrealized losses on available-for-sale debt securities. The new standard is effective for the Company beginning in the first quarter of fiscal 2019. The Company does not believe it will have a significant impact on its consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)," with several amendments subsequently issued. The new guidance provides an updated framework for revenue recognition, resulting in a single revenue model to be applied by reporting companies under U.S. GAAP. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Additional disclosures will be required regarding the nature, amount, timing and uncertainty of cash flows. The Company will adopt the standard in the first quarter of fiscal 2019 using the modified retrospective approach, under which the cumulative effect of adoption is recognized at the date of initial application. The Company has evaluated the impact of the standard and does not anticipate that the adoption of this standard will have a material impact on its consolidated financial statements. The Company is implementing changes to its accounting policies, internal controls and disclosures to support the new standard; however, these changes are not expected to be material. Accounting Pronouncements Recently Adopted In March 2018, the FASB issued ASU 2018-05, "Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118." The amendments incorporate into the ASC the recent SEC guidance related to the income tax accounting implications of the Tax Cuts and Jobs Act (the "Tax Act"). See Note 12 for further disclosures. In May 2017, the FASB issued ASU 2017-09, "Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting." The new guidance clarifies when modification accounting in Topic 718 should be applied to changes to the terms or conditions of a share-based payment award. The Company elected to early-adopt the standard in the first quarter of fiscal 2018 with no impact on its consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force)." The new guidance requires that restricted cash and restricted cash equivalents be included in cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. The Company adopted the provisions of ASU 2016-18 in the second quarter of fiscal 2018 using the retrospective transition method. The adjustment to reclassify restricted cash for each period presented was less than $1.0 million. In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other Than Inventory." The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The Company elected to early-adopt the standard in the first quarter of fiscal 2018 using the modified retrospective method (which resulted in a cumulative adjustment to retained earnings of $1.2 million as of the beginning of the period of adoption). During fiscal 2018, the Company recognized a tax expense of $6.9 million related to transfers of intra-entity assets. In March 2016, the FASB issued ASU 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." The new guidance simplifies certain aspects of accounting for share-based payment transactions, including income tax consequences, forfeitures, classification of awards on the balance sheet and presentation on the statement of cash flows, and became effective for the Company in the first quarter of fiscal 2018. The Company recognized a cumulative-effect adjustment to reduce the Company's accumulated deficit by $36.7 million with a corresponding increase to deferred tax assets for the federal and state net operating losses attributable to excess tax benefits that had not been previously recognized. All excess tax benefits and deficiencies in the current and future periods will be recognized as income tax expense in the Company’s Consolidated Statement of Operations in the reporting period in which they occur. This will result in increased volatility in the Company’s effective tax rate. During fiscal 2018, the Company recognized a discrete tax benefit of $12.2 million related to the excess tax benefits from stock-based compensation. The Company also elected to prospectively adopt the provision that requires excess tax benefits to be presented within operating activities in the statement of cash flows and no prior periods have been restated as a result of the adoption. The Company has continued its existing practice of estimating expected forfeitures in determining compensation cost. In March 2016, the FASB issued ASU 2016-07, "Investments-Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting." The new guidance eliminates the requirement to retrospectively apply the equity method of accounting when an investment previously accounted for under the cost basis qualifies for the equity method of accounting. The Company adopted ASU 2016-07 in the first quarter of fiscal 2018 with no impact on its consolidated financial results. In July 2015, the FASB issued ASU 2015-11, "Inventory (Topic 330): Simplifying the Measurement of Inventory." The new guidance changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. ASU 2015-11 defines net realizable value as the estimated selling price in the ordinary course of business less reasonably predictable costs to completion, transportation, or disposal. The Company adopted ASU 2015-11 in the first quarter of fiscal 2018 with no significant impact on its consolidated financial statements.
Operating Segment	The Company's operating segments as of March 31, 2018 are MP and IDP based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on non-GAAP operating income (loss) and non-GAAP operating income (loss) as a percentage of revenue.
Fair Value Measurement	The carrying values of cash and cash equivalents, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments.

Investments and Fair Value Measurements (Tables)

12 Months Ended

Mar. 31, 2018

Schedule of Cash equivalents and available-for-sale securities

Cash equivalents and available-for-sale securities

The following is a summary of cash equivalents and available-for-sale securities as of March 31, 2018 and April 1, 2017 (in thousands):



	Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
March 31, 2018
Auction rate securities	$	1,950	$	—	$	(107	)	$	1,843
Money market funds	9		—		—			9
	$	1,959	$	—	$	(107	)	$	1,852
April 1, 2017
Auction rate securities	$	2,150	$	—	$	(429	)	$	1,721
Money market funds	14		—		—			14
	$	2,164	$	—	$	(429	)	$	1,735

Expected maturity distribution of cash equivalents and available-for-sale debt securities

The expected maturity distribution of cash equivalents and available-for-sale debt securities is as follows (in thousands):



	March 31, 2018				April 1, 2017
	Cost		Estimated Fair Value		Cost		Estimated Fair Value
Due in less than one year	$	9	$	9	$	14	$	14
Due after ten years	1,950		1,843		2,150		1,721
Total investments in debt securities	$	1,959	$	1,852	$	2,164	$	1,735

Fair value of the financial assets measured at fair value on a recurring basis



				Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
March 31, 2018
	Assets
		Money market funds		$	9	$	9	$	—
		Auction rate securities (1)		1,843		—		1,843
		Invested funds in deferred compensation plan (2)		14,284		14,284		—
			Total assets measured at fair value	$	16,136	$	14,293	$	1,843
	Liabilities
		Deferred compensation plan obligation (2)		$	14,284	$	14,284	$	—
			Total liabilities measured at fair value	$	14,284	$	14,284	$	—

April 1, 2017
	Assets
		Money market funds		$	14	$	14	$	—
		Auction rate securities (1)		1,721		—		1,721
		Invested funds in deferred compensation plan (2)		10,237		10,237		—
			Total assets measured at fair value	$	11,972	$	10,251	$	1,721
	Liabilities
		Deferred compensation plan obligation (2)		$	10,237	$	10,237	$	—
			Total liabilities measured at fair value	$	10,237	$	10,237	$	—

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details

Inventories (Tables)

12 Months Ended

Mar. 31, 2018

Inventory Disclosure [Abstract]

Components of inventories

The components of inventories, net of reserves, are as follows (in thousands):



	March 31, 2018		April 1, 2017
Raw materials	$	110,389	$	92,282
Work in process	221,137		198,339
Finished goods	140,766		139,833
Total inventories	$	472,292	$	430,454

Property and Equipment (Tables)

12 Months Ended

Mar. 31, 2018

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

The components of property and equipment are as follows (in thousands):



	March 31, 2018			April 1, 2017
Land	$	23,778		$	25,025
Building and leasehold improvements	389,234			384,784
Machinery and equipment	1,660,138			1,659,404
	2,073,150			2,069,213
Less accumulated depreciation	(911,910		)	(981,328		)
	1,161,240			1,087,885
Construction in progress	212,872			304,047
Total property and equipment, net	$	1,374,112		$	1,391,932

Goodwill and Intangible Assets (Tables)

12 Months Ended

Mar. 31, 2018

Indefinite-lived Intangible Assets [Line Items]

Schedule of Goodwill [Table Text Block]

The changes in the carrying amount of goodwill for fiscal years 2017 and 2018, are as follows (in thousands):



	Mobile Products		Infrastructure and Defense Products			Total
Balance as of April 2, 2016 (1)	$	1,751,503	384,194			$	2,135,697
GreenPeak acquisition	—		38,217			38,217
Balance as of April 1, 2017 (1)	1,751,503		422,411			2,173,914
GreenPeak acquisition measurement adjustment	—		(25		)	(25		)
Balance as of March 31, 2018 (1)	$	1,751,503	$	422,386		$	2,173,889

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table Text Block]

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):



	March 31, 2018				April 1, 2017
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Intangible Assets:
Customer relationships	$	1,272,725	$	936,175	$	1,272,725	$	656,688
Developed technology	1,246,335		733,081		1,209,335		481,441
Trade names	29,391		29,377		29,353		21,912
Technology licenses	12,379		11,904		13,346		11,711
Non-compete agreement	1,026		983		1,026		470
IPRD	10,000		N/A		47,000		N/A
Total	$	2,571,856	$	1,711,520	$	2,572,785	$	1,172,222

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

The following table provides the Company's estimated amortization expense for intangible assets based on current amortization periods for the periods indicated (in thousands):



Fiscal Year	Estimated Amortization Expense
2019	$	455,000
2020	207,000
2021	155,000
2022	28,000
2023	12,000

Debt (Tables)

12 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments [Table Text Block]

Debt as of March 31, 2018 and April 1, 2017 is as follows (in thousands):



	March 31, 2018			April 1, 2017
6.75% Senior Notes due 2023	$	444,464		$	450,000
7.00% Senior Notes due 2025	548,500			550,000
Less unamortized issuance costs	(9,674		)	(10,846		)
Total long-term debt	$	983,290		$	989,154

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

Income Taxes (Tables)

12 Months Ended

Mar. 31, 2018

Income Tax Disclosure [Abstract]

Income before income taxes

Income (loss) before income taxes consists of the following components (in thousands):



	Fiscal Year
	2018			2017		2016
United States	$	(151,083	)	$	2,439	$	(35,923	)
Foreign	168,228			24,866		33,061
Total	$	17,145		$	27,305	$	(2,862	)

Components of the income tax (provision) benefit

The components of the income tax provision are as follows (in thousands):



	Fiscal Year
	2018			2017			2016
Current (expense) benefit:
Federal	$	(28,168	)	$	(23,835	)	$	(4,285	)
State	(229		)	(476		)	(541		)
Foreign	(61,284		)	(47,579		)	(33,346		)
	(89,681		)	(71,890		)	(38,172		)
Deferred benefit (expense):
Federal	$	11,817		$	2,762		$	27,794
State (1)	253			3,659			(31,229		)
Foreign	20,178			21,606			15,624
	32,248			28,027			12,189
Total	$	(57,433	)	$	(43,863	)	$	(25,983	)

Reconciliation of the (provision for) or benefit from income taxes to income tax(expense) or benefit computed by applying the statutory federal income tax rate to pre-tax income.



	Fiscal Year
	2018					2017					2016
	Amount			Percentage		Amount			Percentage		Amount			Percentage
Income tax (expense) benefit at statutory federal rate	$	(5,407	)	31.54	%	$	(9,557	)	35.00	%	$	1,002		35.00	%
(Increase) decrease resulting from:
State benefit (provision), net of federal (provision) benefit	474			(2.77	)	(662		)	2.42		(1,320		)	(46.14	)
Tax credits	38,054			(221.95	)	15,352			(56.22	)	15,459			540.21
Effect of changes in income tax rate applied to net deferred tax assets	39,168			(228.45	)	1,163			(4.26	)	(2,716		)	(94.92	)
Foreign tax rate difference	21,829			(127.32	)	(11,298		)	41.38		4,114			143.77
Foreign permanent differences	(2,598		)	15.15		(8,432		)	30.88		(1,700		)	(59.40	)
Change in valuation allowance	(1,632		)	9.52		1,363			(4.99	)	(25,120		)	(877.84	)
Stock-based compensation	9,924			(57.88	)	(3,228		)	11.82		(5,362		)	(187.37	)
Tax reserve adjustments	(29,188		)	170.24		(21,789		)	79.80		(8,699		)	(303.99	)
Deemed dividend	(5,098		)	29.73		(6,989		)	25.60		(3,984		)	(139.21	)
U.S. Tax Toll Charge	(116,419		)	679.03		—			—		—			—
Intra-entity transfer	(6,873		)	40.09		—			—		—			—
Other income tax (expense) benefit	333			(1.94	)	214			(0.79	)	2,343			81.89
	$	(57,433	)	334.99	%	$	(43,863	)	160.64	%	$	(25,983	)	(908.00	)%

Significant components of net deferred income taxes

Significant components of the Company’s net deferred income taxes are as follows (in thousands):



	Fiscal Year
	2018			2017
Deferred income tax assets:
Inventory reserve	$	9,894		$	15,599
Equity compensation	37,724			83,333
Net operating loss carry-forwards	50,128			40,575
Research and other credits	39,513			92,793
Employee benefits	12,842			13,247
Other deferred assets	16,620			23,355
Total deferred income tax assets	166,721			268,902
Valuation allowance	(42,787		)	(33,104		)
Total deferred income tax assets, net of valuation allowance	$	123,934		$	235,798

Deferred income tax liabilities:
Amortization and purchase accounting basis difference	$	(101,261	)	$	(258,422	)
Accumulated depreciation/basis difference	(63,363		)	(91,337		)
Total deferred income tax liabilities	(164,624		)	(349,759		)
Net deferred income tax liabilities	$	(40,690	)	$	(113,961	)

Amounts included in the Consolidated Balance Sheets:
Non-current assets	22,394			17,550
Non-current liabilities	(63,084		)	(131,511		)

Net deferred income tax liabilities	$	(40,690	)	$	(113,961	)

Reconciliation of gross unrecognized tax benefits

A reconciliation of fiscal 2016 through fiscal 2018 beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):



	Fiscal Year
	2018			2017			2016
Beginning balance	$	90,615		$	69,052		$	59,397
Additions based on positions related to current year	26,431			20,036			9,374
Additions for tax positions in prior years	5,844			1,878			2,723
Reductions for tax positions in prior years	(67		)	(29		)	(1,973		)
Expiration of statute of limitations	—			(322		)	(469		)
Ending balance	$	122,823		$	90,615		$	69,052

Net Loss Per Share (Tables)

12 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

Reconciliation of the numerators and denominators in the computation of basic and diluted net income (loss) per share

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share data):



	For Fiscal Year
	2018			2017			2016
Numerator:
Numerator for basic and diluted net loss per share — net loss available to common stockholders	$	(40,288	)	$	(16,558	)	$	(28,845	)
Denominator:
Denominator for basic net loss per share — weighted average shares	126,946			127,121			141,937
Effect of dilutive securities:
Stock-based awards	—			—			—
Denominator for diluted net loss per share — adjusted weighted average shares and assumed conversions	126,946			127,121			141,937
Basic net loss per share	$	(0.32	)	$	(0.13	)	$	(0.20	)
Diluted net loss per share	$	(0.32	)	$	(0.13	)	$	(0.20	)

Stock-Based Compensation (Tables)

12 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of activity of the Company's director and employee stock option plans

A summary of activity of the Company’s director and employee stock option plans follows:



	Shares (in thousands)	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of April 1, 2017	4,177	$	19.72
Granted	—	—
Exercised	(1,544)	$	19.07
Canceled	(5)	$	41.86
Forfeited	(5)	$	19.99
Outstanding as of March 31, 2018	2,623	$	20.06	3.64	$	132,217
Vested and expected to vest as of March 31, 2018	2,623	$	20.06	3.64	$	132,216
Options exercisable as of March 31, 2018	2,597	$	19.79	3.64	$	131,585

Assumptions used for stock option plans

The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model based on the assumptions noted in the following tables:



	Fiscal Year
	2018	2017	2016
Expected volatility	N/A	N/A	42.8		%
Expected dividend yield	N/A	N/A	0.0		%
Expected term (in years)	N/A	N/A	5.7
Risk-free interest rate	N/A	N/A	1.6		%
Weighted-average grant-date fair value of options granted during the period	N/A	N/A	$	32.62

Restricted share plans

The following activity has occurred with respect to restricted stock unit awards:



	Shares (in thousands)	Weighted-Average Grant-Date Fair Value
Balance at April 1, 2017	2,375	$	53.00
Granted	998	68.67
Vested	(1,059)	50.30
Forfeited	(127)	57.73
Balance at March 31, 2018	2,187	$	59.46

Operating Segment and Geographical Information (Tables)

12 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Summary of details of reportable segments

The following tables present details of the Company’s reportable segments and a reconciliation of the “All other” category (in thousands):



	Fiscal Year
	2018			2017			2016
Revenue:
MP	$	2,181,161		$	2,384,041		$	2,083,334
IDP	788,495			644,653			523,512
All other (1)	3,880			3,880			3,880
Total revenue	$	2,973,536		$	3,032,574		$	2,610,726
Income from operations:
MP	$	549,574		$	554,001		$	591,751
IDP	235,719			152,539			108,370
All other	(715,011		)	(618,481		)	(688,153		)
Income from operations	$	70,282		$	88,059		$	11,968
Interest expense	$	(59,548	)	$	(58,879	)	$	(23,316	)
Interest income	7,017			1,212			2,068
Other (expense) income	(606		)	(3,087		)	6,418
Income (loss) before income taxes	$	17,145		$	27,305		$	(2,862	)

(1) "All other" revenue relates to royalty income that is not allocated to MP or IDP.

Summary of reconciliation of All other category



	Fiscal Year
	2018			2017			2016
Reconciliation of “All other” category:
Stock-based compensation expense	$	(68,158	)	$	(88,845	)	$	(139,516	)
Amortization of intangible assets	(539,362		)	(494,387		)	(494,589		)
Acquisition and integration related costs	(10,561		)	(25,391		)	(26,503		)
Restructuring charges	(21,406		)	(1,696		)	(4,235		)
Start-up costs	(24,271		)	(9,694		)	(14,110		)
Other (including loss (gain) on assets and other miscellaneous corporate overhead)	(51,253		)	1,532			(9,200		)
Loss from operations for “All other”	$	(715,011	)	$	(618,481	)	$	(688,153	)

Sales to customers by geographic region

The consolidated financial statements include revenue to customers by geographic region that are summarized as follows (in thousands):



	Fiscal Year
	2018		2017		2016
Revenue:
United States	$	524,472	$	467,031	$	306,328
International	2,449,064		2,565,543		2,304,398



	Fiscal Year
	2018	2017	2016
Revenue:
United States	18%	15%	12%
Asia	78	81	83
Europe	3	3	4
Other	1	1	1

Long-lived assets by geographic region

The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands):



	March 31, 2018		April 1, 2017		April 2, 2016
Long-lived tangible assets:
United States	$	1,089,157	$	1,082,754	$	816,882
China	217,205		244,728		183,836
Other countries	67,750		64,450		46,170

Consolidating Financial Information (Tables)

12 Months Ended

Mar. 31, 2018

Consolidating Financial Information [Abstract]

Condensed consolidating balance sheets



	Condensed Consolidating Balance Sheet
	March 31, 2018
(in thousands)	Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations and Reclassifications			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	629,314	$	296,723	$	—		$	926,037
Accounts receivable, less allowance	—		76,863		269,094		—			345,957
Intercompany accounts and note receivable	—		272,409		53,363		(325,772		)	—
Inventories	—		154,651		339,434		(21,793		)	472,292
Prepaid expenses	—		17,530		6,379		—			23,909
Other receivables	—		5,959		38,836		—			44,795
Other current assets	—		29,627		1,188		—			30,815
Total current assets	—		1,186,353		1,005,017		(347,565		)	1,843,805
Property and equipment, net	—		1,085,255		289,146		(289		)	1,374,112
Goodwill	—		1,121,941		1,051,948		—			2,173,889
Intangible assets, net	—		395,317		465,019		—			860,336
Long-term investments	—		1,847		61,918		—			63,765
Long-term intercompany accounts and notes receivable	—		543,127		116,494		(659,621		)	—
Investment in subsidiaries	6,198,885		2,388,222		—		(8,587,107		)	—
Other non-current assets	72,122		31,011		32,516		(70,037		)	65,612
Total assets	$	6,271,007	$	6,753,073	$	3,022,058	$	(9,664,619	)	$	6,381,519
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	—	$	78,278	$	134,915	$	—		$	213,193
Intercompany accounts and notes payable	—		53,363		272,409		(325,772		)	—
Accrued liabilities	23,102		101,286		43,163		(369		)	167,182
Other current liabilities	—		3,882		57,022		—			60,904
Total current liabilities	23,102		236,809		507,509		(326,141		)	441,279
Long-term debt	983,290		—		—		—			983,290
Deferred tax liabilities	—		83,449		16,366		(36,731		)	63,084
Long-term intercompany accounts and notes payable	489,051		116,494		54,076		(659,621		)	—
Other long-term liabilities	—		62,417		55,885		—			118,302
Total liabilities	1,495,443		499,169		633,836		(1,022,493		)	1,605,955
Total stockholders’ equity	4,775,564		6,253,904		2,388,222		(8,642,126		)	4,775,564
Total liabilities and stockholders’ equity	$	6,271,007	$	6,753,073	$	3,022,058	$	(9,664,619	)	$	6,381,519



	Condensed Consolidating Balance Sheet
	April 1, 2017
(in thousands)	Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations and Reclassifications			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—	$	226,186	$	319,277	$	—		$	545,463
Accounts receivable, less allowance	—		57,874		300,074		—			357,948
Intercompany accounts and notes receivable	—		392,075		36,603		(428,678		)	—
Inventories	—		131,225		322,559		(23,330		)	430,454
Prepaid expenses	—		29,032		7,197		—			36,229
Other receivables	—		7,239		58,008		—			65,247
Other current assets	—		25,534		730		—			26,264
Total current assets	—		869,165		1,044,448		(452,008		)	1,461,605
Property and equipment, net	—		1,078,761		314,910		(1,739		)	1,391,932
Goodwill	—		1,121,941		1,051,973		—			2,173,914
Intangible assets, net	—		599,618		800,945		—			1,400,563
Long-term investments	—		25,971		9,523		—			35,494
Long-term intercompany accounts and notes receivable	—		447,613		138,398		(586,011		)	—
Investment in subsidiaries	6,142,568		2,596,172		—		(8,738,740		)	—
Other non-current assets	84,153		33,249		24,746		(83,333		)	58,815
Total assets	$	6,226,721	$	6,772,490	$	3,384,943	$	(9,861,831	)	$	6,522,323
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	—	$	111,799	$	104,447	$	—		$	216,246
Intercompany accounts and notes payable	—		36,603		392,075		(428,678		)	—
Accrued liabilities	23,150		111,700		35,734		—			170,584
Other current liabilities	—		55		31,943		—			31,998
Total current liabilities	23,150		260,157		564,199		(428,678		)	418,828
Long-term debt	989,154		—		—		—			989,154
Deferred tax liabilities	—		171,284		43,560		(83,333		)	131,511
Long-term intercompany accounts and notes payable	317,695		138,398		129,918		(586,011		)	—
Other long-term liabilities	—		35,014		51,094		—			86,108
Total liabilities	1,329,999		604,853		788,771		(1,098,022		)	1,625,601
Total stockholders’ equity	4,896,722		6,167,637		2,596,172		(8,763,809		)	4,896,722
Total liabilities and stockholders’ equity	$	6,226,721	$	6,772,490	$	3,384,943	$	(9,861,831	)	$	6,522,323

Condensed consolidating statements of operations and comprehensive income (loss)



	Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
	Fiscal Year 2018
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Revenue	$	—		$	1,137,783		$	2,689,676		$	(853,923	)	2,973,536
Cost of goods sold	—			828,496			1,723,829			(725,755		)	1,826,570
Gross profit	—			309,287			965,847			(128,168		)	1,146,966
Operating expenses:
Research and development	27,688			54,663			382,109			(19,357		)	445,103
Selling, general and administrative	39,882			248,601			349,739			(110,471		)	527,751
Other operating expense	588			89,454			13,463			325			103,830
Total operating expenses	68,158			392,718			745,311			(129,503		)	1,076,684
Income (loss) from operations	(68,158		)	(83,431		)	220,536			1,335			70,282
Interest expense	(58,133		)	(2,340		)	(1,505		)	2,430			(59,548		)
Interest income	—			2,696			6,751			(2,430		)	7,017
Other (expense) income	(929		)	973			(642		)	(8		)	(606		)
Income (loss) before income taxes	(127,220		)	(82,102		)	225,140			1,327			17,145
Income tax expense	(26		)	(15,586		)	(41,821		)	—			(57,433		)
Income in subsidiaries	86,958			183,319			—			(270,277		)	—
Net (loss) income	$	(40,288	)	$	85,631		$	183,319		$	(268,950	)	$	(40,288	)

Comprehensive (loss) income	$	(38,734	)	$	87,654		$	186,172		$	(273,826	)	$	(38,734	)



	Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
	Fiscal Year 2017
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Revenue	$	—		$	1,316,576		$	2,918,865		$	(1,202,867	)	3,032,574
Cost of goods sold	—			979,190			2,023,715			(1,105,843		)	1,897,062
Gross profit	—			337,386			895,150			(97,024		)	1,135,512
Operating expenses:
Research and development	35,379			40,918			416,869			(22,330		)	470,836
Selling, general and administrative	53,465			253,531			370,812			(132,220		)	545,588
Other operating expense	—			16,065			8,409			6,555			31,029
Total operating expenses	88,844			310,514			796,090			(147,995		)	1,047,453
Income (loss) from operations	(88,844		)	26,872			99,060			50,971			88,059
Interest expense	(57,344		)	(2,619		)	(3,129		)	4,213			(58,879		)
Interest income	—			4,457			759			(4,004		)	1,212
Other (expense) income	—			426			(1,999		)	(1,514		)	(3,087		)
Income (loss) before income taxes	(146,188		)	29,136			94,691			49,666			27,305
Income tax (expense) benefit	46,003			(63,893		)	(25,973		)	—			(43,863		)
Income in subsidiaries	83,627			68,718			—			(152,345		)	—
Net (loss) income	$	(16,558	)	$	33,961		$	68,718		$	(102,679	)	$	(16,558	)

Comprehensive (loss) income	$	(17,731	)	$	34,014		$	67,492		$	(101,506	)	$	(17,731	)



	Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
	Fiscal Year 2016
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Revenue	$	—		$	2,212,062		$	2,762,150		$	(2,363,486	)	2,610,726
Cost of goods sold	—			1,778,336			2,060,702			(2,277,865		)	1,561,173
Gross profit	—			433,726			701,448			(85,621		)	1,049,553
Operating expenses:
Research and development	67,158			106,560			304,219			(29,174		)	448,763
Selling, general and administrative	72,358			151,814			360,593			(50,666		)	534,099
Other operating expense	—			50,928			2,447			1,348			54,723
Total operating expenses	139,516			309,302			667,259			(78,492		)	1,037,585
Income (loss) from operations	(139,516		)	124,424			34,189			(7,129		)	11,968
Interest expense	(21,895		)	(2,419		)	(3,029		)	4,027			(23,316		)
Interest income	—			2,650			3,003			(3,585		)	2,068
Other income (expense)	—			5,467			(298		)	1,249			6,418
(Loss) income before income taxes	(161,411		)	130,122			33,865			(5,438		)	(2,862		)
Income tax (expense) benefit	44,014			(49,751		)	(20,246		)	—			(25,983		)
Income in subsidiaries	88,552			13,619			—			(102,171		)	—
Net (loss) income	$	(28,845	)	$	93,990		$	13,619		$	(107,609	)	$	(28,845	)

Comprehensive (loss) income	$	(31,854	)	$	89,738		$	14,862		$	(104,600	)	$	(31,854	)

Condensed consolidating statements of cash flows



	Condensed Consolidating Statement of Cash Flows
	Fiscal Year 2018
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Net cash provided by operating activities	$	196,848		$	165,883		$	489,789		$	—		$	852,520
Investing activities:
Purchase of property and equipment	—			(226,860		)	(42,975		)	—			(269,835		)
Other investing	—			22,800			(30,374		)	—			(7,574		)
Net transactions with related parties	—			439,925			(24,100		)	(415,825		)	—
Net cash (used in) provided by investing activities	—			235,865			(97,449		)	(415,825		)	(277,409		)
Financing activities:
Proceeds from debt issuances	100,000			—			—			—			100,000
Payment of debt	(107,729		)	—			—			—			(107,729		)
Debt issuance costs	(1,916		)	—			—			—			(1,916		)
Proceeds from the issuance of common stock	57,412			—			—			—			57,412
Repurchase of common stock, including transaction costs	(219,907		)	—			—			—			(219,907		)
Tax withholding paid on behalf of employees for restricted stock units	(24,708		)	—			—			—			(24,708		)
Net transactions with related parties	—			1,380			(417,205		)	415,825			—
Net cash (used in) provided by financing activities	(196,848		)	1,380			(417,205		)	415,825			(196,848		)
Effect of exchange rate changes on cash	—			—			2,360			—			2,360
Net increase (decrease) in cash, cash equivalents and restricted cash	—			403,128			(22,505		)	—			380,623
Cash, cash equivalents and restricted cash at the beginning of the period	—			226,186			319,593			—			545,779
Cash, cash equivalents and restricted cash at the end of the period	$	—		$	629,314		$	297,088		$	—		$	926,402



	Condensed Consolidating Statement of Cash Flows
	Fiscal Year 2017
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Reclassifications			Consolidated
Net cash provided by operating activities	$	165,660		$	175,988		$	435,172					$	776,820
Investing activities:
Purchase of available-for-sale securities	—			(469		)	—			—			(469		)
Proceeds from maturities and sales of available-for-sale securities	—			186,793			—			—			186,793
Purchase of a business, net of cash acquired	—			—			(117,994		)	—			(117,994		)
Purchase of property and equipment	—			(424,175		)	(128,527		)	—			(552,702		)
Other investing	—			3,924			(9,900		)	—			(5,976		)
Net transactions with related parties	—			61,891			—			(61,891		)	—
Net cash used in investing activities	—			(172,036		)	(256,421		)	(61,891		)	(490,348		)
Financing activities:
Excess tax benefit from exercises of stock options	65			—			—			—			65
Proceeds from the issuance of common stock	59,148			—			—			—			59,148
Repurchase of common stock, including transaction costs	(209,357		)	—			—			—			(209,357		)
Tax withholding paid on behalf of employees for restricted stock units	(15,516		)	—			—			—			(15,516		)
Other financing	—			14			(4		)	—			10
Net transactions with related parties	—			1,587			(63,478		)	61,891			—
Net cash (used in) provided by financing activities	(165,660		)	1,601			(63,482		)	61,891			(165,650		)
Effect of exchange rate changes on cash	—			—			(1,105		)	—			(1,105		)
Net increase in cash, cash equivalents and restricted cash	—			5,553			114,164			—			119,717
Cash, cash equivalents and restricted cash at the beginning of the period	—			220,633			205,429			—			426,062
Cash, cash equivalents and restricted cash at the end of the period	$	—		$	226,186		$	319,593		$	—		$	545,779



	Condensed Consolidating Statement of Cash Flows
	Fiscal Year 2016
(in thousands)	Parent Company			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Eliminations and Reclassifications		Consolidated
Net cash provided by operating activities	$	282,955		$	273,171		$	131,801		$	—	$	687,927
Investing activities:
Purchase of available-for-sale securities	—			(340,527		)				—		(340,527		)
Proceeds from maturities of available-for-sale securities	—			390,009						—		390,009
Purchase of property and equipment	—			(244,817		)	(70,807		)	—		(315,624		)
Other investing	—			(12,830		)	258			—		(12,572		)
Net cash used in investing activities	—			(208,165		)	(70,549		)	—		(278,714		)
Financing activities:
Proceeds from debt issuances	1,175,000			—			—			—		1,175,000
Payment of debt	(175,000		)				—			—		(175,000		)
Excess tax benefit from exercises of stock options	935			—			—			—		935
Debt issuance costs	(13,588		)	—			—			—		(13,588		)
Proceeds from the issuance of common stock	51,875			—			—			—		51,875
Repurchase of common stock, including transaction costs	(1,300,009		)	—			—			—		(1,300,009		)
Tax withholding paid on behalf of employees for restricted stock units	(22,168		)	—			—			—		(22,168		)
Other financing	—			57			(86		)	—		(29		)
Net transactions with related parties	—			1,192			(1,192		)	—		—
Net cash (used in) provided by financing activities	(282,955		)	1,249			(1,278		)	—		(282,984		)
Effect of exchange rate changes on cash	—			—			(294		)	—		(294		)
Net increase in cash, cash equivalents and restricted cash	—			66,255			59,680			—		125,935
Cash, cash equivalents and restricted cash at the beginning of the period	—			154,378			145,749			—		300,127
Cash, cash equivalents and restricted cash at the end of the period	$	—		$	220,633		$	205,429		$	—	$	426,062

Quarterly Financial Summary (Unaudited) (Tables)

12 Months Ended

Mar. 31, 2018

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Summary (Unaudited)

QUARTERLY FINANCIAL SUMMARY (UNAUDITED):



Fiscal 2018 Quarter
(in thousands, except
per share data)	First				Second			Third				Fourth
Revenue	$	640,831			$	821,583		$	845,739			$	665,383
Gross profit	236,377				321,022			336,927				252,640
Net (loss) income	(30,624		)	^(1),(2),(3)	35,919		^(1),(2),(3)	(33,082		)	^{(1),(2),(3),(4)}	(12,501		)	^{(1),(2),(3),(5)}
Net (loss) income per share:
Basic	$	(0.24	)		$	0.28		$	(0.26	)		$	(0.10	)
Diluted	$	(0.24	)		$	0.27		$	(0.26	)		$	(0.10	)

Fiscal 2017 Quarter
(in thousands, except
per share data)	First				Second			Third				Fourth
Revenue	$	698,537			$	864,698		$	826,347			$	642,992
Gross profit	276,475				316,799			310,642				231,596
Net (loss) income	(5,675		)	^(1),(2),(3)	11,847		^(1),(2),(3)	(78,638		)	^{(1),(2),(3),(6)}	55,908			^{(1),(2),(3),(7)}
Net (loss) income per share:
Basic	$	(0.04	)		$	0.09		$	(0.62	)		$	0.44
Diluted	$	(0.04	)		$	0.09		$	(0.62	)		$	0.43

4. Income tax expense of $98.5 million for the third quarter of fiscal 2018 relates primarily to a discrete provisional tax expense related to the enactment of the Tax Act (Note 12).

6. Income tax expense of $123.2 million for the third quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

7. Income tax benefit of $93.2 million for the fourth quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

The Company and Its Significant Accounting Policies (Details) - USD ($)

3 Months Ended

12 Months Ended

Sep. 30, 2017

Mar. 28, 2015

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Mar. 28, 2015

Jan. 01, 2015

The Company and Its Significant Accounting Policies [Line Items]

Effective Income Tax Rate Reconciliation, Intra-Entity Transfer, Amount

$ 6,873,000

$ 0

Maturity Period For Available For Sale Investments Classification As Current Investments Minimum [greater than]

3 months

Maturity Period For Available For Sale Investments Classification As Current Investments Maximum [less than]

1 year

Maturity Period for Available for Sale Investments Classification As Long Term Investments Minimum [exceeding]

1 year

Value Added Tax Receivable

$ 38,100,000

55,400,000

Goodwill, Impairment Loss

2,173,889,000

^[1]

2,173,914,000

2,135,697,000

^[1]

$ 0

Period of Projected Net Cash Flows

8 years

Completed and transferred acquired in-process research and development during period

$ 37,000,000

220,000,000

203,000,000

Accrued compensation and benefits

96,700,000

98,700,000

Interest Payable

$ 23,100,000

23,200,000

Rebates As Percentage Of Sales [Less Than]

5.00%

Percentage Of Net Revenue Other Agreements [Less Than]

1.00%

Total remaining unearned compensation cost related to nonvested restricted stock units and options

$ 72,800,000

Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units and options

1 year 2 months 12 days

Minimum

The Company and Its Significant Accounting Policies [Line Items]

Property, Plant and Equipment, Useful Life

1 year

The Company and Its Significant Accounting Policies [Line Items]

$ 1,000,000

Maximum

Property, Plant and Equipment, Useful Life

39 years

In-process research and development

$ 2,000,000

The Company and Its Significant Accounting Policies [Line Items]

Technology licenses | Minimum

$ 10,000,000

The Company and Its Significant Accounting Policies [Line Items]

Technology licenses | Maximum

5 years

The Company and Its Significant Accounting Policies [Line Items]

Customer Relationships | Minimum

8 years

The Company and Its Significant Accounting Policies [Line Items]

Customer Relationships | Maximum

4 years

3 years

The Company and Its Significant Accounting Policies [Line Items]

Developed Technology | Minimum

6 years

10 years

The Company and Its Significant Accounting Policies [Line Items]

Developed Technology | Maximum

4 years

3 years

The Company and Its Significant Accounting Policies [Line Items]

The Company and Its Significant Accounting Policies [Line Items]

6 years

Trade Names | Minimum

The Company and Its Significant Accounting Policies [Line Items]

2 years

Trade Names | Maximum

The Company and Its Significant Accounting Policies [Line Items]

3 years

TriQuint Merger

Finite-Lived Intangible Assets, Period Increase (Decrease)

$ 2,036,700,000

$ 2,394,000,000

TriQuint Merger | In-process research and development

The Company and Its Significant Accounting Policies [Line Items]

Indefinite-lived Intangible Assets, Period Increase (Decrease)

$ 470,000,000

Finite-Lived Intangible Assets, Period Increase (Decrease)

470,000,000

TriQuint Merger | Customer Relationships

The Company and Its Significant Accounting Policies [Line Items]

Finite-Lived Intangible Assets, Period Increase (Decrease)

1,220,000,000

TriQuint Merger | Developed Technology

The Company and Its Significant Accounting Policies [Line Items]

Finite-Lived Intangible Assets, Period Increase (Decrease)

$ 610,000,000

The Company and Its Significant Accounting Policies [Line Items]

Effect of one percent decrease in discount rate

$ 422,386,000

422,411,000

384,194,000

Discount rate

16.00%

$ 140,000,000

Effect of a one percent increase in discount rate

110,000,000

Effect of one point decrease in long-term growth rate

50,000,000

Effect of a one percent increase in the long-term growth rate

70,000,000

Infrastructure and Defense Products | TriQuint Merger

The Company and Its Significant Accounting Policies [Line Items]

291,200,000

The Company and Its Significant Accounting Policies [Line Items]

Effect of one percent decrease in discount rate

$ 1,751,503,000

1,751,503,000

Long term growth rate

3.00%

Discount rate

15.00%

$ 660,000,000

Effect of a one percent increase in discount rate

560,000,000

Effect of one point decrease in long-term growth rate

290,000,000

Effect of a one percent increase in the long-term growth rate

340,000,000

Mobile Products | TriQuint Merger

The Company and Its Significant Accounting Policies [Line Items]

Change in Accounting Method Accounted for as Change in Estimate [Member]

$ 1,745,500,000

The Company and Its Significant Accounting Policies [Line Items]

Change in Accounting Estimate Impact, Depreciation Expense

59,700,000

New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Operating Results

47,400,000

New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income

$ 44,100,000

New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Diluted Earnings Per Share

$ 0.34

Change in Accounting Estimate Impact, Inventory Change

$ 12,300,000

Accounting Standards Update 2016-18 [Member] | New Accounting Pronouncement, Early Adoption, Effect [Member] | Cash and Cash Equivalents

The Company and Its Significant Accounting Policies [Line Items]

New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification

$ 1,000,000

Accounting Standards Update 2016-16 [Member] | New Accounting Pronouncement, Early Adoption, Effect [Member] | Retained Earnings [Member]

The Company and Its Significant Accounting Policies [Line Items]

New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification

1,200,000

Accounting Standards Update 2016-09 [Member] | Retained Earnings [Member]

The Company and Its Significant Accounting Policies [Line Items]

New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification

(36,700,000)

Income tax benefit (expense) [Member] | Accounting Standards Update 2016-09 [Member]

The Company and Its Significant Accounting Policies [Line Items]

New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification

$ 12,200,000

[1]	The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Concentrations of Credit Risk (Details) - Sales Revenue, Net - Customer Concentration Risk	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Apple
Revenue from significant customers
Percentage	36.00%	34.00%	37.00%
Huawei
Revenue from significant customers
Percentage	8.00%	11.00%	12.00%

Concentrations of Credit Risk (Details Textual)	12 Months Ended
Concentrations of Credit Risk (Details Textual)	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Accounts Receivable \| Credit Concentration Risk
Concentrations of Credit Risk (Textual)
Percentage	26.00%	40.00%	40.00%

Investments and Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Schedule of Cash equivalents and available-for-sale securities
Cost	$ 1,959	$ 2,164
Gross unrealized losses	(107)	(429)
Estimated fair value	1,852	1,735
Auction rate securities
Schedule of Cash equivalents and available-for-sale securities
Cost	1,950	2,150
Gross unrealized losses	(107)	(429)
Estimated fair value	1,843	1,721
Money market funds
Schedule of Cash equivalents and available-for-sale securities
Cost	9	14
Estimated fair value	$ 9	$ 14

Investments and Fair Value Measurements (Details 1) - Debt Securities - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Schedule of Cash equivalents and available-for-sale securities
Cost of investments in cash equivalents and debt securities due in less than one year	$ 9	$ 14
Cost of investments in cash equivalents and debt securities due after ten years	1,950	2,150
Total cost of investments in cash equivalents and debt securities	1,959	2,164
Estimated fair value of cash equivalents and investments in debt securities due in less than one year	9	14
Estimated fair value of cash equivalents and investments in debt securities due after ten years	1,843	1,721
Estimated fair value	$ 1,852	$ 1,735

Investments and Fair Value Measurements (Details 2) - Recurring - USD ($)
$ in Thousands

Mar. 31, 2018

Apr. 01, 2017

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Deferred compensation plan assets

^[1]

$ 14,284

$ 10,237

Total assets measured at fair value

16,136

11,972

Deferred compensation plan liability

^[1]

14,284

10,237

Total liabilities measured at fair value

14,284

10,237

Quoted Prices In Active Markets For Identical Assets (Level 1)

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Deferred compensation plan assets

^[1]

14,284

10,237

Total assets measured at fair value

14,293

10,251

Deferred compensation plan liability

^[1]

14,284

10,237

Total liabilities measured at fair value

14,284

10,237

Significant Other Observable Inputs (Level 2)

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Deferred compensation plan assets

Total assets measured at fair value

1,843

1,721

Auction rate securities

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Available-for-sale Securities, Debt Securities

^[2]

1,843

1,721

Auction rate securities | Significant Other Observable Inputs (Level 2)

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Available-for-sale Securities, Debt Securities

^[2]

1,843

1,721

Money market funds

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Cash equivalents

Money market funds | Quoted Prices In Active Markets For Identical Assets (Level 1)

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Cash equivalents

$ 9

$ 14

[1]

[2]

Investments and Fair Value Measurements (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Schedule of Cash equivalents and available-for-sale securities
Estimated fair value	$ 1,852	$ 1,735
Fair Value, Inputs, Level 3
Schedule of Cash equivalents and available-for-sale securities
Estimated fair value	0	$ 0
Cavendish
Schedule of Cash equivalents and available-for-sale securities
Equity Method Investments	$ 45,000

Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Components of inventories
Raw materials	$ 110,389	$ 92,282
Work in process	221,137	198,339
Finished goods	140,766	139,833
Total inventories	$ 472,292	$ 430,454

Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Property, Plant and Equipment [Abstract]
Land	$ 23,778	$ 25,025
Building and leasehold improvements	389,234	384,784
Machinery and equipment	1,660,138	1,659,404
Property, Plant and Equipment, Gross	2,073,150	2,069,213
Less accumulated depreciation	(911,910)	(981,328)
Property And Equipment Net Excluding Construction In Progress	1,161,240	1,087,885
Construction in progress	212,872	304,047
Property and equipment, net	$ 1,374,112	$ 1,391,932

Business Acquisitions (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Apr. 29, 2016

Mar. 31, 2018

Dec. 30, 2017

Sep. 30, 2017

Jul. 01, 2017

Apr. 01, 2017

Dec. 31, 2016

Oct. 01, 2016

Jul. 02, 2016

Mar. 28, 2015

Jan. 02, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Jan. 01, 2015

Business combination, Cash acquired

Share Price

$ 70.45

$ 700

Integration related costs

$ 1,200

$ 1,700

$ 1,800

$ 1,500

$ 2,700

$ 3,900

$ 5,000

$ 5,300

$ 6,200

$ 16,900

$ 26,500

2,173,889

^[1]

2,173,914

2,173,889

^[1]

2,173,914

2,135,697

^[1]

In-process research and development placed in service

(38,217)

37,000

Restructuring costs

41,500

$ 15,200

$ 10,500

$ 500

400

$ 400

$ 500

$ 800

67,700

GreenPeak

Business Combination, Consideration Transferred

(118,100)

82,100

38,200

TriQuint Merger

Finite-Lived Intangible Assets, Period Increase (Decrease)

$ 2,036,700

$ 2,394,000

Restructuring costs

2,600

2,000

10,100

1,751,503

Mobile Products | TriQuint Merger

1,745,500

$ 422,386

$ 422,411

422,386

422,411

$ 384,194

Infrastructure and Defense Products | TriQuint Merger

$ (38,217)

Property, Plant and Equipment | TriQuint Merger

$ 291,200

Deferred Taxes | TriQuint Merger

$ 3,800

Developed Technology | GreenPeak

$ 1,100

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

$ 74,200

7 years

Developed Technology | TriQuint Merger

Finite-Lived Intangible Assets, Period Increase (Decrease)

610,000

Customer Relationships | GreenPeak

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

$ 5,600

3 years

Customer Relationships | TriQuint Merger

Finite-Lived Intangible Assets, Period Increase (Decrease)

1,220,000

In-process research and development | TriQuint Merger

Finite-Lived Intangible Assets, Period Increase (Decrease)

$ 470,000

In-process research and development placed in service

$ 460,000

Minimum | Developed Technology

Minimum | Customer Relationships

4 years

3 years

Minimum | Transferred and in service in-process research and development

4 years

3 years

Maximum | Developed Technology

4 years

Maximum | Customer Relationships

6 years

Maximum | Transferred and in service in-process research and development

6 years

10 years

6 years

[1]	The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Goodwill and Intangible Assets (Details) - USD ($)
$ in Thousands

12 Months Ended

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

$ 2,173,914

$ 2,135,697

^[1]

38,217

Goodwill, accumulated impairment losses and write-offs

2,173,889

^[1]

2,173,914

621,600

$ 621,600

1,751,503

1,751,503

422,411

384,194

38,217

422,386

422,411

GreenPeak

Goodwill, Acquired During Period

38,200

(25)

GreenPeak | Mobile Products

$ 38,200

Goodwill, Acquired During Period

GreenPeak | Infrastructure and Defense Products

Goodwill, Acquired During Period

$ (25)

[1]	The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Goodwill and Intangible Assets (Details 1) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Gross carrying amounts and amortization of intangibles
Accumulated Amortization	$ 1,711,520	$ 1,172,222
Gross Carrying Amount	2,571,856	2,572,785
Technology licenses
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	12,379	13,346
Accumulated Amortization	11,904	11,711
Noncompete Agreements [Member]
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	1,026	1,026
Accumulated Amortization	983	470
Customer Relationships
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	1,272,725	1,272,725
Accumulated Amortization	936,175	656,688
Developed Technology
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	1,246,335	1,209,335
Accumulated Amortization	733,081	481,441
Trade Names
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	29,391	29,353
Accumulated Amortization	29,377	21,912
In-process research and development
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	$ 10,000	$ 47,000

Goodwill and Intangible Assets (Details 2) $ in Thousands	Mar. 31, 2018 USD ($)
Estimated Amortization Expense
2019	$ 455,000
2020	207,000
2021	155,000
2022	28,000
2023	$ 12,000

Goodwill and Intangible Assets (Details 3) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization (Note 7)	$ 539,790	$ 494,752	$ 494,589

Goodwill and Intangible Assets (Details Textual) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Apr. 29, 2016

Mar. 28, 2015

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Mar. 28, 2015

Jan. 01, 2015

Intangible assets amortization (Note 6)

$ 2,173,889

^[1]

$ 2,173,914

$ 2,135,697

^[1]

539,790

494,752

494,589

In-process research and development placed in service

37,000

In-process research and development

Intangible assets

10,000

47,000

10,000

GreenPeak

82,100

GreenPeak | Developed Technology

38,200

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

$ 74,200

7 years

GreenPeak | Customer Relationships

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

$ 5,600

3 years

TriQuint Merger

Finite-Lived Intangible Assets, Period Increase (Decrease)

$ 2,036,700

$ 2,394,000

TriQuint Merger | Developed Technology

Finite-Lived Intangible Assets, Period Increase (Decrease)

610,000

TriQuint Merger | Customer Relationships

Finite-Lived Intangible Assets, Period Increase (Decrease)

1,220,000

TriQuint Merger | In-process research and development

Indefinite-lived Intangible Assets, Period Increase (Decrease)

$ 470,000

Finite-Lived Intangible Assets, Period Increase (Decrease)

$ 470,000

In-process research and development placed in service

460,000

Mobile Products | TriQuint Merger

1,751,503

1,745,500

Infrastructure and Defense Products | TriQuint Merger

422,386

$ 422,411

$ 384,194

$ 291,200

Minimum

Minimum | Developed Technology

$ 1,000

Minimum | Customer Relationships

4 years

3 years

Minimum | Transferred and in service in-process research and development

4 years

3 years

4 years

Maximum

Maximum | Developed Technology

$ 2,000

Maximum | Customer Relationships

6 years

Maximum | Transferred and in service in-process research and development

6 years

10 years

Document Fiscal Year Focus

6 years

[1]	The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Debt (Details) - USD ($) $ in Thousands	12 Months Ended
Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Debt Instrument [Line Items]
Document Period End Date	Mar. 31, 2018
Long-term debt (Note 8)	$ 983,290	$ 989,154
Unamortized Debt Issuance Expense	9,674	10,846
6.75% Senior Notes due 2023
Debt Instrument [Line Items]
Long-term debt (Note 8)	444,464	450,000
7.00% Senior Notes due 2025
Debt Instrument [Line Items]
Long-term debt (Note 8)	$ 548,500	$ 550,000

Debt (Details Textual) $ in Thousands		1 Months Ended	12 Months Ended
Debt (Details Textual) $ in Thousands	Dec. 05, 2017 USD ($)	Mar. 31, 2018 USD ($)	Mar. 31, 2018 USD ($)	Apr. 01, 2017 USD ($)	Apr. 02, 2016 USD ($)	Nov. 19, 2015 USD ($)
Debt Instrument [Line Items]
Document Period End Date			Mar. 31, 2018
Interest paid			$ 70,208	$ 71,171	$ 2,164
Net carrying amount of debt		$ 983,290	983,290	989,154
Proceeds from debt issuances			$ 100,000	0	1,175,000
Document Fiscal Year Focus			2018
Senior Notes
Debt Instrument [Line Items]
Interest Expense, Borrowings				69,900	25,800
Interest Costs Capitalized				13,600	$ 5,200
Interest paid			$ 68,900	71,200
6.75% Senior Notes due 2023
Debt Instrument [Line Items]
Debt Instrument, Face Amount						$ 450,000
Debt Instrument, Interest Rate, Stated Percentage		6.75%	6.75%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed			35.00%
Debt Instrument, Redemption Price, Percentage			106.75%
Repayments of Senior Debt		$ 5,500
Senior notes, redemption percentage, actual		107.50%
Long-term Debt, Fair Value		$ 474,500	$ 474,500	489,400
Net carrying amount of debt		$ 444,464	$ 444,464	450,000
7.00% Senior Notes due 2025
Debt Instrument [Line Items]
Debt Instrument, Face Amount						$ 550,000
Debt Instrument, Interest Rate, Stated Percentage		7.00%	7.00%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed			35.00%
Debt Instrument, Redemption Price, Percentage			107.00%
Repayments of Senior Debt		$ 1,500
Senior notes, redemption percentage, actual		109.50%
Long-term Debt, Fair Value		$ 596,500	$ 596,500	607,800
Net carrying amount of debt		$ 548,500	548,500	$ 550,000
Senior Delayed Draw Term Loan
Debt Instrument [Line Items]
Interest paid			700
Senior Notes and Senior Delayed Draw Term Loan [Member]
Debt Instrument [Line Items]
Interest Expense, Borrowings			70,500
Interest Costs Capitalized			$ 13,600
Bank of America Syndicate [Member] \| Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Consolidated Total Leverage Ratio Allowed		3.0	3.0
Permitted acquisition amount for increase in leverage ratio		$ 300,000	$ 300,000
Line of credit facility, maximum consolidated total leverage ratio allowed, with permitted acquisition		3.5	3.5
Line of Credit Facility, Minimum Consolidated Interest Coverage Ratio Required		3.0	3.0
Bank of America Syndicate [Member] \| Revolving Credit Facility \| Credit Agreement
Debt Instrument [Line Items]
Net carrying amount of debt		$ 0	$ 0
Line of Credit Facility, Maximum Borrowing Capacity	$ 300,000
Line of Credit Facility, Maximum amount of increase that may be requested	300,000
Bank of America Syndicate [Member] \| Senior Delayed Draw Term Loan \| Credit Agreement
Debt Instrument [Line Items]
Senior Delayed Draw Term Loan, Maximum Amount	400,000
Proceeds from debt issuances	100,000
Bank of America Syndicate [Member] \| Standby Letters of Credit \| Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	25,000
Bank of America Syndicate [Member] \| Swingline Loan \| Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 10,000
Bank of America Syndicate [Member] \| Federal Funds Rate [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate			0.50%
Bank of America Syndicate [Member] \| Eurodollar [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate			1.00%
Bank of America Syndicate [Member] \| Default rate increase [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate			2.00%
Maximum \| Bank of America Syndicate [Member] \| Eurodollar [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		1.375%	1.375%
Maximum \| Bank of America Syndicate [Member] \| Base Rate [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		0.375%	0.375%
Minimum \| Bank of America Syndicate [Member] \| Eurodollar [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		1.125%	1.125%
Minimum \| Bank of America Syndicate [Member] \| Base Rate [Member] \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		0.125%	0.125%

Retirement Benefit Plans (Details) $ in Millions	12 Months Ended
Retirement Benefit Plans (Details) $ in Millions	Mar. 31, 2018 USD ($)	Apr. 01, 2017 USD ($)	Apr. 02, 2016 USD ($)
U. S. Defined Contribution Plan [Member]
Retirement Benefit Plan (Textual)
Defined Contribution Plan, Company Contribution Amount	$ 14.0	$ 11.5	$ 11.7
Non-Qualified Deferred Compensation Plan [Member]
Retirement Benefit Plan (Textual)
Assets held in rabbi trust	14.3	10.2
Assets held in rabbi trust, current	1.0	0.7
Assets held in rabbi trust, noncurrent	13.3	9.5
Foreign Plan [Member]
Retirement Benefit Plan (Textual)
Defined benefit plan insurance receivable	4.0	3.3
Defined Benefit Pension Plan, Benefit Obligation	12.7	11.4
Defined Benefit Pension Plan, Net Periodic Benefit Cost	$ 0.7	$ 0.6	$ 0.8
Number of retirement benefit plans offered by the Company	2

Commitments and Contingent Liabilities (Details) $ in Thousands	Mar. 31, 2018 USD ($)
Schedule of Operating Lease Future Minimum Lease Payments [Line Items]
Operating Leases due 2019	$ 12,490
Operating Leases due 2020	11,429
Operating Leases due 2021	10,469
Operating Leases due 2022	8,577
Operating Leases due 2023	7,163
Operating Leases due Thereafter	18,454
Total operating minimum payment	68,582
Capital Lease due 2019	0
Capital Lease due 2020	1,047
Capital Lease due 2021	1,047
Capital Lease due 2022	1,047
Capital Lease due 2023	1,047
Capital Lease due Thereafter	48,243
Total capital lease minimum payment	52,431
Total Leases due 2019	12,490
Total Leases due 2020	12,476
Total Leases due 2021	11,516
Total Leases due 2022	9,624
Total Leases due 2023	8,210
Total Leases due Thereafter	66,697
Total minimum payment	$ 121,013

Commitments and Contingent Liabilities (Details Textual) $ in Thousands	12 Months Ended
	Mar. 31, 2018 USD ($) period	Apr. 01, 2017 USD ($)	Apr. 02, 2016 USD ($)
Commitments and Contingent Liabilities (Textual)
Total future minimum lease payments	$ 68,582
Rent expense under operating leases	$ 16,300	$ 14,800	$ 14,200
Capital Lease Term	5 years
Maximum
Commitments and Contingent Liabilities (Textual)
Capital Lease Term	30 years
Facility
Commitments and Contingent Liabilities (Textual)
Number of renewal periods for operating leases \| period	2
Operating lease renewal period	10 years
Equipment \| Minimum
Commitments and Contingent Liabilities (Textual)
Operating Leases, remaining terms	1 year
Equipment \| Maximum
Commitments and Contingent Liabilities (Textual)
Operating Leases, remaining terms	4 years

Restructuring (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Restructuring (Details) - USD ($) $ in Millions	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges									$ 46.3
Restructuring costs	$ 41.5	$ 15.2	$ 10.5	$ 0.5	$ 0.4	$ 0.4	$ 0.5	$ 0.8	$ 67.7
Document Period End Date									Mar. 31, 2018
Restructuring and Related Cost, Expected Cost Remaining	0.9								$ 0.9
Business combination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring costs									2.7	$ 2.1	$ 10.2
Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring costs									18.3
Accrued Liabilities [Member] \| Employee termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring obligations	6.1				1.6				6.1	1.6
Other Noncurrent Liabilities [Member] \| Lease obligations
Restructuring Cost and Reserve [Line Items]
Restructuring obligations	$ 2.6				$ 2.1				$ 2.6	$ 2.1

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Income Tax Disclosure [Abstract]
Document Fiscal Year Focus	2018
Income (loss) before income taxes
United States	$ (151,083)	$ 2,439	$ (35,923)
Foreign	168,228	24,866	33,061
Income (loss) before income taxes	$ 17,145	$ 27,305	$ (2,862)

Income Taxes (Details 1) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 30, 2017

Apr. 01, 2017

Dec. 31, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Income Tax Disclosure [Abstract]

2018

Current (expense) benefit:

Federal

$ (28,168)

$ (23,835)

$ (4,285)

State

(229)

(476)

(541)

Foreign

(61,284)

(47,579)

(33,346)

Total current (expense) benefit

(89,681)

(71,890)

(38,172)

Deferred (expense) benefit:

Federal

11,817

2,762

27,794

State

253

3,659

(31,229)

^[1]

Foreign

20,178

21,606

15,624

Total deferred (expense) benefit

32,248

28,027

12,189

Total

$ 31,200

$ (98,500)

$ 93,200

$ (123,200)

$ (57,433)

$ (43,863)

$ (25,983)

[1]	(1) In fiscal 2016, the state deferred tax expense included a $31.0 million income tax expense related to an increase in the valuation allowance for the deferred tax asset related to state net operating losses and tax credits.

Income Taxes (Details 2) - USD ($) $ in Thousands	3 Months Ended				12 Months Ended
Income Taxes (Details 2) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 30, 2017	Apr. 01, 2017	Dec. 31, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
ReconciliationOfProvisionOfIncomeTaxes [Line Items]
Document Fiscal Year Focus					2018
Income tax expense at statutory federal rate					$ (5,407)	$ (9,557)	$ 1,002
Income tax expense at statutory federal rate, Percentage					31.54%	35.00%	35.00%
Decrease (increase) resulting from:
State benefit (provision), net of federal (provision) benefit					$ 474	$ (662)	$ (1,320)
State benefit (provision), net of federal (provision) benefit, Percentage					(2.77%)	2.42%	(46.14%)
Research and development credits					$ 38,054	$ 15,352	$ 15,459
Research and development credits, Percentage					(221.95%)	(56.22%)	540.21%
Effect of changes in income tax rate applied to net deferred tax assets					$ 39,168	$ 1,163	$ (2,716)
Effect of changes in income tax rate applied to net deferred tax assets, Percentage					(228.45%)	(4.26%)	(94.92%)
Foreign tax rate difference					$ 21,829	$ (11,298)	$ 4,114
Foreign tax rate difference, Percentage					(127.32%)	41.38%	143.77%
Foreign permanent differences, amount					$ (2,598)	$ (8,432)	$ (1,700)
Foreign permanent differences, percent					15.15%	30.88%	(59.40%)
Change in valuation allowance					$ (1,632)	$ 1,363	$ (25,120)
Change in valuation allowance, Percentage					9.52%	(4.99%)	(877.84%)
Stock-based compensation					$ 9,924	$ (3,228)	$ (5,362)
Share-based compensation, Percentage					(57.88%)	11.82%	(187.37%)
Tax reserve adjustments					$ (29,188)	$ (21,789)	$ (8,699)
Tax reserve adjustments, Percentage					170.24%	79.80%	(303.99%)
Deemed dividend					$ (5,098)	$ (6,989)	$ (3,984)
Deemed Dividend, Percentage					29.73%	25.60%	(139.21%)
U.S. Tax Toll Charge					$ (116,419)	$ 0	$ 0
U.S. Tax Toll Charge, Percent					679.03%	0.00%	0.00%
Intra-entity transfer					$ (6,873)	$ 0	$ 0
Intra-entity transfer, percent					40.09%	0.00%	0.00%
Other income tax benefit (expense)					$ 333	$ 214	$ 2,343
Other income tax benefit (expense), Percentage					(1.94%)	(0.79%)	81.89%
Total	$ 31,200	$ (98,500)	$ 93,200	$ (123,200)	$ (57,433)	$ (43,863)	$ (25,983)
Total, Percentage					334.99%	160.64%	(908.00%)

Income Taxes (Details 3) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017
Deferred income tax assets:
Inventory reserve	$ 9,894	$ 15,599
Equity compensation	37,724	83,333
Net operating loss carry-forwards	50,128	40,575
Research and other credits	39,513	92,793
Employee benefits	12,842	13,247
Other deferred assets	16,620	23,355
Total deferred income tax assets	166,721	268,902
Valuation allowance	(42,787)	(33,104)
Total deferred income tax assets, net of valuation allowance	123,934	235,798
Deferred income tax liabilities:
Amortization and purchase accounting basis difference	(101,261)	(258,422)
Accumulated depreciation/basis difference	(63,363)	(91,337)
Total deferred tax liabilities	164,624	349,759
Amounts included in consolidated balance sheets:
Non-current assets	22,394	17,550
Non-current liabilities	(63,084)	(131,511)
Total deferred income tax liabilities	$ (40,690)	$ (113,961)

Income Taxes (Details 4) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 4) - USD ($) $ in Thousands	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Income Tax Contingency [Line Items]
Document Fiscal Year Focus	2018
Reconciliation of gross unrecognized tax benefits
Beginning balance	$ 90,615	$ 69,052	$ 59,397
Additions based on positions related to current year	26,431	20,036	9,374
Additions for tax positions in prior years	5,844	1,878	2,723
Reductions for tax positions in prior years	(67)	(29)	(1,973)
Expiration of statute of limitations	0	(322)	(469)
Ending balance	$ 122,823	$ 90,615	$ 69,052

Income Taxes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				12 Months Ended
	Mar. 31, 2018	Dec. 30, 2017	Apr. 01, 2017	Dec. 31, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016	Mar. 28, 2015
Valuation Allowance [Line Items]
U.S. statutory federal rate					31.54%	35.00%	35.00%
Document Fiscal Year Focus					2018
Document Period End Date					Mar. 31, 2018
Income Taxes (Textual)
Valuation Allowance	$ 42,787		$ 33,104		$ 42,787	$ 33,104
Valuation Allowance, Deferred Tax Asset, Change in Amount					(9,700)	$ 1,600	$ (20,900)
North Carolina State Corporate Tax Rate							5.00%
New North Carolina State Corporate Tax Rate						4.00%
Foreign jurisdiction exemption reduction, Dollar Amount					$ 7,900	$ 2,700
Foreign jurisdiction exemption reduction, per share amount					$ 0.06	$ 0.02
Gross unrecognized tax benefits	122,823		90,615		$ 122,823	$ 90,615	$ 69,052	$ 59,397
Unrecognized tax benefits, if recognized, would impact the effective tax rate	118,700		84,400		118,700	84,400	64,200
Additions for tax positions in prior years					5,844	1,878	2,723
Interest and penalties expense (benefit) recognized related to uncertain tax positions					(2,500)	2,100	1,600
Accrued interest and penalties related to unrecognized tax benefits	4,600		7,100		4,600	7,100	5,000
Long-term Tax Liability	18,300				$ 18,300
Period gross unrecognized tax benefits may be reduced					12 months
Taxes Payable, Current	60,000		31,700		$ 60,000	31,700
Long-term income taxes payable	24,200				24,200
Income tax expense (benefit)	(31,200)	$ 98,500	(93,200)	$ 123,200	57,433	43,863	25,983
Deferred Income Tax Expense (Benefit)					(32,248)	(28,027)	(12,189)
State deferred tax assets
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount						(31,000)
Tax rate changes [Member]
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount					(6,800)
Domestic and foreign deferred tax assets
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount						(2,800)
Domestic deferred tax assets
Income Taxes (Textual)
Valuation Allowance	40,800		32,300		40,800	32,300	29,500
Foreign deferred tax assets
Income Taxes (Textual)
Valuation Allowance	2,000		$ 800		2,000	800	5,200
Valuation Allowance, Deferred Tax Asset, Change in Amount					500	5,200
Business Combination deferred tax asset
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount							4,300
State net operating losses and credits
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount					(1,900)		(20,200)
Foreign net operating losses
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount					(1,000)	$ (800)	$ (5,000)
State tax credits [Member]
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount					(500)
U.S. Tax Cuts and Jobs Act, Effective 2018 [Member]
Income Taxes (Textual)
Increase (decrease) in deferred tax liability	39,100
Income tax expense (benefit)					77,300
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount					116,400
Deferred Income Tax Expense (Benefit)					(39,100)
U.S. Federal
Income Taxes (Textual)
Loss carryovers	305,000				305,000
State
Income Taxes (Textual)
Loss carryovers	147,300				147,300
Research Tax Credit Carryforward [Member]
Income Taxes (Textual)
Income tax credits	54,900				54,900
State
Income Taxes (Textual)
Income tax credits	58,700				58,700
NETHERLANDS \| Foreign deferred tax assets
Income Taxes (Textual)
Loss carryovers	$ 7,800				$ 7,800

Net Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 30, 2017

Sep. 30, 2017

Jul. 01, 2017

Apr. 01, 2017

Dec. 31, 2016

Oct. 01, 2016

Jul. 02, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Numerator:

Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders

$ (12,501)

^{[1],[2],[3],[4]}

$ (33,082)

^{[2],[3],[4],[5]}

$ 35,919

^[2],[3],[4]

$ (30,624)

^[2],[3],[4]

$ 55,908

^{[2],[3],[4],[6]}

$ (78,638)

^{[2],[3],[4],[7]}

$ 11,847

^[2],[3],[4]

$ (5,675)

^[2],[3],[4]

$ (40,288)

$ (16,558)

$ (28,845)

Denominator:

Denominator for basic net (loss) income per share — weighted average shares

126,946

127,121

141,937

Effect of dilutive securities:

Stock-based awards

Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions

126,946

127,121

141,937

Basic net (loss) income per share

$ (0.10)

$ (0.26)

$ 0.28

$ (0.24)

$ 0.44

$ (0.62)

$ 0.09

$ (0.04)

$ (0.32)

$ (0.13)

$ (0.20)

Diluted net (loss) income per share

$ (0.10)

$ (0.26)

$ 0.27

$ (0.24)

$ 0.43

$ (0.62)

$ 0.09

$ (0.04)

$ (0.32)

$ (0.13)

$ (0.20)

[1]	Income tax benefit of $31.2 million for the fourth quarter of fiscal 2018 relates primarily to a discrete provisional benefit for adjustments to a third quarter fiscal 2018 provisional estimate of the impact of the Tax Act (Note 12).
[2]	The Company recorded integration related expenses of $1.5 million, $1.8 million, $1.7 million and $1.2 million in the first, second, third and fourth quarters of fiscal 2018, respectively, associated with the Business Combination. The Company recorded integration related expenses of $5.3 million, $5.0 million, $3.9 million and $2.7 million in the first, second, third and fourth quarters of fiscal 2017, respectively, associated with the Business Combination (Note 6).
[3]	The Company recorded restructuring expenses of $0.5 million, $10.5 million, $15.2 million and $41.5 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded restructuring expenses of $0.8 million, $0.5 million, $0.4 million and $0.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively (Note 11).
[4]	The Company recorded start-up expenses of $6.6 million, $7.2 million, $5.4 million and $5.1 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded start-up expenses of $2.1 million, $2.0 million, $2.2 million and $3.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively.
[5]	Income tax expense of $98.5 million for the third quarter of fiscal 2018 relates primarily to a discrete provisional tax expense related to the enactment of the Tax Act (Note 12).
[6]	Income tax benefit of $93.2 million for the fourth quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).
[7]	Income tax expense of $123.2 million for the third quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

Stock-Based Compensation (Details) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2018 USD ($) $ / shares shares
Summary of activity of the Company's director and employee stock option plans
Outstanding beginning balance, Shares \| shares	4,177
Outstanding beginning balance, Weighted-Average Exercise Price \| $ / shares	$ 19.72
Granted, Shares \| shares	0
Granted, Weighted-Average Exercise Price \| $ / shares	$ 0
Exercised, Shares \| shares	(1,544)
Exercised, Weighted-Average Exercise Price \| $ / shares	$ 19.07
Canceled, Shares \| shares	(5)
Canceled, Weighted-Average Exercise Price \| $ / shares	$ 41.86
Forfeited, Shares \| shares	(5)
Forfeited, Weighted-Average Exercise Price \| $ / shares	$ 19.99
Outstanding ending balance, Shares \| shares	2,623
Outstanding ending balance, Weighted-Average Exercise Price \| $ / shares	$ 20.06
Outstanding ending balance, Weighted-Average Remaining Contractual Term	3 years 7 months 22 days
Outstanding ending balance, Aggregate Intrinsic Value \| $	$ 132,217
Vested and expected to vest, Shares \| shares	2,623
Vested and expected to vest, Weighted-Average Exercise Price \| $ / shares	$ 20.06
Vested and expected to vest, Weighted-Average Remaining Contractual Term	3 years 7 months 22 days
Vested and expected to vest, Aggregate Intrinsic Value \| $	$ 132,216
Options exercisable, Shares \| shares	2,597
Options exercisable, Weighted-Average Exercise Price Ending Balance \| $ / shares	$ 19.79
Options exercisable, Weighted-Average Remaining Contractual Term Ending Balance	3 years 7 months 22 days
Options exercisable, Aggregate Intrinsic Value \| $	$ 131,585

Stock-Based Compensation (Details 1)	12 Months Ended
Stock-Based Compensation (Details 1)	Apr. 02, 2016 $ / shares
Assumptions used for stock option plans
Expected volatility	42.80%
Expected dividend yield	0.00%
Expected term (in years)	5 years 8 months 23 days
Risk-free interest rate	1.60%
Weighted-average grant-date fair value of options granted during the period	$ 32.62

Stock-Based Compensation (Details 2) shares in Thousands	12 Months Ended
Stock-Based Compensation (Details 2) shares in Thousands	Mar. 31, 2018 $ / shares shares
Restricted share plans
Balance at beginning balance, Shares \| shares	2,375
Balance at beginning balance, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 53.00
Granted, Shares \| shares	998
Granted, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 68.67
Vested, Shares \| shares	(1,059)
Vested, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 50.30
Forfeited, Shares \| shares	(127)
Forfeited, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 57.73
Balance at ending balance, Shares \| shares	2,187
Balance at ending balance, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 59.46

Stock-Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016	Apr. 01, 2006
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	6,254,000
Shares granted	0
Expected term (in years)			5 years 8 months 23 days
Stock-based compensation expense	$ 68,158	$ 88,845	$ 139,516
Closing stock price	$ 70.45
Total intrinsic value of options exercised	$ 87,800	81,000	74,900
Cash received from the exercise of stock options (excluding accrued unremitted employee funds)	$ 57,500
Annual forfeiture rate	1.60%
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 72,800
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	1 year 2 months 12 days
Total fair value of vested restricted stock units	$ 73,200	$ 46,100	$ 60,200
Certain officers of the Company (Section 16 Officers) [Member]
Share-Based Compensation (Textual)
Shares granted	300,000
Stock-based compensation expense	$ 20,500
Employee Stock Purchase Plan [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	4,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	85.00%
Period employees can acquire common stock	6 months
Shares issued under plan	500,000	700,000	400,000
2006 Directors' Stock Option Plan [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Reserved additional shares of common stock				300,000
1996 Stock Incentive Program - TriQuint [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2008 Inducement Award Plan - TriQuint [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2009 Incentive Plan - TriQuint [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2013 Incentive Plan - TriQuint [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance		2,400,000
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2015 Inducement Stock Plan - Qorvo [Member]
Share-Based Compensation (Textual)
Maximum number of shares of common stock to be issued under plan	300,000
Maximum available options under the plan, description	The maximum number of shares issuable under the 2015 Inducement Plan may not exceed the sum of (a) 0.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2015 Inducement Stock Plan under the TriQuint 2008 Inducement Award Plan and (ii) subject to an award granted under the TriQuint 2008 Inducement Award Plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason.
Shares granted	0	0	0
2012 Stock Incentive Plan - RF Micro Devices [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	3,600,000
Maximum number of shares of common stock to be issued under plan	4,300,000
2003 Stock Incentive Plan - RF Micro Devices [Member]
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Performance-based restricted stock \| 2012 Stock Incentive Plan - RF Micro Devices [Member]
Share-Based Compensation (Textual)
Shares granted	200,000
Restricted Stock
Share-Based Compensation (Textual)
Vesting period	4 years
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 72,500
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	1 year 2 months 10 days
Stock Options
Share-Based Compensation (Textual)
Expiration period	10 years
Vesting period	4 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 300
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	6 months
Performance and service-based restricted stock units
Share-Based Compensation (Textual)
Vesting percentage when earned	50.00%
Vesting period	2 years
Performance period 1
Share-Based Compensation (Textual)
Vesting period	1 year
Performance period 2
Share-Based Compensation (Textual)
Vesting period	2 years
Performance period 3
Share-Based Compensation (Textual)
Vesting period	3 years

Stockholders' Equity (Details) - shares shares in Thousands	Mar. 31, 2018	Apr. 01, 2017
Common stock reserved for future issuance
Outstanding stock options under formal directors’ and employees’ stock option plans	2,623	4,177
Possible future issuance under Company stock incentive plans	6,254
Employee stock purchase plan	4,594
Restricted stock-based units granted	2,187	2,375
Total shares reserved	15,658

Stockholders' Equity (Details Textual) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands			3 Months Ended	12 Months Ended
	Mar. 10, 2016	Feb. 16, 2016	Jul. 02, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016	Nov. 03, 2016	Nov. 05, 2015
Shareholders' Equity (Textual)
Stock Repurchased During Period, Shares				2,929	4,084	24,258
Stock Repurchased During Period, Value				$ 219,907	$ 209,357	$ 1,300,009
Common stock reserved for future issuance				15,658
Common stock, shares authorized				405,000	405,000
Accelerated Share Repurchases, Shares Received						10,000
November 2016 Program [Member]
Shareholders' Equity (Textual)
Share repurchase program, authorized amount							$ 500,000
Stock Repurchase Program, Authorized Amount rolled into new plan							$ 150,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount				$ 162,100
November 2015 Program [Member]
Shareholders' Equity (Textual)
Share repurchase program, authorized amount								$ 1,000,000
Accelerated Share Repurchases, Settlement (Payment) or Receipt		$ 500,000
Accelerated share repurchase, total shares received			400		10,400
November 2015 Program [Member] \| Collared Agreement [Member]
Shareholders' Equity (Textual)
Share repurchase program, authorized amount		$ 250,000
Accelerated Share Repurchases, Shares Received	2,000	3,100
Accelerated Share Repurchases, percent		50.00%
Accelerated Share Repurchases, Initial Price Paid Per Share		$ 40.78
November 2015 Program [Member] \| Uncollared Agreement [Member]
Shareholders' Equity (Textual)
Share repurchase program, authorized amount		$ 250,000
Accelerated Share Repurchases, Shares Received		4,900
Accelerated Share Repurchases, percent		80.00%
Accelerated Share Repurchases, Initial Price Paid Per Share		$ 40.78

Operating Segment and Geographical Information (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 30, 2017

Sep. 30, 2017

Jul. 01, 2017

Apr. 01, 2017

Dec. 31, 2016

Oct. 01, 2016

Jul. 02, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Document Fiscal Year Focus

2018

Revenue:

$ 665,383

$ 845,739

$ 821,583

$ 640,831

$ 642,992

$ 826,347

$ 864,698

$ 698,537

$ 2,973,536

$ 3,032,574

$ 2,610,726

70,282

88,059

11,968

(59,548)

(58,879)

(23,316)

7,017

1,212

2,068

(Loss) income before income taxes

(606)

(3,087)

6,418

17,145

27,305

(2,862)

Operating Segments [Member] | MP [Member]

Revenue:

2,181,161

2,384,041

2,083,334

Operating Segments [Member] | IDP [Member]

549,574

554,001

591,751

Revenue:

788,495

644,653

523,512

235,719

152,539

108,370

All other [Member]

Revenue:

3,880

^[1]

Condensed Financial Statements, Captions [Line Items]

$ (715,011)

$ (618,481)

$ (688,153)

[1]	(1) "All other" revenue relates to royalty income that is not allocated to MP or IDP.

Operating Segment and Geographical Information (Details 1) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Segment Reporting Information [Line Items]
Document Fiscal Year Focus									2018
Reconciliation of "All other" category:
Stock-based compensation expense									$ (68,158)	$ (88,845)	$ (139,516)
Amortization of intangible assets									(539,790)	(494,752)	(494,589)
Start-up costs	$ (5,100)	$ (5,400)	$ (7,200)	$ (6,600)	$ (3,400)	$ (2,200)	$ (2,000)	$ (2,100)
Income from operations									70,282	88,059	11,968
All other [Member]
Reconciliation of "All other" category:
Stock-based compensation expense									(68,158)	(88,845)	(139,516)
Amortization of intangible assets									(539,362)	(494,387)	(494,589)
Acquisition and integration related costs									(10,561)	(25,391)	(26,503)
Restructuring and disposal costs									(21,406)	(1,696)	(4,235)
Start-up costs									(24,271)	(9,694)	(14,110)
Other expenses (including (gain) loss on assets and other miscellaneous corporate overhead)									(51,253)	1,532	(9,200)
Income from operations									$ (715,011)	$ (618,481)	$ (688,153)

Operating Segment and Geographical Information (Details 2) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Revenues from External Customers [Line Items]
Document Fiscal Year Focus									2018
Revenue	$ 665,383	$ 845,739	$ 821,583	$ 640,831	$ 642,992	$ 826,347	$ 864,698	$ 698,537	$ 2,973,536	$ 3,032,574	$ 2,610,726
Geographic Concentration Risk [Member] \| Sales [Member] \| United States
Revenues from External Customers [Line Items]
Revenue									$ 524,472	$ 467,031	$ 306,328
Percentage									18.00%	15.00%	12.00%
Geographic Concentration Risk [Member] \| Sales [Member] \| International
Revenues from External Customers [Line Items]
Revenue									$ 2,449,064	$ 2,565,543	$ 2,304,398
Geographic Concentration Risk [Member] \| Sales [Member] \| Asia
Revenues from External Customers [Line Items]
Percentage									78.00%	81.00%	83.00%
Geographic Concentration Risk [Member] \| Sales [Member] \| Europe
Revenues from External Customers [Line Items]
Percentage									3.00%	3.00%	4.00%
Geographic Concentration Risk [Member] \| Sales [Member] \| Other
Revenues from External Customers [Line Items]
Percentage									1.00%	1.00%	1.00%

Operating Segment and Geographical Information (Details 3) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Long-Lived Assets [Line Items]
Document Period End Date	Mar. 31, 2018
Long-lived tangible assets	$ 1,374,112	$ 1,391,932
CHINA
Long-Lived Assets [Line Items]
Long-lived tangible assets	217,205	244,728	$ 183,836
Geographic Concentration Risk [Member] \| Property, Plant and Equipment \| United States
Long-Lived Assets [Line Items]
Long-lived tangible assets	1,089,157	1,082,754	816,882
Geographic Concentration Risk [Member] \| Property, Plant and Equipment \| Other Countries
Long-Lived Assets [Line Items]
Long-lived tangible assets	$ 67,750	$ 64,450	$ 46,170

Operating Segment and Geographical Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Segment Reporting Information [Line Items]
Asset Impairment Charges									$ 46,300
Document Period End Date									Mar. 31, 2018
Document Fiscal Year Focus									2018
Operating Segment and Geographic Information (Textual)
Revenue	$ 665,383	$ 845,739	$ 821,583	$ 640,831	$ 642,992	$ 826,347	$ 864,698	$ 698,537	$ 2,973,536	$ 3,032,574	$ 2,610,726
Long-lived tangible assets	1,374,112				1,391,932				1,374,112	1,391,932
China [Member]
Operating Segment and Geographic Information (Textual)
Long-lived tangible assets	$ 217,205				$ 244,728				$ 217,205	$ 244,728	$ 183,836
Geographic Concentration Risk [Member] \| Sales [Member] \| China [Member]
Operating Segment and Geographic Information (Textual)
Percentage									52.00%	62.00%	61.00%
Revenue									$ 1,539,700	$ 1,866,000	$ 1,601,000
Geographic Concentration Risk [Member] \| Sales [Member] \| Taiwan [Member]
Operating Segment and Geographic Information (Textual)
Percentage									19.00%	13.00%	14.00%
Revenue									$ 564,800	$ 398,400	$ 365,100

Consolidating Financial Information Condensed Consolidating Balance Sheet (Details) - USD ($)
$ in Thousands

12 Months Ended

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Mar. 28, 2015

Document Period End Date

Mar. 31, 2018

$ 926,037

$ 545,463

345,957

357,948

472,292

430,454

23,909

36,229

Other receivables

44,795

65,247

Other current assets

30,815

26,264

1,843,805

1,461,605

1,374,112

1,391,932

2,173,889

^[1]

2,173,914

$ 2,135,697

^[1]

860,336

1,400,563

Long-term intercompany accounts and notes receivable

63,765

35,494

Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures

65,612

58,815

6,381,519

6,522,323

213,193

216,246

167,182

170,584

60,904

31,998

441,279

418,828

983,290

989,154

63,084

131,511

118,302

86,108

1,605,955

1,625,601

4,775,564

4,896,722

$ 4,999,672

$ 6,173,160

Condensed Financial Statements, Captions [Line Items]

6,381,519

6,522,323

Parent Company [Member]

Long-term intercompany accounts and notes receivable

Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures

6,198,885

6,142,568

72,122

84,153

6,271,007

6,226,721

23,102

23,150

23,102

23,150

983,290

989,154

489,051

317,695

1,495,443

1,329,999

4,775,564

4,896,722

Guarantor Subsidiaries [Member]

6,271,007

6,226,721

Condensed Financial Statements, Captions [Line Items]

629,314

226,186

76,863

57,874

272,409

392,075

154,651

131,225

17,530

29,032

Other receivables

5,959

7,239

Other current assets

29,627

25,534

1,186,353

869,165

1,085,255

1,078,761

1,121,941

395,317

599,618

Long-term intercompany accounts and notes receivable

1,847

25,971

543,127

447,613

Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures

2,388,222

2,596,172

31,011

33,249

6,753,073

6,772,490

78,278

111,799

53,363

36,603

101,286

111,700

3,882

236,809

260,157

83,449

171,284

116,494

138,398

62,417

35,014

499,169

604,853

6,253,904

6,167,637

Non-Guarantor Subsidiaries [Member]

6,753,073

6,772,490

Condensed Financial Statements, Captions [Line Items]

296,723

319,277

269,094

300,074

53,363

36,603

339,434

322,559

6,379

7,197

Other receivables

38,836

58,008

Other current assets

1,188

730

1,005,017

1,044,448

289,146

314,910

1,051,948

1,051,973

465,019

800,945

Long-term intercompany accounts and notes receivable

61,918

9,523

116,494

138,398

Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures

32,516

24,746

3,022,058

3,384,943

134,915

104,447

272,409

392,075

43,163

35,734

57,022

31,943

507,509

564,199

16,366

43,560

54,076

129,918

55,885

51,094

633,836

788,771

2,388,222

2,596,172

Eliminations and Reclassifications

3,022,058

3,384,943

Condensed Financial Statements, Captions [Line Items]

(325,772)

(428,678)

(21,793)

(23,330)

(347,565)

(452,008)

(289)

(1,739)

Long-term intercompany accounts and notes receivable

(659,621)

(586,011)

Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures

(8,587,107)

(8,738,740)

(70,037)

(83,333)

(9,664,619)

(9,861,831)

(325,772)

(428,678)

(369)

(326,141)

(428,678)

(36,731)

(83,333)

(659,621)

(586,011)

(1,022,493)

(1,098,022)

(8,642,126)

(8,763,809)

$ (9,664,619)

$ (9,861,831)

[1]	The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Consolidating Financial Information Condensed Consolidating Statements of Comprehensive Income (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 30, 2017

Sep. 30, 2017

Jul. 01, 2017

Apr. 01, 2017

Dec. 31, 2016

Oct. 01, 2016

Jul. 02, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

Document Period End Date

Mar. 31, 2018

$ 665,383

$ 845,739

$ 821,583

$ 640,831

$ 642,992

$ 826,347

$ 864,698

$ 698,537

$ 2,973,536

$ 3,032,574

$ 2,610,726

1,826,570

1,897,062

1,561,173

252,640

336,927

321,022

236,377

231,596

310,642

316,799

276,475

1,146,966

1,135,512

1,049,553

445,103

470,836

448,763

527,751

545,588

534,099

103,830

31,029

54,723

1,076,684

1,047,453

1,037,585

70,282

88,059

11,968

(59,548)

(58,879)

(23,316)

7,017

1,212

2,068

(606)

(3,087)

6,418

17,145

27,305

(2,862)

31,200

(98,500)

93,200

(123,200)

(57,433)

(43,863)

(25,983)

$ (12,501)

^{[1],[2],[3],[4]}

$ (33,082)

^{[2],[3],[4],[5]}

$ 35,919

^[2],[3],[4]

$ (30,624)

^[2],[3],[4]

$ 55,908

^{[2],[3],[4],[6]}

$ (78,638)

^{[2],[3],[4],[7]}

$ 11,847

^[2],[3],[4]

$ (5,675)

^[2],[3],[4]

(40,288)

(16,558)

(28,845)

(38,734)

(17,731)

(31,854)

Parent Company [Member]

27,688

35,379

67,158

39,882

53,465

72,358

588

68,158

88,844

139,516

(68,158)

(88,844)

(139,516)

(58,133)

(57,344)

(21,895)

(929)

(127,220)

(146,188)

(161,411)

(26)

46,003

44,014

86,958

83,627

88,552

(40,288)

(16,558)

(28,845)

Guarantor Subsidiaries [Member]

(38,734)

(17,731)

(31,854)

1,137,783

1,316,576

2,212,062

828,496

979,190

1,778,336

309,287

337,386

433,726

54,663

40,918

106,560

248,601

253,531

151,814

89,454

16,065

50,928

392,718

310,514

309,302

(83,431)

26,872

124,424

(2,340)

(2,619)

(2,419)

2,696

4,457

2,650

973

426

5,467

(82,102)

29,136

130,122

(15,586)

(63,893)

(49,751)

183,319

68,718

13,619

85,631

33,961

93,990

Non-Guarantor Subsidiaries [Member]

87,654

34,014

89,738

2,689,676

2,918,865

2,762,150

1,723,829

2,023,715

2,060,702

965,847

895,150

701,448

382,109

416,869

304,219

349,739

370,812

360,593

13,463

8,409

2,447

745,311

796,090

667,259

220,536

99,060

34,189

(1,505)

(3,129)

(3,029)

6,751

759

3,003

(642)

(1,999)

(298)

225,140

94,691

33,865

(41,821)

(25,973)

(20,246)

183,319

68,718

13,619

Eliminations and Reclassifications

186,172

67,492

14,862

(853,923)

(1,202,867)

(2,363,486)

(725,755)

(1,105,843)

(2,277,865)

(128,168)

(97,024)

(85,621)

(19,357)

(22,330)

(29,174)

(110,471)

(132,220)

(50,666)

325

6,555

1,348

(129,503)

(147,995)

(78,492)

1,335

50,971

(7,129)

2,430

4,213

4,027

(2,430)

(4,004)

(3,585)

(8)

(1,514)

1,249

1,327

49,666

(5,438)

(270,277)

(152,345)

(102,171)

(268,950)

(102,679)

(107,609)

Integration related costs

$ (273,826)

$ (101,506)

$ (104,600)

[1]	Income tax benefit of $31.2 million for the fourth quarter of fiscal 2018 relates primarily to a discrete provisional benefit for adjustments to a third quarter fiscal 2018 provisional estimate of the impact of the Tax Act (Note 12).
[2]	The Company recorded integration related expenses of $1.5 million, $1.8 million, $1.7 million and $1.2 million in the first, second, third and fourth quarters of fiscal 2018, respectively, associated with the Business Combination. The Company recorded integration related expenses of $5.3 million, $5.0 million, $3.9 million and $2.7 million in the first, second, third and fourth quarters of fiscal 2017, respectively, associated with the Business Combination (Note 6).
[3]	The Company recorded restructuring expenses of $0.5 million, $10.5 million, $15.2 million and $41.5 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded restructuring expenses of $0.8 million, $0.5 million, $0.4 million and $0.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively (Note 11).
[4]	The Company recorded start-up expenses of $6.6 million, $7.2 million, $5.4 million and $5.1 million in the first, second, third and fourth quarters of fiscal 2018, respectively. The Company recorded start-up expenses of $2.1 million, $2.0 million, $2.2 million and $3.4 million in the first, second, third and fourth quarters of fiscal 2017, respectively.
[5]	Income tax expense of $98.5 million for the third quarter of fiscal 2018 relates primarily to a discrete provisional tax expense related to the enactment of the Tax Act (Note 12).
[6]	Income tax benefit of $93.2 million for the fourth quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).
[7]	Income tax expense of $123.2 million for the third quarter of fiscal 2017 relates primarily to the timing of income and loss recognition in the various tax jurisdictions for the quarter (Note 12).

Consolidating Financial Information Condensed Consolidating Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2018	Apr. 01, 2017	Apr. 02, 2016
Net Cash Provided by (Used in) Operating Activities	$ 852,520	$ 776,820	$ 687,927
Purchase of available-for-sale securities	0	(469)	(340,527)
Proceeds from maturities of available-for-sale securities	0	186,793	390,009
Purchase of business, net of cash acquired (Note 6)	0	(117,994)	0
Purchase of property and equipment	(269,835)	(552,702)	(315,624)
Other investing	(7,574)	(5,976)	(12,572)
Net transactions with related parties, investing	0	0
Net cash used in investing activities	(277,409)	(490,348)	(278,714)
Proceeds from debt issuances	100,000	0	1,175,000
Repayments of Long-term Debt	(107,729)	0	(175,000)
Excess tax benefit from exercises of stock options	0	65	935
Debt issuance costs	(1,916)	0	(13,588)
Proceeds from the issuance of common stock	57,412	59,148	51,875
Repurchase of common stock, including transaction costs	(219,907)	(209,357)	(1,300,009)
Tax withholding paid on behalf of employees for restricted stock units	(24,708)	(15,516)	(22,168)
Other financing	0	10	(29)
Net transactions with related parties	0	0	0
Net cash used in financing activities	(196,848)	(165,650)	(282,984)
Effect of Exchange Rate on Cash and Cash Equivalents	2,360	(1,105)	(294)
Net increase in cash, cash equivalents and restricted cash	380,623	119,717	125,935
Cash, cash equivalents and restricted cash at the beginning of the period	545,779	426,062	300,127
Cash, cash equivalents and restricted cash at the end of the period	926,402	545,779	426,062
Parent Company [Member]
Net Cash Provided by (Used in) Operating Activities	196,848	165,660	282,955
Purchase of available-for-sale securities		0	0
Proceeds from maturities of available-for-sale securities		0	0
Purchase of business, net of cash acquired (Note 6)		0
Purchase of property and equipment	0	0	0
Other investing	0	0	0
Net transactions with related parties, investing	0	0
Net cash used in investing activities	0	0	0
Proceeds from debt issuances	100,000		1,175,000
Repayments of Long-term Debt	(107,729)		(175,000)
Excess tax benefit from exercises of stock options		65	935
Debt issuance costs	(1,916)		(13,588)
Proceeds from the issuance of common stock	57,412	59,148	51,875
Repurchase of common stock, including transaction costs	(219,907)	(209,357)	(1,300,009)
Tax withholding paid on behalf of employees for restricted stock units	(24,708)	(15,516)	(22,168)
Other financing		0	0
Net transactions with related parties	0	0	0
Net cash used in financing activities	(196,848)	(165,660)	(282,955)
Effect of Exchange Rate on Cash and Cash Equivalents	0	0	0
Net increase in cash, cash equivalents and restricted cash	0	0	0
Cash, cash equivalents and restricted cash at the beginning of the period	0	0	0
Cash, cash equivalents and restricted cash at the end of the period	0	0	0
Guarantor Subsidiaries [Member]
Net Cash Provided by (Used in) Operating Activities	165,883	175,988	273,171
Purchase of available-for-sale securities		(469)	(340,527)
Proceeds from maturities of available-for-sale securities		186,793	390,009
Purchase of business, net of cash acquired (Note 6)		0
Purchase of property and equipment	(226,860)	(424,175)	(244,817)
Other investing	22,800	3,924	(12,830)
Net transactions with related parties, investing	439,925	61,891
Net cash used in investing activities	235,865	(172,036)	(208,165)
Proceeds from debt issuances	0		0
Repayments of Long-term Debt	0
Excess tax benefit from exercises of stock options		0	0
Debt issuance costs	0		0
Proceeds from the issuance of common stock	0	0	0
Repurchase of common stock, including transaction costs	0	0	0
Tax withholding paid on behalf of employees for restricted stock units	0	0	0
Other financing		14	57
Net transactions with related parties	1,380	1,587	1,192
Net cash used in financing activities	1,380	1,601	1,249
Effect of Exchange Rate on Cash and Cash Equivalents	0	0	0
Net increase in cash, cash equivalents and restricted cash	403,128	5,553	66,255
Cash, cash equivalents and restricted cash at the beginning of the period	226,186	220,633	154,378
Cash, cash equivalents and restricted cash at the end of the period	629,314	226,186	220,633
Non-Guarantor Subsidiaries [Member]
Net Cash Provided by (Used in) Operating Activities	489,789	435,172	131,801
Purchase of available-for-sale securities		0
Proceeds from maturities of available-for-sale securities		0
Purchase of business, net of cash acquired (Note 6)		(117,994)
Purchase of property and equipment	(42,975)	(128,527)	(70,807)
Other investing	(30,374)	(9,900)	258
Net transactions with related parties, investing	(24,100)	0
Net cash used in investing activities	(97,449)	(256,421)	(70,549)
Proceeds from debt issuances	0		0
Repayments of Long-term Debt	0		0
Excess tax benefit from exercises of stock options		0	0
Debt issuance costs	0		0
Proceeds from the issuance of common stock	0	0	0
Repurchase of common stock, including transaction costs	0	0	0
Tax withholding paid on behalf of employees for restricted stock units	0	0	0
Other financing		(4)	(86)
Net transactions with related parties	(417,205)	(63,478)	(1,192)
Net cash used in financing activities	(417,205)	(63,482)	(1,278)
Effect of Exchange Rate on Cash and Cash Equivalents	2,360	(1,105)	(294)
Net increase in cash, cash equivalents and restricted cash	(22,505)	114,164	59,680
Cash, cash equivalents and restricted cash at the beginning of the period	319,593	205,429	145,749
Cash, cash equivalents and restricted cash at the end of the period	297,088	319,593	205,429
Eliminations and Reclassifications
Net Cash Provided by (Used in) Operating Activities	0		0
Purchase of available-for-sale securities		0	0
Proceeds from maturities of available-for-sale securities		0	0
Purchase of business, net of cash acquired (Note 6)		0
Purchase of property and equipment	0	0	0
Other investing	0	0	0
Net transactions with related parties, investing	(415,825)	(61,891)
Net cash used in investing activities	(415,825)	(61,891)	0
Proceeds from debt issuances	0		0
Repayments of Long-term Debt	0		0
Excess tax benefit from exercises of stock options		0	0
Debt issuance costs	0		0
Proceeds from the issuance of common stock	0	0	0
Repurchase of common stock, including transaction costs	0	0	0
Tax withholding paid on behalf of employees for restricted stock units	0	0	0
Other financing		0	0
Net transactions with related parties	415,825	61,891	0
Net cash used in financing activities	415,825	61,891	0
Effect of Exchange Rate on Cash and Cash Equivalents	0	0	0
Net increase in cash, cash equivalents and restricted cash	0	0	0
Cash, cash equivalents and restricted cash at the beginning of the period	0	0	0
Cash, cash equivalents and restricted cash at the end of the period	$ 0	$ 0	$ 0

Quarterly Financial Summary (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2018

Dec. 30, 2017

Sep. 30, 2017

Jul. 01, 2017

Apr. 01, 2017

Dec. 31, 2016

Oct. 01, 2016

Jul. 02, 2016

Mar. 31, 2018

Apr. 01, 2017

Apr. 02, 2016

$ 1,200

$ 1,700

$ 1,800

$ 1,500

$ 2,700

$ 3,900

$ 5,000

$ 5,300

$ 6,200

$ 16,900

$ 26,500

Restructuring costs

41,500

15,200

10,500

500

400

500

800

67,700

Start-up costs

5,100

5,400

7,200

6,600

3,400

2,200

2,000

2,100

Income tax expense (benefit)

(31,200)

98,500

(93,200)

123,200

57,433

43,863

25,983

Quarterly Financial Summary (Unaudited)

665,383

845,739

821,583

640,831

642,992

826,347

864,698

698,537

2,973,536

3,032,574

2,610,726

Gross profit

252,640

336,927

321,022

236,377

231,596

310,642

316,799

276,475

1,146,966

1,135,512

1,049,553